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ABSTRACT 
Congenital heart disease (CHD) is the most common and deadly congenital anomaly, 
accounting for up to 7.5% of all infant deaths. Survival in children born with CHD has 
improved dramatically over the past several decades, this positive trend being counterbalanced 
by the fact that more patients develop heart failure. Seminal data indicate an alteration of the 
extracellular matrix occurs with time in these hearts due to diffuse and abundant interstitial 
fibrosis. This results in an escalation in stiffness of the local microenvironment. However, the 
influence of matrix stiffness in regulating the function of resident human stromal cells has not 
been reported. The objective of this study was to determine the impact of stiffness on the 
antigenic and functional profile of cardiac pericytes (CPs) isolated from patients with CHD. 
To this aim, firstly, gelatin nanofibrous scaffolds with varying degree of stiffness using an in-
situ electrospinning technique were produced. The Young’s Modulus were assessed and then 
performed a comprehensive physicochemical characterisation of the scaffolds employing 
scanning electron microscopy, atomic force microscopy, and Fourier-transform infrared 
spectroscopy. This study next evaluated the changes induced by different scaffold stiffness on 
CPs morphology, antigenic profile, viability, proliferation, angiocrine activity, and induced 
differentiation. Results indicate that soft matrixes (Young’s modulus  0.3 MPa) with larger 
fiber diameter (~400 nm), increase CPs adhesion, proliferation, secretion of Angiopoietin 2, 
Vascular Endothelial Growth Factor A (VEGF A) and F-actin stress fiber formation upon 
induced differentiation into vascular smooth muscle cells. There was no effect of stiffness on 
CPs antigenic profile or viability. To the best of my knowledge, these data indicate for the first 
time that human CPs can be functionally influenced by subtle changes in matrix stiffness. The 
study elucidates the importance of mechanical/morphological cues in modulating stromal cell 
behaviour and the feasibility of exploiting matrix stiffness to increase key features instrumental 
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1.   INTRODUCTION 
 
 
In this chapter, the factors concerned with successful cardiovascular regeneration and 
tissue engineering with a particular focus on congenital heart defects (CHDs) and the 
current situation of research into correcting CHDs and the future strategies for treating 
CHDs will be introduced. The stem cell therapy and cardiac pericytes (CPs) as potential 
stem cells for cardiovascular regeneration and tissue engineering will also be discussed. 
The biomimetic ECM and the factors affecting the stem cell fate, notably the matrix 
stiffness/elasticity of the material and the evaluation of nanofiber matrix stiffness will be 
reviewed in detail. The electrospinning technique, gelatin and the cross-linking method 
of gelatin will also be appraised in detail and areas that require further research will be 
highlighted.  
The native extracellular matrix (ECM) can be regarded as a dynamic and hierarchically 
organised nanomaterial that not only provides mechanical support for embedded cells, but also 
interacts with the cells and regulates cellular functions such as adhesion, migration, 
proliferation, and differentiation (1). A typical ECM is composed of structural protein 
nanofibers such as collagen, with dimensions ranging from tens to hundreds of nanometers in 
the three-dimensional form (1-3). It is expected that such 3D biomimetic ECM will play a 
similar role in supporting cell growth in vitro as native ECM does in vivo. Creation of such a 
niche is thus imperative to basic stem cell biological studies and tissue engineering applications 
(4, 5).  
 
Stem cell-based therapies are gaining widespread attention in the field of tissue engineering 
and regenerative medicine because of their self-renewal capacity and pluripotency (5). In in 
vivo conditions, stem cells are surrounded by a specialised microenvironment called “stem cell 
 2 
niches” consisting of soluble and surface-bound signalling factors, cell-cell contacts, stem cell 
niche support cells, ECM, and local mechanical microenvironment (5, 6). The stem cell fate is 
affected by all these microenvironmental factors and how these biophysical signals are filtered 
and taken up by the stem cells to regulate tissue regeneration based on physiological demand 
is still incompletely understood (4, 5). Moreover, it is hard to mimic the same 
microenvironmental conditions in vitro because of its complex nature. So, the critical aspect of 
enabling stem-cell based therapies is the ability to manipulate the interactions with the local 
microenvironment (5, 7). 
 
Currently, most studies of cell culture system are focused on chemical cues, i.e. cell-binding 
proteins and peptides, or topographical cues, i.e. nanofibrous form (8-10). There has been 
increasing evidence that mechanical stiffness is also a sufficient cue to modulate cellular 
behaviours of stem cells, particularly their fate (self-renewal and differentiation). It is known 
that native ECM consisting of collagen or fibrin nanofibers often have a much higher local 
stiffness (elastic modulus of ~MPa at the individual-fibre level) than the bulk ECM (elastic 
modulus of ~kPa). Therefore, the mechanical stiffness of ECM is not just dependent on its 
material property of individual fibre but also on its 3D structure (11-13). Even though stem 
cells have been widely used for many clinical applications, our knowledge on how they are 
engaged in the differentiation process via cell-scaffold interaction is somewhat limited. Hence, 
a thorough understanding of how the mechanical properties of scaffolds influence these stem 
cells is of fundamental importance to functional tissue engineering and regenerative medicine 
applications (8).  
 
Electrospinning is the most common method used for the fabrication of nanofibers utilizing 
both natural and synthetic polymers. The polymer selected in this work is gelatin as gelatin is 
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a natural polymer, and hydrolysed form of collagen which is the most common protein in the 
animal kingdom. However, the electrospinnability of gelatin is poor compared to synthetic 
polymers with defined molecular weight and distribution, such as Polycaprolactone (PCL), 
Polylactic acid (PLA) and Polylactic-co-glycolic acid (PLGA) as electrospinnability is strongly 
dependent on polymer chain confirmations and entanglements. Gelatin is polyelectrolytic in 
nature and possesses a 3-D macromolecular cross-linked network because of the strong 
hydrogen bonds formed at room temperature, which in turn reduces the mobility of polymer 
chains (14). Hence, for the successful electrospinning of gelatin, high-polarity solvents such as 
2,2,2, -trifluoroethanol (TFE) and hexafluoroisopropanol (HFIP) are commonly used and are 
cytotoxic and expensive. This work exploits an alternative biocompatible and cheap water 
solvent system to obtain gelatin nanofibers using an in situ electrospinning method. Despite 
other conventional cross-linking methods, which cross-links by diffusion, in situ 
electrospinning technique with a double-barrel syringe benefits homogeneous mixing of the 
polymer solution with the cross-linker, and hence the formation of internally cross-linked 
uniform gelatin nanofibrous scaffolds. Additionally, this technique will also allow the fine-
tuning of the requisite amount of cross-linking agent and reduces the unwanted deposition of 
cross-linker on the surface of the material.  
 
Therefore, in this work, electrospun gelatin nanofibrous scaffolds with different crosslinking 
densities were fabricated to understand the effect of matrix stiffness on cardiac stem cell fate. 
Currently, a great deal of research is going on in examining various types of fibers and how 
they interact with stem cells to drive differentiation into specific cell lineages (8, 15, 16). An 
ideal ECM substrate should be biocompatible, highly porous, biodegradable and mechanically 
durable depending upon the application (17, 18). Nanofibrous scaffolds can be fabricated with 
tunable porosity and mechanical strength, and its three-dimensional (3D) architecture can 
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enhance cell adhesion, alter focal-adhesion signalling cascades, and thereby the stem cell fate 
(19, 20). Similarly, the high surface to volume ratio of nanofibrous scaffolds can aid better cell 
adhesion, proliferation and differentiation (21). Hence, the best way to mimic the ECM is to 
create a nanofibrous matrix to achieve specific stem cell lineages. 
 
The stem cells under investigation in this study are cardiac pericytes (CPs). They are CD34 
positive cells, negative for the endothelial markers CD31 and CD146. They reside in the heart 
as an interface between the coronary vasculature and cardiomyocyte compartment and play an 
essential role in maintaining cardiac homeostasis and repair. The previous studies from our 
group have revealed the possibility of immunosorting and expanding CPs from small biopsies 
of the human heart (22). There are also reports showing that pericytes can be effectively used 
for the repair of infarcted heart, myocardial ischemia, cardiovascular repair, skeletal muscle 
tissue engineering, etc.(23-28). Hence CPs have potential applications in the cardiovascular 
regeneration, and it is crucial to understand how these cells behave to different mechanical cues 
to be used in a stem cell engineered graft for cardiovascular reconstruction. 
 
This study addresses the problem of Congenital Heart Defects (CHDs), which affects 9 in every 
1000 babies born in the United Kingdom (UK) (20). For the reconstruction of complex cardiac 
defects, surgeons are using prosthetic materials such as xenografts, autografts, allografts and 
synthetic Gore-tex (29). For example, it has been reported that decellularized porcine small 
intestinal submucosa extracellular matrix (SIS-ECM) can be used as a vascular graft for tissue 
regeneration in animal models and noncardiac human applications. However, these implants 
are often a failure in repairing an infant’s heart due to their lack of cardiomyocytes and 
remodelling capacity when it comes clinically (30). It is also associated with a higher risk of 
infections and thrombotic complications (29). Hence, stem cell engineered grafts or cell 
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therapy are gaining a wide range of attention in correcting the heart defects nowadays because 
they can grow as the child’s body grows and remodels physiologically (31). 
 
Changes in stiffness occur in the hearts and arterial vessels of patients with congenital heart 
disease (CHD), currently acknowledged as the most common congenital anomaly responsible 
for 7.5% of all infant deaths and for an increased heart failure morbidity and mortality (32). A 
previous study examining the effects of matrix stiffness on the behaviour of ovine and murine 
adult cardiac side population cells documented that rigid substrates caused a reduction in 
cardiomyogenic differentiation, accelerated cell ageing and stimulated the upregulation of 
extracellular matrix and adhesion proteins gene expression (33). Nonetheless, to the best of our 
knowledge, no study has assessed the effect of stiffness on the behaviour of stromal cells from 
the heart of patients with congenital cardiac defects. Investigating this matter could not only 
improve the current understanding of cell behaviour during maladaptive heart remodelling but 
also help to refine the biocompatibility of matrices for tissue engineering correction of cardiac 
defects.   
 
Therefore, in the present study, in situ electrospun gelatin nanofibrous scaffolds  (CLGS) with 
different crosslinking concentrations, prepared in a cheap and biocompatible water system 
were used as an in vitro platform to investigate the effect of matrix stiffness on CP antigenic 
profile, morphology, viability, proliferation, angiocrine activity and capacity to differentiate 






1.1.  Cardiovascular Regeneration and Tissue Engineering 
 
It is considered that heart disease remains the number one cause of mortality in both developed 
and developing countries. This can be due to many pathophysiological conditions of the heart 
such as the myocardial infarction, atherosclerosis, diabetic and ischemic diseases and loss of 
cardiomyocytes (CMs) due to ageing. All these circumstances can lead to fatal conditions from 
cardiac arrhythmias to heart failure (34). 
 
Tissue engineering has been considered as a prospective bioengineering technology for treating 
cardiovascular diseases with the objective of creating biomimetic 3D synthetic or natural 
substitutes made of polymers usually known as scaffolds. Mostly these scaffolds were used 
along with autologous stem cells and differentiated cells, to permit individual patients’ therapy 
with physiological remodelling and tissue regeneration (29, 35, 36). The scaffolds act as a 
matrix and support cell adhesion, proliferation, differentiation and finally new tissue formation 
in the in vivo. 
 
The cardiovascular disease under consideration of this study was congenital heart defects 
(CHDs), which is the most common and deadly congenital anomaly, accounting for up to 7.5% 
of all infant deaths. Children born with CHD are surviving, and this rate has improved 
dramatically over the past several decades, but this positive trend being counterbalanced by the 






1.1.1.    Congenital Heart Defects (CHDs) 
 
CHDs are becoming a leading cause of death among infants in developed countries. It has been 
reported that every year, around 4600 babies are born with CHD in the United Kingdom alone 
(21). Despite the advances in foetal care, surgical and medical technologies with CHDs, the 
mortality and morbidity rates associated with CHDs are still a cause of concern. According to 
the researchers, 80% of the patients born with CHDs are expected to reach their adulthood and 
later develop heart dysfunction and other neurological and respiratory problems. Hence, there 
is a necessity to extend the clinical needs of CHDs not only to the young patients but also to 
adulthood (37). 
 
Palliative surgery for CHDs has allowed patients to survive in most cases, with lethal heart 
abnormalities. However, these patients have to undergo repeated surgeries associated with an 
increased risk of surgical complications and considerable psycho-social stress for young 
patients and their families. Moreover, these surgical procedures often place a burden on the 
heart over time and cause heart failure due to the low inherent capacity of mammalian heart to 
form new cardiomyocytes.  
 
Depending on the severity of the defects, the CHDs are classified into different types. It varies 
from common congenital heart abnormalities such as valves or septal defects, alterations of 
pulmonary veins and arteries, to severe malfunctions such as the absence of one or more 
chambers or valves. This condition results in abnormal blood circulation, which eventually 
results in heart failure and death (29, 38, 39). Among these, septal defects are the most common 
CHDs in infants which are associated with holes between the two ventricles or atrium. This 
causes abnormal blood circulation due to the mixing of oxygenated and deoxygenated blood 
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between the two chambers of the heart. The complex CHDs include Tetralogy of Fallot (ToF) 
and Hypoplastic Left Heart Syndrome (HLHS) (or univentricular heart syndrome) (29, 35, 38). 
Tetralogy of Fallot (ToF) is a condition which occurs due to the combination of different heart 
abnormalities. They are narrowing of the pulmonary artery, the hole between two ventricles, 
the position of the aorta above the aperture of ventricular chambers and right ventricle 
hypertrophy (39, 40). HLHS is due to the hypoplastic conditions of both aorta and left ventricle.  
In this condition, blood from the systemic circulation and the lungs mixes before it is being 
pumped by the right ventricle. This causes increased pressure and workload on the right 
ventricle and finally, the failure of the right ventricle (41). The classifications of CHDs are 
shown in figure.1.1. 
 
 
                




1.1.2.   Current treatment for CHDs and their limitations  
 
The ideal treatment option for CHD patients is the corrective surgery, during which the holes 
in the heart are corrected with stitches or a patch, repairs or substitutes valves, broadens 
arteries, and alter the position of major blood vessels for active blood circulation (29). 
However, to correct complex structural defects, patients should undergo repeated open-heart 
surgeries, which are expensive and distressing to the patients (29, 38, 39). The deterioration of 
implanted grafts is another reason for these risky operations (42). On the other hand, heart 
transplantation is the only option for patients who are at the highest risk of death, which is very 
rare due to the lack of donors (43). 
 
Currently, for the reconstruction of complex cardiac defects, surgeons are using prosthetic 
materials such as xenografts, autografts, allografts and synthetic Gore-tex (29). For example, 
it has been reported that decellularized porcine small intestinal submucosa extracellular matrix 
(SIS-ECM) can be used as a vascular graft for tissue regeneration in animal models and 
noncardiac human applications. However, these implants are often a failure in repairing an 
infant’s heart due to their lack of cardiomyocytes and remodelling capacity when it comes 
clinically (40). It is also linked with a higher risk of infections and thrombotic complications 
(29). The advantages and disadvantages of using the current treatment modality are shown in 
table.1.1. Hence, stem cell therapy and stem cell engineered grafts is being investigated 





Table.1.1. Schematic representation of different grafts currently used for surgical correction of 
CHD in children and their advantages and limitations (29). 
 
Substitutes Advantages Disadvantages 
Autografts  Not immunogenic 
 No thromboembolism 
risk 
 Growth potential 
 Replacement surgeries 
required 
 
Allografts  Good hemodynamic 
profile 
 Non antigenic ECM is 
repopulated after 
implantation 
 Preservation of 
morphology 
 Lack of growth 
potential 




 Immunogenic response 
if decellularization is 
not complete 
Xenografts  Limitless supply 
 Adequate anatomic 
structure 
 
 Lack of growth 
potential 




 Risk of calcification 
 Immunogenic response 
 
Stem cell therapy offers enormous therapeutic potential and is currently used to treat many 
diseases and disorders, including neurological conditions, orthopaedics and traumatology and 
cardiovascular diseases. This treatment modality is based on the injection of stem cells directly 
to the site of damage, aimed at the restoration of the damaged tissue by the self-renewing 
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capacity of stem cells and thereby recovering the lost function. This approach has been trialed 
used in the treatment of cardiovascular diseases, particularly in adult patients with myocardial 
ischemia (45). Only recently, it has also been proposed for the correction of CHDs (31, 46). A 
recent pre-clinical study was also conducted in a piglet ToF model and disclosed the safety and 
feasibility of intramyocardial administration of human MesP1 (mesodermal posterior 1)- 
embryonic stem cell-derived cardiac progenitors. But, at 3 months follow-up, the animals that 
had received cell therapy showed some improvements in RV (right ventricle) remodelling, and 
there was no substantial progress in RV function compared to control animals (47). A clinical 
study was also performed recently by administrating autologous umbilical cord blood-derived 
stem cells in a 4-months-old baby during a second palliative surgery.  At 3 months of follow-
up, the patient exhibited positive results in the improvement of right ventricular ejection 
fraction (RVEF) from 30 to 50% (48). 
 
Tissue engineering is considered as one of the promising strategies for the regeneration of 
impaired tissues. Various synthetic biodegradable polymers such as polycaprolactone (PCL)  
polyglycolic acid (PGA) and poly-L-lactic acid (PLLA) have been commonly used in 
cardiovascular tissue regeneration. However, the mechanical properties, biodegradation rates 
and cytotoxicity of degradation products still remain as a factor of concern (49-51). In addition 
to these polymeric scaffolds, cell sheets engineering is another methodology used for tissue 
engineering and regenerative medicine applications. This technology makes use of confluent 
cell sheet constructs by harvesting the cells along with their deposited ECM. For this, the cells 
are grown on petridishes coated with temperature-responsive poly (N-isopropylacrylamide) 
(PIPAAm) and these cells form cell-cell junctions and ECM as they become confluent which 
favours the extraction of intact cell sheets. The cells are cultured at 37C and the hydrophobic 
nature of the plates help the cells to adhere and proliferate. When the temperature is lowered, 
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the polymer is hydrated and become hydrophilic. This reduces the interaction with the ECM 
and hence the cell sheets are harvested. Three-dimensional cell sheet constructs are also 
developed by layering the cell sheets and are currently used for myocardial tissue engineering 
(52-54).  
 
Even though there are not many clinical trials on treating CHDs with tissue engineered grafts, 
there are few pieces of evidence of positive outcomes involving the application of tissue 
engineered-grafts for correcting CHDs. Usually, the scaffolds were made with any of the 
above-mentioned polymers or combination of polymers and the most commonly used cell types 
were bone marrow-derived mononuclear cells (BMMNCs) or endothelial cells (ECs) because 
of the ease of harvesting from the bone marrow and peripheral veins (29). In 2001, cells were 
isolated from the peripheral vein of a 4-years-old girl affected with univentricular heart and 
pulmonary atresia and were seed on to a biodegradable graft made of PLLA/PCL which is 
reinforced with PGA. This trial was successful, and after 7 months of implantation, there was 
no evidence of occlusion and aneurysm. Two years later, the same group performed this trial 
in another 5-years-of-old child with the same scaffold incorporated with BMMNCs, and that 
was also successful with no stenosis (55). In 2010, Hibino et al. published a paper, and they 
performed a human trial for evaluating the remodelling potential of a tissue-engineered 
vascular graft. They isolated mononuclear cells from bone marrow (BMMNCs) from 25 
patients (17 out of 25 patients recruited were 7 years of old) and were seeded onto a 
biodegradable scaffold made of PLLA/PCL/PLGA and implanted as conduits in patients with 
single ventricle physiology. They found that there was no evidence of rupture, infection or 
calcification of the grafts, but graft stenosis was reported in a few patients (56). Despite these 
successful trials, the application of these tissue engineered grafts in treating CHDs still needs 
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to be investigated thoroughly, since it is entirely a new field of study which will be explored in 
the future. 
 
Thus, in cell therapy, the cells are isolated from different sources and are transplanted directly 
to the dysfunctional myocardial areas. This approach has been hampered due to the significant 
cell death followed by the cell transplantation clinically. There has been increasing evidence 
that the administrated cells may die soon after the implantation into the heart, and their 
therapeutic function is just to secrete the paracrine factors in the initial post-transplantation 
phase. So, this approach is not sufficient to correct complex CHDs as they require additional 
tissues in the form of grafts, valves and patches to recreate the fundamental biological 
structures (51), (29, 57). When the polymer scaffolds were used with BMMNCs or endothelial 
cells, their limitations were the inadequate supply of cell populations for tissue regeneration. 
Hence, stem cell therapy and tissue engineering are the two areas which hold together for the 
repair of complex heart defects (31). 
 
1.1.3. Future Strategies for treating CHDs 
 
As mentioned in the above section, it is imperative to have a matrix substrate that mimics the 
anatomy of heart tissue and suitable cell populations for the efficient creation of cell engineered 
scaffolds for correcting CHDs. The future strategies for correcting CHDs described by Avolio 
et al. in 2015 is displayed in figure.1.2. 
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Figure.1.2. Cartoon illustrating possible future strategies for treating CHDs (29). 
 
The advancements in the diagnostic screening allow the early detection of CHDs nowadays. 
Hence, if diagnosed prenatally, either the foetus cells can be harvested and induced pluripotent 
cells is generated, or during birth, the stem cells can be isolated from the umbilical cord and 
used for further treatments. On the other hand, if the diagnosis is made after birth, the cells can 
be isolated from the surgical leftovers of patients who undergo corrective surgeries. The 
isolated cells are then cultured on the scaffolds, and they are kept in the bioreactor, which 
provides all the essential nutrients for the cells to grow, proliferate and differentiate. The cells 
incorporated implants are then implanted to the defected part of the heart and can remodel the 
child’s heart physiologically and grow simultaneously with the child’s growth (29, 41). 
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 In this study, cardiac pericytes isolated from the heart biopsies obtained from young patients 
who undergo palliative surgery in the Bristol Royal Infirmary were used. The details of clinical 
characteristics and pathology of the tissue donors recruited for this study are mentioned in the 
Materials and Methods chapter. 
 
1.2.   The Extracellular Matrix (ECM) 
 
The ECM can be considered as a dynamic and physiologically active component of all living 
organisms. It provides structural and mechanical support to the cells embedded within a tissue 
as well as regulates the cell division, growth and development. In other words, ECM interacts 
with the cells and regulates cellular functions such as adhesion, migration, proliferation and 
differentiation.  
 
1.2.1.   Components of ECM 
 
The ECM is mainly composed of proteoglycans, water, minerals, and fibrous proteins. Among 
them, proteoglycans and fibrous proteins are the major components of ECM. Proteoglycans are 
composed of a protein core surrounded by long chains of starch-like molecules called 
glycosaminoglycans. They provide resistance to stretching forces while fibrous proteins 
provide resistance to compressive forces. The fibrous proteins in the ECM consist of collagen, 
elastin, fibronectin and laminin (1-3). The ECM and its components present in all living 
organisms are presented in figure.1.3. The plasma membrane and cell surface receptors called 




Figure.1.3. Representative image of ECM and its components (https://ib.bioninja.com.)  
 
1.2.2. Cardiac ECM 
 
 
In the heart, the ECM consists of all these components and provide a specialised 
microenvironment for the cells to survive and maintain a homeostasis. The ECM here acts as 
a structural and functional unit in maintaining the integrity of the organ by providing 
mechanical support for the cardiomyocytes, cardiac fibroblasts and endothelial cells and acts 
in response to the actomyosin contractions. Usually cardiomyocytes are differentiated and non-
proliferating cells which allows the heart to pump blood into the pulmonary and systemic 
circulations by generating electric impulses and thereby coordinating the contractile behaviour. 
The coronary vasculature act as a tissue compartment by providing oxygen and helps in the 
waste removal. The coronary vasculature consists of both arterial and venous tissue. Both the 
cardiomyocytes and coronary vasculature are embedded in an ECM which mainly consists of 
collagen, proteoglycans and glycoproteins. Among these cells, cardiac fibroblasts form the 
largest population on the ECM(58). The stiffness of the cardiac ECM varies according to 
different factors such as ageing, blood pressure and diseased conditions(59). It has been 
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reported that the increased deposition of collagen results in a condition called fibrosis and 
fibrotic hearts are stiffer compared to normal myocardium. The stiffness of normal 
myocardium reported is 18 to 60 kPa and 55 to 295 kPa in fibrotic myocardium(60). 
 
1.3.   Stem Cells 
 
Stem cells are the undifferentiated cells found in all multicellular living organisms. They can 
differentiate into specialized cells as well as they can divide itself to produce more stem cells 
(Figure.1.4). This ability of self-renewal makes the stem cells more attractive among the 
researchers to work on stem cell-based therapies. Stem cells can be divided into two main 
types. They are embryonic stem cells and adult stem cells. Embryonic stem cells can divide 
into any kinds of cells, while the adult stem cells can differentiate into specialized lineages (5). 
 
 
Figure.1.4. Diagrammatic representation of a stem cell replication and differentiation (61). 
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In this study, the stem cells under investigation are Cardiac Pericytes. Cardiac pericytes (CPs) 
are NG2 and PDGFRb expressing stromal cells that typically locate around capillaries and in 
close vicinity of coronary arterioles. They are CD34 positive cells, negative for the endothelial 
markers CD31 and CD146. They reside in the heart as an interface between the coronary 
vasculature and cardiomyocyte compartment and plays a vital role in maintaining cardiac 
homeostasis and repair.  Our group have previously reported the antigenic profile, 
expansion/differentiation capacity, paracrine activity, and pro-angiogenic potential of CPs 
from neonatal and adult human hearts (21). In addition, we succeeded in immunosorting and 
expanding CPs from small biopsies of neonatal human hearts and demonstrated their engrafting 
capacity in clinically certified prosthetic grafts (21). There are also preclinical reports showing 
that pericytes can be effectively used for treating many cardiovascular diseases. For example, 
saphenous vein-derived pericytes (SVPs) along with cardiac stem cells (CSCs) were isolated 
and administrated to the infarcted heart of Beige mice affected with SCID (severe combined 
immunodeficiency) and tested their synergistic effect in repairing the heart defect. The 
coculture system showed reduction in the size of infract and interstitial fibrosis. They also 
reported SVPs capability in inducing angiogenesis while CSCs promoted cardiomyocyte 
proliferation and endogenous stem cells recruitment and hence proved the ability of this 
coculture system in repairing infarcted heart (22). In another study, SVPs were isolated from 
patients undergoing coronary artery bypass surgery and tested their therapeutic potential such 
as antigenic profile, proangiogenic potential and expansion of SVPs in treating patients with 
ischemic hearts. They observed the integration of CPs into endothelial cells and enhanced 
angiogenesis. Moreover, when these cells were administrated to the ischemic limbs of mice, 
they exhibited improved blood flow and neovascularization (23). 
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Furthermore, pericytes are attaining greater focus in cardiac tissue engineering, and researchers 
have been doing many works to differentiate cardiac pericytes into cardiac specific lineages. 
Even though, there are reports showing that pericytes can be effectively used for the repair of 
infarcted heart, myocardial ischemia, cardiovascular repair, skeletal muscle tissue engineering 
etc. only minimal studies are associated with combining CPs on scaffolds and assessing their 
capability to regenerate heart tissues. Our group has also stated CPs potential to be used as a 
graft in treating CHDs. The isolated CPs were incorporated into a patch called CorMatrix 
which is a decellularized patch, and when they were kept in a bioreactor for up to 3 weeks, they 
showed engraftment and viability of cells suggesting their potential to be used as a graft in 
treating CHDs. Still there exist a lack of investigations regarding the capacity of CPs to grow, 
proliferate and differentiate on biodegradable scaffolds to be used as a promising substitute for 
the prosthetic grafts and valves. As mentioned in the above section, it is a new field of study, 
and hence, more researches are adequate in expanding the use of CPs in tissue engineering 
scaffolds. In this scenario, it is, therefore, crucial to understand how these cells behave in 
response to mechanical cues in their native environment as well as in artificially modified 
substrates for the optimal design and preparation of scaffolds. 
 
Usually, a cardiac stem cell differentiates into three types of cells known as cardiomyocytes, 
smooth muscle cells and endothelial cells. In the studies reported so far, only the differentiation 
of pericytes into smooth muscle cells have been reported (21-28, 62). For example, our group 
has also evaluated CPs potential to differentiate into any of these lineages by treating with 
corresponding differentiation inductive media containing specific growth factors. The results 
were only positive towards the differentiation of CPs into VSMCs while no differentiation has 
occurred towards the other two lineages (21). The cardiac stem cell differentiation and its 





Figure.1.5. Differentiation of cardiac stem cells into their specific lineages (63). 
 
 
1.4.    Factors Affecting Stem Cell Fate 
 
In in vivo stem cells are surrounded by a group of supporting cells, ECM and many soluble 
factors such as growth factors, cytokines, enzymes etc. A variety of chemical/biochemical cues, 
structural, mechanical and electrical cues are responsible for directing stem cells to the desired 
behaviour for the tissue engineering and regenerative purposes. Stem cells respond to these 
microenvironmental factors via numerous interactions with the adjacent cells and also with the 
tissue matrix, thereby the remodelling occurs consequently (64, 65). Regulation of stem cell 
fate is controlled by a wide range of microenvironmental factors such as matrix rigidity and 
topography, flow shear stress, strain forces, and other mechanical forces exerted by adjacent 
support cells. Figure 1.6. depicts the various biophysical factors/signals in the stem cell niche 







Figure. 1.6. Schematic representation of various biophysical signals/factors acting in the stem 
cell niche (5).  
Cells are exposed to mainly three types of forces such as extracellular, intercellular and 
intracellular forces. The extracellular forces are the forces exerted to the cells from the outer 
regions, and this includes the shear forces and tensile forces. Intercellular forces are the forces 
created when the cells contact each other. Finally, intracellular forces are cytoskeletal 
generated contractile forces due to actomyosin contraction, microtubule polymerisation and 
depolymerisation, osmotic forces etc. All these forces can create a mechanical stimulus in the 
stem cell niche, and the cells are subjected to adjust themselves to the external forces from the 
microenvironment by modulating their cytoskeletal contractility. The cytoskeletal contractility 
is dependent on the elastic modulus (stiffness) of the ECM. Thus, there occurs a tensional 
homeostasis or force balance between the external forces from the microenvironment to the 
cells and the force exerted by the cells (traction force) due to their endogenous cytoskeletal 
contractility. This plays an essential role in the basic cellular functions such as adhesion, 
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proliferation, differentiation, survival and apoptosis (5, 66, 67). Any variations in maintaining 
this tensional homeostasis can cause severe disease conditions such as arteriosclerosis, 
osteoarthritis, osteoporosis and cancer (5, 68-70). 
There has been increasing evidence that the stem cells can sense all these stimuli through cell 
surface receptors called integrins and convert them into intracellular biochemical and 
functional responses through a series of cell signalling pathways (Ras/MAPK, PI3k/Akt, 
RhoA/ROCK, Wnt/β-catenin, TGF-β) by a process known as mechanotransduction (5, 70, 71). 
Integrin provides a mechanical linkage between the ECM and the actin cytoskeleton. Any 
mechanical forces acting on the cells such as shear stress or strain can activate integrins which 
are bound to the focal adhesion points. This, in turn, results in the recruitment of signalling 
proteins to strengthen the focal adhesion sites and to transmit biochemical signals to the cells. 
These mechanotransduction pathways can activate actin-myosin cytoskeletal contractility with 
the help of integrin engagement. Figure.1.7. explains how such mechanotransduction results in 
the modulation of protein expression and cellular functions such as survival, proliferation and 
differentiation (5, 72). 
In a study by Chowdhury et al., reported that mESCs cultured on soft polyacrylamide gels 
(~500 Pa) could maintain their pluripotency for 15 passages without exogenous leukaemia 
inhibitory factor (LIF; a soluble factor critical for maintenance of pluripotency of mESCs). 
This demonstrated the mechanosensitivity of pluripotent ESCs to matrix mechanics and 
showed that they are sensitive to subtle changes in external mechanical forces (73). In another 
study, fluid shear stress-induced the differentiation of Flk-1-positive mouse ESCs into vascular 
endothelial cells in vitro than the mouse ESCs incubated in a static culture condition (74). 
These observations suggest that matrix mechanics is a crucial regulator in controlling the stem 
cell function and differentiation (75, 76). 
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Figure.1.7. Schematic representation of cell mechanical stimulation (5). 
 
1.4.1.   Matrix Stiffness 
Matrix stiffness is another crucial factor in determining stem cell self-renewal and commitment 
(11, 77-79). Stiffness of the ECM is usually represented as elastic modulus or Young’s 
modulus. As mentioned earlier, the cytoskeletal contractility is directly dependent on the ECM 
stiffness. This can activate various mechanotransduction pathways with the help of integrins 
and regulates the stem cell fate (5, 11, 72). There are studies regarding the effect of ECM 
stiffness in determining stem cell fate. For example, MSCs were grown on polyacrylamide gel 
having different matrix stiffness, and it was found that the cell properties were not similar in 
the substrates with less stiffness. The stiffer substrates induced stiffer cells and differentiated 
into MSCs specific lineages than in the soft substrates. Furthermore, soft substrates with 
mechanical properties similar to that of brain tissue were found to be neurogenic, intermediate 
stiffness substrates with mechanical properties similar to muscle tissues were myogenic, and 
relatively rigid substrates with mechanical properties similar to bone were found to be 
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osteogenic (77, 80). Matrix stiffness also has effects on cell adhesion, migration, proliferation 
and differentiation. For example, different gel matrices were prepared with varying cross-
linking degrees, and ligand densities and the cells were seeded to understand their adhesion on 
various substrates. It was found that most of the cells anchored firmly towards the stiffer 
substrates forming focal adhesion points and actin-myosin stress fibers (65, 77). Also, when 
MSCs were cultured on a rigid substrate differentiated into osteoblasts instead of adipocytes 
while on soft hydrogel substrates, they maintained self-renewal in vitro (65) (79, 81).  
Even though there are plenty of studies based on hydrogel systems for regulating stem cell fate, 
only a few studies have reported the effect of nanofibers and its mechanical stiffness that 
determines the stem cell fate. In 2012, Wingate et al. fabricated three-dimensional nanofiber 
matrixes with the variable elastic modulus (2-15kPa) by adjusting the photopolymerization 
time, and MSCs were seeded to see their differentiation into vascular endothelial cells and 
smooth muscle cells (82). Nam et al. fabricated a core-shell poly (ether sulfone)-poly(ε-
caprolactone) (PES-PCL) fibers of modulus 30.6 MPa, which is four times more than that of 
PCL alone. The embryonic mesenchymal progenitor cells behaviour was studied, and they 
found that the cells seeded on PES-PCL showed chondrogenesis, whereas the cells on PCL 
showed osteogenesis. Hence, by changing the nanofiber matrix modulus, the stem cell fate 
could be altered (8). This can be achieved in many ways such as introducing one more polymer 
and thereby creating a composite scaffold as done by Nam et al. or by changing some factors 
such as crosslinking density, functionalizing the nanofibers with nanoparticles etc. All these 
can have a significant influence in affecting the stem cell mechanisms (8, 83, 84).  
Matrix stiffness is usually evaluated by measuring Young’s modulus (YM). It is considered as 
the ability of the material to withstand the changes in length under tension or compression. YM 
is measured by the longitudinal stress divided by the strain. 
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                                                         E = (FL)/A × ∆L  
where F is the force applied, L is the initial length, A is the area, ∆L is the change in length, 
and E is Young's modulus in Pascals (Pa). 
The YM of electrospun nanofibers can be measured using a Nano tensile testing machine and 
Atomic Force Microscopy (AFM). Both single fibers and entire scaffolds are subjected to YM 
measurements depending on their applications. In tensile testing, MTS Nanomechanical 
Testing System or Instron machinery are usually used by researchers to measure the YM of 
nanofibers. In 2006, Chew et.al., performed YM analysis of single electrospun nanofibers 
composed of poly(ε-caprolactone) (PCL) and its copolymer, poly (caprolactone-co-ethyl 
ethylene phosphate) (PCLEEP) by electrospinning fibers on an aluminium frame, and a single 
fiber was then mounted on a cardboard mount to test the YM. The vertical sides of the 
cardboard mount were cut off before performing the tensile testing, and the fiber specimen was 
pulled at a constrain strain rate of 0.001s-1. The same method was followed by Naraghi et al. 
in 2007, but the nanofibers were collected on a Transmission Electron Microscopy (TEM) grid 
to perform the YM measurements (85). The YM was calculated from the obtained stress-strain 
curves (86). This method has certain limitations particularly the practical difficulty in the 
selection and mounting a single fiber for measurements, and a large number of measurements 
should be required to minimise the standard deviation as the fibers formed will be of different 
diameter. Hence, most of the studies are based on evaluating the YM of the whole nanofibrous 
scaffolds. Carrabba et al., investigated the YM of PCL nanofibrous scaffolds by holding the 
scaffolds between a custom-made gripping system and a strain rate of 0.01 min-1 were applied 
until failure (87). Studies which involve the application of cell/tissue engineering usually 
investigates the YM of the scaffolds in wet condition as well, since the scaffolds will be in the 
hydrated form when it is associated with the cells. Therefore, it is crucial to check the YM of 
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scaffolds in wet condition as different mechanical properties of the scaffolds will affect the 
cellular functions. For example, Dias et al., studied the YM of gelatin meshes, crosslinked with 
varying concentrations of 1,4-butanediol diglycidyl ether (BDDGE) both at the wet state and 
dry state and found a significant difference in the YM of the scaffolds when measured in both 
conditions (88). The picture of commercial nano tensile testing machine is shown in figure.1.8. 
 
Figure.1.8. Nano tensile testing machine (78). 
AFM utilizes different experimental methods commonly nanoindentation, tensile testing and 
three-point bend test to characterize the mechanical properties of nanofibers. Of all these 
characterisation techniques, nanoindentation is the most convenient method because of its easy 
sample preparation. To perform nanoindentation, a nanofiber is mounted on a hard and flat 
substrate, and an AFM tip is used to indent the nanofiber (89). AFM is operated in the force 
mode, in which the depth of the indent is always monitored relative to the indentation load and 
sample surface. The cantilever deflection is measured according to the vertical displacement 
of the cantilever tip as the loading and unloading occur through piezoelectric transducer 
expansion. Later, the force curves (force versus displacement) can be detected, and mechanical 
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properties such as YM and hardness can be derived (89). In 2005, Tan et al. reported the 
nanoindentation study of individual PCL nanofiber to measure the YM using AFM (90). The 
same group has also published the AFM based nanoindentation system for the tensile testing 
of nanofibers. This involves the use of a nanoindenter to pull a single fiber by clamping the 
nanofiber between the nanoindenter tip and the base, and the stepper motor of the AFM was 
used to stretch the fiber. In another approach by the same group, one end of the nanofiber was 
attached to (AFM) cantilever tip and the other end to, a movable optical microscope stage to 
perform the YM analysis. The nanofiber was stretched by moving the stage and the force was 
measured by the deflection of the cantilever. The YM of Polyethylene oxide (PEO) nanofibers 
(700 nm) measured by this method was found to be ~45 MPa (91). A schematic representation 





Figure.1.9. Schematic diagram of AFM based nanoindentation system for the tensile testing 
of nanofibers (91). 
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In three-point bend test, a nanofiber is suspended across an etched groove which is clamped by 
adhesives at both ends. An AFM tip is then used to apply a point load at the centre point of the 
suspended nanofiber (92). The YM of PLLA nanofibers with a diameter of less than 350 nm 
were found to be 1.00.2 GPa when measured by using this method (93). The schematic 




Figure.1.10. The schematic representation of AFM based three-point test using fibrin 
nanofiber (84). The dimensions of the substrates are also shown. 
 
There are many limitations of using AFM for the mechanical characterisation of nanofibers, 
particularly the selection and mounting of ultrafine nanofiber and the complexity of the 
technique. Thus, the sample preparation and manipulation of nanofibers for their mechanical 
characterisation still remains the most significant challenge to date. Although AFM 
nanoindentation is convenient compared to other techniques, the uncertainties in the 
nanoindenter tip shape, the surface roughness, the curvature, the relative configuration of tip-
fibre, and the adhesion force between the sample and the indenter makes this technique less 
reliable (85). In the AFM three-point bend test, the angles of inclination formed between the 
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deformed and original position of the nanofiber could give an axial fiber force value which 
may lower than the actual value and could lead to the misinterpretation of the data (85). 
 
In this work, matrix stiffness of the fabricated gelatin nanofibrous scaffolds was evaluated by 
measuring the YM using tensile testing machine both at the dry state and wet state. More details 
about the experiment are explained in the Materials and Methods section. An attempt to 
measure the YM of individual fibers using AFM is also carried out, and the details of this are 
described in the Future Work section.  
1.4.2.   Matrix topography 
For the regulation of stem cells, the matrix topography and its interactions with the cell is also 
a crucial factor. The recent advancements in the field of nanotechnology paved the way for the 
new possibilities to regulate the stem cell fate with specially designed nano topographies. It 
has been reported that the nanopatterned surfaces (ridges, steps, grooves, pillars and pits) can 
affect the cellular functions such as adhesion, morphology and gene expressions which in turn 
results in cell survival, apoptosis, proliferation and differentiation (81, 94). Macbeth et al., in 
2004, showed that the nano-topography caused significant changes in the focal adhesion and 
resulted in the cytoskeletal changes, which also altered the gene expression (81). Dalby et al. 
were the first one to report that based on the degree of variation in the nanoscale order in the 
nano pit array, the hMSCs are capable enough to produce bone mineral in vitro without any 
osteogenic supplements. Also, the cells cultured on ordered arrays of nano pits showed less 
osteoblastic differentiation (95).  
There are various methods for creating the nano-topography similar to the ECM. 
Nanolithography is one among them to control the shape, size, spacing, symmetry etc. of 
nanomaterials which are generally used for surface patterning. Phase separation , self-assembly 
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and electrospinning are other methods to synthesise nanofibers from synthetic as well as natural 
polymers (96). These techniques are reviewed in detail in the next section.  
It has been reported that the nanofiber alignment is also an essential factor in affecting the stem 
cell adhesion, proliferation and differentiation. For example, Schwann cells cultured on aligned 
fiber scaffolds were shown to have more focal adhesion and proliferation than on the random 
meshes. The cells cultured on the aligned fibers can grow in the direction of the alignment of 
fibers, and it is a significant aspect in the neural tissue engineering. Fiber alignment has also 
been investigated for the regeneration of the anterior cruciate ligament. Also, there are studies 
showing the change in diameter can create a significant difference in the spreading, adhesion, 
proliferation and differentiation of the stem cells. Hence the fiber morphology and alignment 
can directly affect the mechanical properties of the scaffolds, which in turn affects the cellular 
behaviours (97).  
Therefore, it is evident that ECM plays a vital role in regulating the stem cell fate, particularly 
in terms of its mechanical forces acting on it (stress and strain), stiffness and topography. The 
use of biomaterials is a useful tool to create a biomimetic ECM in the in vitro conditions.  
1.5.   Biomimetic ECM  
To better mimic ECM, polymers have been widely used in the field of tissue engineering and 
regenerative medicine. Both synthetic and natural polymers are widely used to create ECM in 
the form of hydrogels, nanofilms, nanofibers etc. (96, 98-100). For example, natural polymers 
like hyaluronic acid, alginate, chitosan, gelatin, silk etc. have been widely used both 
individually and as composites using different fabrication process to study the stem cells (101-
106). Some of the synthetic polymers using in this field are Poly (L-lactic acid) (PLLA), Poly 
(lactic-glycolic acid) (PLGA), Polycaprolactone, Polyvinyl alcohol (PVA) etc. (14, 78).  
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A typical ECM is composed of structural protein nanofibers such as collagen with dimensions 
ranging from tens to hundreds of nanometres in three-dimensional form. It is expected that 
such 3D biomimetic ECM will play a similar role in supporting cell growth in vitro as native 
ECM does in vivo. An ideal ECM substrate should be biocompatible, non-toxic, highly porous 
biodegradable and mechanically strong enough depending upon the application.  
In the present study, I focused on creating nanofibrous matrixes for investigating the effect of 
CPs behaviour on substrates with different stiffness/elasticity.Nanofibrous scaffolds can be 
fabricated with tunable porosity and mechanical strength, and it's three- dimensional (3D) 
architecture can enhance the cell adhesion, alter the focal-adhesion signalling cascades, and as 
a result the stem cell fate (18, 19). Also, the high surface to volume ratio of nanofibrous 
scaffolds can aid better cell adhesion, proliferation and differentiation. Hence, the best way to 
mimic the ECM is to create a nanofibrous matrix in order to achieve specific stem cell lineages. 
Currently, a great deal of research is going on in examining various types of fibers and how 
they interact with stem cells to push differentiation into specific cell lineages. In a study using 
a composite nanofibrous material, made of PCL and collagen increased the proliferation of 
nerve-like cells. Moreover, the incorporation of collagen increased the biocompatibility of PCL 
and the amino groups of collagen help in cell adhesion and proliferation (15). Another 
pioneering work in the field of stem cell research using nanofibers is the differentiation of 
MSCs into chondrocytes using electrospun PCL fibers containing chondrogenic medium TGF- 
β1. Also, electrospun nanofibers with different chemical compositions were fabricated using 
poly [(L-lactide)-co-(ε-caprolactone)] (PLCL) and gelatin, and its osteogenic differentiation of 
MSCs was studied. It was found that hMSCs cultured on PLCL/gelatin nanofibers showed 
better in vitro cell growth and osteogenic differentiation than hMSCs grown on PLCL-only 
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nanofibers (16). In another work done by Kang et al., PCL scaffolds were found to be an 
appropriate matrix for the mouse ES cells to grow and differentiate into adipocytes (17).  
As discussed above, there are many works related to the efficient use of electrospun nanofibers 
for various tissue engineering applications. In the field of cardiac regeneration, recently a 
research group revealed the potential of using beta-PVDF as a nanofibrous implantable 
electrospun scaffold in conjugation with stem cells for the reconstruction of damaged heart 
muscles. The fabricated nanocomposite material was found to be mechanically stable and 
showed enhanced cardiomyocyte differentiation with respect to control (107). In another work, 
FDA approved polymer PCL was functionalized with gold nanoparticles and mesenchymal 
stem cells and cardiomyocytes were cocultured on to the scaffolds to investigate the scaffolds 
potential in the regeneration of infarcted myocardium. Notably, the scaffolds mechanical 
strength of 2.56 MPa was similar to the native myocardium and the gold nanoparticle 
incorporated PCL scaffolds exhibited positive expression of cardiac-specific markers in 
differentiated mesenchymal cells suggesting its ability to support and cardiogenic 
differentiation potential (108). 
Alternatively, self-assembly and phase separation has been used for synthesizing nanofibers. 
Phase separation is the most commonly used technique for the production of highly porous 
polymeric scaffolds or membranes. This process is usually accomplished by the thermally-
induced polymerization, which involves several steps such as the dissolution of the polymer 
with an appropriate solvent, gelation by applying adequate gelling temperature and finally, the 
solvent separation (109). This will result in the production of the porous nanofibrous structure 
whereas self-assembly is an entirely different approach for nanofiber formation; which utilizes 
the bottom-up approach that relies on weak noncovalent bonds to form nanofibers from 
peptides (109). Both these approaches have their own advantages and disadvantages. For 
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example, self-assembled nanofibers are excellent for drug delivery applications, and phase 
separation is exceptional for obtaining highly porous scaffolds for various tissue engineering 
applications, particularly for bone regeneration. However, both these systems would be 
difficult to scale up to a commercial setting and only limited number of polymers can be 
utilized for these approaches. Also, these techniques consume tremendous time as they involve 
various steps. Compared to these processes, electrospinning is the most feasible and 
reproducible nanofiber fabrication technique, which is less expensive, scalable and can be 
performed with any type of polymers. 
There are works based on the fabrication of nanofibers using phase separation and self-
assembly. For example, differentiation of mouse ES cell and MEF to osteoblast-like cells were 
studied using self-assembled peptide nanofibers, which also expressed osteopontin and 
collagen type I with high alkaline phosphatase activity and calcium phosphate mineralization. 
Smith et al. used phase separation method to form poly (L-lactic acid) (PLLA) nanofibrous 
matrices for osteogenic differentiation of both mouse and human ES cells and compared this 
with the 2D flat films and 3D solid-wall scaffolds. It showed the importance of nanofibrous 
architecture in promoting osteogenic differentiation (35, 106, 110, 111).  
Hence nanofibers hold promising applications in the cardiac tissue regeneration and the 
nanofiber production technique called electrospinning is commonly used for the fabrication of 
nonwoven fibers.   
1.6. Electrospinning for producing nanofibrous scaffolds 
Electrospinning is the most widely used technique for the manufacture of ultra-fine polymer 
fibers (112). It has been widely used for various applications such as wound dressing, drug 
delivery applications and in the field of tissue engineering and regenerative medicine (113-
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117). This old technique was first observed in 1897 by Rayleigh, and a detailed study on this 
technique was done by Zeleny (1914) and patented by Formhals in 1934. The work of Taylor 
(1969) on electrically driven jets has laid the groundwork for electrospinning. It is believed 
that the term “electrospinning”, is derived from “electrostatic spinning” since it uses 
electrostatic forces to produce ultrafine fibers ranging from nanometre scale to micrometre. 
(118, 119). It consists of a high voltage power supply in the range of several tens of kVs to 
generate the electrospinning. This voltage is essential to inject charge to the polymer solution 
and is accelerated towards the collector plate having opposite charge. The collector can be 
either static or rotating mandrel. In most of the spinning setups, the collector is usually a metal 
screen or plate (119). Also, it has a pipette tip known as spinneret to eject the polymer solution 
to the collector. Currently, there exist two different methods for electrospinning, vertical and 
horizontal. With the advancement of technologies, more sophisticated spinning techniques 
have been introduced and used by various research groups which can form more complex 
nanofibrous structures in a controllable and efficient way (119, 120) (121-123). The polymers 
are dissolved in appropriate solvents before spinning, and the polymer solution is then 
introduced to the spinneret. The high voltage supply can create a charge on the polymer 
solution, and when it reaches a critical value, the electrostatic force of the solution overcomes 
the surface tension, and Taylor cone is formed. Eventually, a charged polymer jet is ejected 
from the tip of the Taylor cone and is collected on the collector which is positioned at a specific 
distance from the spinneret. This creates an unstable and rapid whipping of the jet in the space 
between the tip and collector, which leads to evaporation of the solvent (124-126). The diagram 
of the conventional electrospinning technique is shown in figure.1.11. 
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Figure. 1.11. Schematic representation of the conventional electrospinning technique. 
1.6.1.  Principle of electrospinning 
 
There are three stages involved in the process of electrospinning, namely jet initiation, 
propagation and termination. In the first stage, the ejection of polymer solution occurs by 
forming a spinning jet from the spinneret. In the second stage, the polymer jet acquires a 
smooth stretching due to the applied electrical forces. In the final step, jet undergoes splitting 
and whipping instability, making it travel in a helical path until they are stopped by the collector 
(120). These three stages are briefly explained below. 
 
1.6.1.1.  Jet initiation 
  
The polymer solution taken in a needle forms a droplet at the tip of the spinneret and remains 
in equilibrium because of the gravitational force and surface tension acting on it, and this 
prevents the solution from flowing out of the spinneret (127). When a high voltage is applied, 
the polymer solution attains a charge, and these charges get accumulate at the droplet surface. 
This causes the surface to be pulled into the shape of ‘a section of the sphere’. At a particular 
point, the electrical force overcomes the force of surface tension, and the meniscus bulges out; 
 36 
hence, charges get accumulated on the protruding part of the meniscus (128). Further 
accumulation of charges on the meniscus causes the  meniscus to be pulled out in the shape of 
a cone – “Taylor cone”, which was mathematically reported by Taylor (124).When the applied 
voltage attains a threshold value, the electric force exceeds the surface tension, and a fine jet 
of the fluid is pulled out from the spinneret tip. 
 
 
Figure.1.12. Schematic representation of Taylor cone formation and the charge accumulation 
at the surface (129). 
1.6.1.2.  Jet propagation 
 
During the jet propagation, the diameter of the jet decreases with increase in length while the 
total mass per unit time remains the same at any point in the Z axis (130). Under this condition, 
the velocity of this polymer jet surpasses the speed of sound in air (131). The elongation of the 
polymer jet and evaporation of solvent results in the further reduction in the diameter of the 
spinning jet. Hence jet elongation is initiated by electric forces and gravitational forces, which 
is counter-balanced by viscosity, surface tension, and inertia (132). 
 
1.6.1.3.   Jet termination 
 
The jet elongation results in the process of jet thinning, and according to Feng, this generates 
a fluctuation in the surface charge density, which alters the electric field and increases the 
viscosity. This results in the deceleration of the jet along the straight path. The viscous 
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resistance continues to grow as the jet undergoes a steady acceleration under the influence of 
electrical force. At a certain point, the jet experiences instability when the viscous resistance 
defeats the electrical force and even a slight perturbation caused by air may result in oscillations 
(131). The electrospun nanofibers remain charged throughout the flight and travel down the 
stream until they deposit on the collector as randomly oriented nanofibers in the form of 
nonwoven mats. It has also been reported that the deposited nanofibers have a tendency to repel 
the incoming fibres due to the force of repulsion (125). Moreover, the nanofibers form as coils 
or loops if the nanofibers are deposited onto the collector is at higher velocity (133). For the 
successful deposition and overlapping of fibers, it is essential for the fibres to have a random 
orientation. 
 
1.6.2.  Parameters involved in the electrospinning process 
 
 
The process of electrospinning is controlled by many parameters which are widely categorized 
into solution parameters, process parameters, and ambient parameters. Viscosity, conductivity, 
molecular weight, and surface tension are the solution parameters. Process parameters include 
applied voltage, tip target distance and flow rate. All these parameters drastically affect the 
fibre morphology, and thus, proper optimization of these parameters can yield nanofibers of 
required morphology and diameter (134). The effect of each parameter on fibre diameter and 








Table 1.2.  Details of processing parameters which influence the electrospinning process 
(119). 
Parameters Effect of fiber morphology 
Polymer 
Concentration 
Increase in fiber diameter with increase in polymer concentration 
Viscosity High viscosity-Increase in fiber diameter and absence of beads 
Low viscosity-Appearance of beads 
Conductivity Increase in conductivity reduces the fiber diameter 
Molecular weight Absence of beads and droplets with increase in molecular weight 
Surface tension No conclusive evidence that link with fiber morphology, but as surface 
tension increases the jet instability also increases 
Applied voltage Increase in voltage reduces the fiber diameter 
Tip target distance Increase in tip target distance reduces the fiber diameter 
Change for bead formation if the distance is too large or too small 
Flow rate Decrease in flow rate decreases the fiber diameter 
Humidity Formation of circular pores if the humidity is high 
Temperature Increase in temperature decreases the fiber diameter 
 
1.7. Gelatin for electrospinning 
The polymer used in this study is gelatin, which is a naturally occurring polymer. Gelatin is 
widely used in the field of tissue engineering as it occurs abundantly and is less expensive. It 
is the hydrolysed form of collagen; hence, it is the most suitable polymer for mimicking the 
ECM. Ideally, the ECM should be biocompatible, nontoxic and biodegradable to be used as a 
right candidate for tissue engineering and regeneration applications. Gelatin favours all these 
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properties which enable this material as a good choice for mimicking the ECM (135-137). The 
structure of gelatin is shown in figure.1.13.  
 
 
Figure.1.13. Structure of gelatin (adapted from http://www.madehow.com/Volume-5/Gelatin.html) 
 
One of the unique properties of the gelatin is its temperature dependent cross-linking ability. 
The gelation temperature of gelatin is at 40C in a water solvent. Hence to aid electrospinning 
in aqueous solution, it is necessary to overcome this characteristic feature of gelatin. In most 
of the electrospinning experiments, gelatin is electrospun using organic solvents, which is 
expensive, and toxic. This challenge was approached by setting up the whole electrospinning 
apparatus in an enclosed incubator with facilities to raise the temperature and humidity, which 
assisted the successful electrospinning of gelatin nanofibers in a pure water solvent. Further 
details regarding the novelty of the electrospinning technique used in this work are explained 
in the Results and Discussions section.  
1.7.1. Cross-linking of gelatin 
 
The term cross-linking refers to the “linking of polymer chains” to enhance the physical and 
mechanical properties of polymers. Since the polymer used in this study is gelatin, which is 
readily soluble in water, it should be cross-linked physically or chemically to retain its structure 
to be used in cell culture studies. There are different cross-linking methods such as physical 
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and chemical processes by which the water resistance and the mechanical properties of the 
nanofibers can be increased (138). The physical processes include dehydrothermal (DHT) 
treatment and plasma treatment or UV irradiation, which is less efficient in cross-linking 
gelatin nanofibers because the cross-linking occurs only on the surface of the gelatin. Hence, 
chemical cross-linking is the most widely used method for cross-linking gelatin nanofibers. 
This includes 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride/Sulfo-NHS (N-
hydroxysulfosuccinimide (EDC/NHS) and glutaraldehyde (GA) vapour cross-linking, which 
can cross-link the entire material rather than on the surfaces alone (139, 140). 
DHT treatment is the process of applying a high temperature of above 98°C under vacuum. 
This results in the evaporation of water molecules and leads to the formation of intermolecular 
crosslinks through condensation reactions.  It has been widely used for the stabilization of 
collagen scaffolds and natural biopolymers for the enhanced mechanical properties and 
reduced degradation rates. It has also been reported that DHT treated collagen fibers supported 
cell proliferation and tissue formation.  Another advantage of DHT treatment is that it does not 
involve the use of toxic chemical reagents and provide biocompatibility (141-143). 
1.7.1.1.   EDC/NHS Cross-linking 
EDC/NHS facilitates the activation of carboxylic acid residues of aspartic and glutamic acid 
on gelatin and reacts with the free amino groups of EDCs to form O-acylisourea intermediate 
residues. NHS acts as a catalyst to carry out this reaction process by reacting with the activated 
carboxylic acid groups and forms NHS-activated, a carboxylic acid group which in turn reacts 
with the amine groups in the lysine residues of gelatin to form amide bonds (Figure.1.14). 
Compared to GA cross-linking, EDC/NHS is less toxic, and there is evidence to support the 
cell viability and proliferation on EDC/NHS cross-linked scaffolds (144, 145). 
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Figure.1.14. Diagram illustrating EDC/NHS cross-linking mechanism (adapted from 
https://www.thermofisher.com/uk/ ) 
1.7.1.2. Glutaraldehyde cross-linking 
The aldehyde group of glutaraldehyde reacts with the amino groups of lysine residues in gelatin 
to form aldimine linkages, as shown in figure.1.15. Even though GA is toxic to the cells, small 
amounts of GA is found to be nontoxic and proper pre-treatment, and sterilization steps must 
be done to remove the uncross-linked GA from the scaffolds. Among the chemical cross-
linkers, GA is the most efficient method of cross-linking since it can cross-link not only 
molecules that are close to each other but also the molecules that are separated by a distance. 
It has been reported that GA cross-linking enhanced the strength of gelatin by two-fold and 






Figure.1.15. Cross-linking mechanism of glutaraldehyde (148) 
 In 2010, R.Juthamas et al. reported that the structure and cross-linking degrees were different 
for physical and chemical cross-linked gelatin nanofibers. The DHT or plasma treated gelatin 
nanofibers showed a low cross-linking degree but retained the original structure of fiber mats. 
When the mats were cross-linked with DHT method followed by EDC/NHS, the cross-linking 
degrees were high, but the fibers were interconnected with swollen morphology. The DHT and 
GA vapour treated nanofibers were merged without interconnected pores. This result shows 
the importance of choosing the correct cross-linking method and the effects of these methods 
in controlling the structure, morphology and degradation of the material (149). 
1.7.2.  In situ cross-linking method 
Previous works have reported the inefficiency of DHT and EDC/NHS treatment methods in 
maintaining the nanofibrous structure. This could preclude the use of scaffolds for tissue/cell 
engineering applications in the wet condition (150). So, a different cross-linking methodology 
was introduced recently with the aim of cross-linking nanofibers internally during 
electrospinning. This process is called in situ cross-linking by which the fibers can be cross-
linked internally and results in high cross-linking degree with an adequate amount of cross-
linker (151). 
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There were studies which utilized in situ cross-linking methods to fabricate nanofibers such as 
PVA, gelatin, alginate/PVA, PNIPAM/gelatin etc. (151-153). But all these works were done 
by the direct mixing of polymer solution with a cross-linking agent just before the time of 
spinning. In this work, a recently modified technique of electrospinning with a double-barrel 
syringe so that the amount of cross-linking agent added can be minimized with an efficient 
cross-linking degree is used. In 2015, A. P. Kishan et al., first studied the in situ cross-linking 
of gelatin using double-barrel syringe to produce electrospun fibers with improved fiber 
morphology, stability and tunable degradation rates (97). 
 This study employs both in situ cross-linking, and external crosslinking with Glu vapour with 
the aim of retaining the fibrous structure of gelatin nanofibers for the stem cell adhesion, 
proliferation and differentiation. 
1.8.  AIM AND OBJECTIVES OF THIS WORK 
The first objective of the work in this thesis was, to use an in situ electrospinning technique to 
fabricate non-woven and internally cross-linked nanofibrous materials consisting of gelatin, in 
aqueous solution with varying matrix stiffness.  
 
The second objective of this work was to examine the CPs viability, antigenic profile, 
proliferation, morphology, angiocrine activity and differentiation potential by incorporating 







2.    MATERIALS AND METHODS    
  
All solutions were prepared in the laboratory conditions at a temperature of 19-25C and 
relative humidity of 35-70%. The details of the gelatin polymer used for the preparation of 
gelatin solutions are mentioned below. Gelatin was used as supplied by the manufacturers 
(Sigma Aldrich, Cat. no. - G2500). 
 
2.1.        FABRICATION OF GELATIN NANOFIBROUS SCAFFOLD 
 
 
2.1.1.   Gelatin solution preparation  
 
The gelatin solution for electrospinning was prepared by dissolving 10% and 15% of gelatin in 
distilled water. The solution was heated above 35°C and was stirred continuously for the 
homogeneous mixing of gelatin in water. Gelatin from porcine skin (Type A) with a bloom 
number of 300 which denotes the gel strength of the polymer was purchased from Sigma Life 
Sciences UK and was used for the entire study. 
 
2.1.2.   Electrospinning of gelatin nanofibers 
 
 
The gelatin nanofibers were fabricated using the electrospinning technique in a controlled 
temperature and humidity. The details of the electrospinning equipment are listed in Table 3.1. 
The electrospinning setup consisted of a high voltage supply, spinneret and a grounded 
collector. In addition to this, a hot plate, and an ultrasonic nebuliser were also used to control 
the temperature above 40°C and humidity above 60% respectively. The whole setup was placed 
in a closed incubator to which a thermostat is attached for maintaining the heat and humidity. 
The image of the electrospinning setup used in the fabrication of gelatin nanofibrous scaffold 
is shown in figure 2.1. 
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Table 2.1. Details of apparatus used in the electrospinning technique. 
 
Label Equipment Details Supplier/Manufacturer 
1 Power Supply EL Series (1-30 
kV) 
Glassman High Voltage 
Inc. 
2 Syringe Pump PHD 2000 Infusion 
pump 
Harvard Apparatus 
3 Syringes 10 ml PlastipakTM Becton Dickinson 
4 Needles Flat-ended stainless 
steel 
Becton Dickinson 
5 Hot Plate IKA™ RH basic 2 Fisher Scientific 
6 Thermostat Incubator Stuart thermostat 
incubator 
Stuart 
7 Ultrasonic Nebuliser Omron NE-U12 Omron 
 
 
                                  
 
Figure 2.1. Electrospinning set-up used for producing gelatin nanofibers.  
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The gelatin solution was taken in a syringe (10 ml) fitted with a needle (21G) and was mounted 
on the spinneret. Initially, electrospinning was carried out with different concentrations of 
gelatin, and the electrospinning parameters were varied according to the concentration of 
solutions being spun. The duration of electrospinning was dependent on the requirements of 
the investigation. The solutions were electrospun for 4 hours, in order to obtain a sufficient 
thickness to peel off  the nanofibrous membranes from the aluminium foil. For SEM analysis, 
the gelatin solution was electrospun for 30 minutes. AFM preparation only required the 
electrospinning of fibres for less than 1 minute. The fabricated nanofibrous scaffolds were 
stored in a desiccator until they were used and were cut into the needed shapes using a scalpel. 
 
2.2       FABRICATION OF IN SITU CROSS-LINKED GELATIN NANOFIBERS (CLGS) 
 
2.2.1.    Solution preparation for the fabrication of CLGS 
 
All solutions were prepared in the laboratory conditions at a temperature of 19-25C and 
relative humidity of 35-70%. The details of the gelatin polymer used for the preparation of 
gelatin solutions and EDC/NHS are mentioned below. Gelatin (Sigma Aldrich, Cat. no. -
G2500) and EDC/NHS (Thermo Fischer Scientific UK Ltd. Cat. no. - NHS-2451 and EDC-
22980) was used as supplied by the manufacturers. 
 
 
The optimised gelatin concentration of 15% (wt/vol) was used in the fabrication of CLGS. 
EDC/NHS solution was used for the in situ cross-linking of gelatin nanofibers. The 
concentrations of 14mM EDC and 5.5mM NHS were prepared in absolute ethanol (139).  The 
final pH of the prepared solution was 6.5. Both EDC and NHS were obtained from Life 
Technologies Ltd, UK and absolute ethanol were supplied by Fisher Scientific UK Ltd. 
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2.2.2.    Solution characterisation 
 
 
The rheological characterisation of gelatin solution and gelatin solutions with different cross-
linking concentrations (2X, 5X and 8X (X=14mM EDC and 5.5mM NHS)) were performed 
by using a Bohlin Gemini Rheometer (Malvern Instruments Ltd.).  Viscosity measurements 
were performed by using a cone-plate configuration. Details of the parameters used for the 
investigation are given in table 2.2. 
 
The solutions were loaded on the base plate of the rheometer by avoiding the incorporation of 
bubbles, and the geometry was lowered. A solvent trap was also used, and the excess solution 
was wiped out before starting the test. 
 
Table 2.2.  Details of the parameters used in viscometry measurements of gelatin and gelatin 
solutions with different cross-linking densities. 
 
Viscometry Parameters Details 
Geometry CP/40:4 cone angle, 40 mm in diameter 
Shear rates 0.1 – 10 s-1 
Mode of measurement Controlled rate 
 
2.2.3. Electrospinning of CLGS 
 
The in situ cross-linking of gelatin nanofibers were achieved by using a double-barrel syringe 
(10:1) which was purchased from Sulzer Chemtech UK Ltd. Initially, electrospinning was 
executed with four different cross-linking densities of EDC/NHS (denoted as 2X, 5X, 8X and 
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10X, X= 14mM of EDC and 5.5mM of NHS) to fabricate gelatin nanofibrous scaffolds with 
different matrix stiffness. The electrospinning was accomplished by maintaining the 
concentration of gelatin and distance between the needle and collector constant. The other 
parameters, such as voltage and flow rate of the solution, were changed accordingly to get 
nanofibers without any beads.  
 
The gelatin solution was loaded in the largest barrel, and the second barrel was filled with 
EDC/NHS cross-linking solution. Both were fed at a fixed rate so that they reach the needle at 
the same time and mix inside the needle before getting ejected to the collector. The mixing was 
attained with the help of mixing heads attached to the syringe, and a high voltage was applied 
to the solution. The polymer jet formation was achieved when the surface tension of the 
solution overcome the applied voltage. Thus, randomly oriented, internally cross-linked, 
gelatin nanofibers were deposited on the grounded collector, which was kept at a fixed distance 
from the needle tip.  The schematic representation of electrospinning set up is shown in 
figure.2.2. The fabricated nanofibrous scaffolds were stored in a desiccator until they were 
used and were cut into the required shapes using a scalpel for further studies.  
 
 
                    
Figure.2.2.  Schematic representation of double-barrel syringe for in situ cross-linked gelatin 
nanofibers during electrospinning. 
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2.3 CHARACTERISATION OF CLGS 
2.3.1.   Scanning electron microscope (SEM) analysis 
The structural morphology of gelatin nanofibers was analysed using SEM (JEOL IT300). The 
nanofibers were spun on an aluminium foil for 30 minutes and were cut into small pieces.  They 
were fixed on aluminium stubs (12mm) with sticky carbon tapes for observation. All the 
samples were sputter coated with the silver of thickness 15nm using the sputter coater (SC7620, 
Quorum Technologies, East Grinstead, UK), and were imaged at various magnifications. After 
SEM analysis, the measurement of electrospun fibre diameters was performed by using Image 
J, and the average fiber diameter of each scaffold was quantified. 
2.3.2.  Atomic force microscopy (AFM) analysis 
The 3D morphological analysis of the scaffolds was also carried out by using a Multi-mode 
VIII AFM with Nanoscope V controller. The fibers were spun on an aluminium foil for few 
seconds to make the fibres less dense and were cut into small pieces using an 8 mm diameter 
sterile biopsy punch. The microscope uses a non-resonant, Peak Force feedback control 
mechanism. In Peak Force control, an approach force curve was collected as the AFM tip 
interacts with the sample. From this, the force applied to the sample by the tip was measured. 
A force level was selected as a set-point value for the feedback; this is the level of force that 
will always be applied to the sample. A curve is taken over each pixel of the image, and the 
approach halted when the set-point value is reached. In this way, the amount of force applied 
to the sample remains constant across the entire image. An additional benefit to this is that the 
force curve can be used to measure specific properties of the sample, which is more common 
tapping mode is just inferred from phase changes in the resonant cantilever. In these 
experiments, cantilevers with typical spring constants in the range of 40 N/m, namely SCOUT 
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cantilevers [NuNano, Bristol, UK] and RTESPA cantilevers [Bruker, CA, USA] were utilized. 
The tip width was less than 5nm, and the scanning speed very slow at a rate of 0.25 Hz. 
2.3.3. Degradation test   
The CLGS were cut into small pieces (2cmx2cm) using a scalpel. Each of these scaffolds was 
then placed in a Petri-plate containing 5 ml of Phosphate Buffer Saline (PBS). A pH of 7.4 was 
used to mimic the human body conditions. The solubility of the samples was measured after 
two weeks and three weeks of immersion. The samples were taken out at different time points 
(14 days and 21 days) and were air-dried before imaging. 
Later, the SEM images were taken to analyse the stability of nanofibrous scaffolds after 
immersed in PBS for two weeks and three weeks. All the samples were fixed on aluminium 
stubs with sticky carbon tapes and were silver coated (15 nm) before performing the SEM 
imaging. The fiber diameter of the hydrated nanofibers was also measured using Image J. 
 
The CLGS were further chemically cross-linked in the glutaraldehyde (5%) vapour at room 
temperature by placing the scaffolds in a desiccator. The glutaraldehyde solution (5ml) was 
poured at the bottom of the desiccator and kept for 24 hrs at room temperature to occur cross-
linking. After cross-linking, the samples were exposed in a fume hood for 2 hrs and heat treated 
at 100C for 1 hr to remove the residuals of glutaraldehyde and to partially enhance the cross-
linking (154).   
 2.3.4.  Fourier transform infrared (FTIR) spectroscopy analysis 
FTIR analysis was carried out to confirm the cross-linking ability of EDC/NHS and Glu. For 
this, the electrospun nanofibrous scaffolds were peeled off from the aluminium substrate, and 
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2mg of all the samples (pure gelatin, Glu alone treated gelatin and Glu and EDC/NHS cross-
linked gelatin nanofibers) were weighed.  The spectrum analysis was measured in the 
frequency range of 500 to 4000 cm-1 
2.3.5.   Ninhydrin assay  
The cross-linking degree of the CLGS was measured by using a UV-Visible Spectrophotometer 
(U-1900: Hitachi, Tokyo, Japan). Each scaffold with different cross-linking densities of 
EDC/NHS (2X, 5X, 8X) and Glu/EDC/NHS cross-linked gelatin scaffolds, were cut into small 
pieces without the aluminium foil. All samples were weighed 10mg before starting the 
experiment. Later, 2 ml of the ninhydrin solution (0.3M) was taken in four test tubes, and each 
of the samples was added to the test tubes. The test tubes were heat-treated at 95 °C for 5 
minutes (155, 156). Afterwards, 100l of ninhydrin solution from each test tubes were taken 
to measure the absorbance. Ethanol was added to these solutions before measurements, and the 
absorbance was taken at 570nm. The degree of cross-linking was calculated by the formula, 
Cross-linking index (%) = (Cb-Ca) ∕ Cb × 100 
        where Ca – Absorbance after cross-linking and Cb – Absorbance before cross-linking 
Glycine at various known concentrations was used as standard (157). All the samples were 
triplicated for the experiment. 
2.3.6.    Mechanical testing 
All scaffolds (pure gelatin, 2X, 5X and 8X CLGS, cross-linked with both EDC/NHS and Glu) 
were mechanically tested using an Instron testing machine (Cat. no.-2752 006). The 
mechanical testing was performed at two different conditions, i.e., at the dry and wet state of 
the scaffolds. The samples were cut into rectangular pieces of dimensions 10±5 mm in length, 
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5±3 mm in width and 100±50 µm in thickness, respectively. The length, breadth and thickness 
measurements were acquired by using Vernier callipers. Since the wet samples were difficult 
to handle, they were placed on an aluminium foil for measuring the thickness. Later, the 
thickness of the aluminium foil was subtracted from the total thickness to get the width of wet 
samples. All samples were triplicated, and measurements were taken without aluminium foil 
substrate. Six measurements were taken at different positions of the scaffolds and mean 
averages were calculated. 
The instrument consisted of a pressure pump, a chamber to fill the water and a thermostat to 
set the temperature. It was also equipped with a gripping system to which the scaffolds were 
held for testing. The testing machine was connected to the data acquisition software called 
‘Bluehill-3’. The chamber was filled with tap water, and the temperature was set at 37C. Both 
ends of the samples were attached to a custom-made gripping system which was connected to 
the mechanical testing device (Figure 2.3). A strain rate of 1mm/min was applied to the 
scaffolds until failure, and the stress-strain curves were derived from the force-displacement 
data. The elastic modulus/stiffness of the fibers was evaluated from the slope of the first linear 
portion of the stress-strain curve. The mechanical testing of the scaffolds under wet conditions 
was performed by immersing the samples in a chamber containing water at 37ºC. The tensile 
strength of the scaffolds was also measured from the obtained values.  
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Figure.2.3. Images of dry and wet scaffolds held between the grips of a mechanical testing 
machine. 
2.4.    IN VITRO CELL STUDIES 
2.4.1.  Ethics 
Studies comply with the principles stated in the Declaration of Helsinki. The protocol for 
collection of cardiac leftovers from patients undergoing corrective surgery of congenital heart 
disease was approved by the North Somerset and South Bristol Research Ethics Committee 
(REC reference 15/LO/1064). Paediatric patients’ custodians gave written informed consent 
for inclusion in the study. The pathology and characteristics of tissue donors used in this work 







Dry scaffold Wet scaffold 
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Table 2.3.   Clinical characteristics of tissue donors used in the study. The numbers 10, 
11, 12 and 32 represents different donors. 
 
Cells Used Age Source Pathology 
CP10 17 months Right Ventricle Tetralogy of Fallot (TOF) 
CP11 Three years Right Atrium Atrioventricular Canal Septal Defect 
CP12 Three years Right Ventricle Atrioventricular Canal Septal Defect 
CP32 Three years Right Atrium Mitral Valve Defect 
 
To investigate the effect of matrix stiffness on stem cell fate, the CPs were seeded on scaffolds 
with different cross-linking densities. Various assays such as viability, immunocytochemistry, 
cell attachment, proliferation, ELISA and differentiation assays were performed to analyse, 
how the cells are behaving on these substrates in terms of its adhesion, proliferation and 
differentiation into cardiac specific lineages.  
All scaffolds were cut into round pieces of 8mm diameter using accupuch and sterilised before 
cell seeding. The accupunch is a skin biopsy punch supplied by Schuco International (London) 
Limited. All experiments were carried out in 48 well plates (CELLSTAR®) except the ELISA 
test. For ELISA, 96 well plates (R&D Systems) specially designed for ELISA test was used. 
All scaffolds were immobilised in 48 well plates using Cell Crowns (Sigma Aldrich) before 
the sterilisation process. The sterilisation was achieved by soaking the scaffolds in ethanol 
(70%) for 20 minutes and washing with PBS twice. Later the scaffolds were placed under UV 
light for 30 minutes. After drying, the scaffolds were immersed in ECGM2 media (Promocell) 
supplemented with 2% FBS for overnight to pre-condition the scaffolds. Pre-conditioning also 
helps to remove the uncross-linked glutaraldehyde residues from the scaffolds. Next day, each 
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well was seeded with 20,000 cells. The CPs three donors were used in all the following in vitro 
assays except the viability assay, and all the scaffolds were duplicated for this study. Cells from 
four donors were used for performing viability assay to attain a statistical significance. The 
four cell lines used were denoted as CP10, CP11, CP12 and CP32.  
2.4.2.   Isolation and expansion of CPs and cell culture 
The isolation of CPs was accomplished, as described by Avolio et al. (21). Briefly, the surgical 
leftovers of atrium or ventricle specimens from children having congenital heart defects were 
taken and washed with PBS. All the specimens were 3 to 5 mm in length and <100 mg in 
weight. After PBS wash, they were manually minced, and the tissue suspension was incubated 
for 30 minutes with 0.45 WU/mL/g Liberase 2 (Roche Technologies, UK). The minced cell 
suspension was passed through 70, 40, and 30 m cell strainers subsequently to obtain a single 
cell suspension. Endothelial cells were separated using anti-CD31 (Miltenyi Biotech) 
conjugated beads, following the manufacturer’s instructions. From the remaining cells, CD34+ 
cells were separated by anti-CD34 beads (Miltenyi Biotech). Hence, these obtained cells were 
cultured in the presence of ECGM2 medium supplemented with 2% fetal bovine serum (FBS). 
When the cells were 80% confluent, they were passaged to new culture dishes, and frozen 
stocks were generated for the experiments. The frozen vials were stored initially in -80C and 
later they were transferred to liquid nitrogen. Trypsin-EDTA (Life Technologies, UK) was 
utilised to detach cells from the growth substrate. 
As required, the frozen cryovials were taken from liquid nitrogen, and the cells were thawed. 
For this, the cell suspension was kept in a water bath at 37C for 1 min. They were then 
transferred immediately to pre-warmed 5ml of ECGM2 media taken in a 15 ml falcon tube. 
The centrifugation was carried out at 400xg for 10 min. After this, the cells were resuspended 
with 1 ml of ECGM2 media without any cell aggregates. They were then seeded to 2 T25 flasks 
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by adding 5ml of media in each T25. The T25 flasks were incubated at 37C until they become 
confluent. When they are confluent, the cells were split and used for further cell studies. 
The 80% confluent T25 flasks were taken out of the incubator, and the media was removed. A 
PBS wash was done, and 2 ml of trypsin (1X trypsin in PBS) was added to detach the cells. 
After incubation at 37°C for a few mins, the flask was viewed under a microscope to check the 
detachment of cells. After ensuring all cells were detached, the trypsinisation process was 
stopped by adding the blocking solution. The blocking solution was prepared by adding 5% of 
FBS in PBS. This media, along with the cells, were transferred to a falcon tube and centrifuged 
at 400xg for 10 min. After centrifugation, the cells were resuspended, and the cells were 
counted. Usually, there should be 700,000-1million CP cells in a confluent T25 flask. 
Cell counting was performed using a Burker Counting Chamber. Briefly, 10 l of cell 
suspension was diluted with 10 l of Trypan Blue (Life Technologies). Trypan blue can stain 
the dead cells in blue colour. The cells were counted in all the four squares, excluding Trypan 
blue positive cells. The average number of cells was calculated, and the required number of 
cells/ml was also calculated by the formula, 
Number of cell/ml= Average number of cell x 10000 x 2  
(2 is the dilution factor with Trypan Blue). 
Each well was added 500 l of media and the scaffolds were seeded with 20,000 cells/well. 
For this, according to the number of scaffolds, the media required was also calculated and 
added to each well accordingly. 
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2.4.3.   Characterisation of CPs 
The isolated CPs were characterised by immunocytochemistry (ICC) assay to assess the cells 
are expressing their characteristics features. For this, the CPs were seeded on eight-chamber 
slides at a density of 8,000 cells/cm2 . The primary antibodies Vimentin, neural/glial antigen 2 
(NG2) and octamer-binding transcription factor 4 (OCT4) were used for the ICC assay. The 
details of dilution factor, primary and secondary antibodies etc. are listed in table.2.4. All three 
cell cultures (CP10, CP11 and CP12) were stained with each marker to do ICC assay.  
Table 2.4.  The details of antibodies used for the ICC assay. 
Primary Antibody TritonX Supplier Dilution Secondary Antibody 
Vimentin Yes Abcam  1:400 Alexa Fluor 647 Goat anti-Rb 
NG2 Yes Abcam 1:100 Alexa Fluor 647 Goat anti-Rb 
OCT4 Yes Abcam  1:400 Alexa Fluor 647 Goat anti-Rb 
 
To perform ICC, the cells seeded on eight-chamber slides were taken after two days of 
incubation, and they were fixed and permeabilised. The cell fixation was done by treating the 
cells with 4% paraformaldehyde (PFA) for 15 min at room temperature after a PBS wash.  This 
was done under a chemical hood to avoid the possible hazards of using toxic PFA. Later, PFA 
was removed, and the cells were washed with PBS twice. They were stored at 4C until the 
ICC staining is done, but not more than five days as the cells may detach from the scaffolds. 
The cells were maintained in a wet condition, and when required, the cells were taken out of 
the fridge, and permeabilisation was carried out. Permeabilisation was carried out by treating 
the cells with 0.1% Triton (Sigma Aldrich) in PBS for 10 min at room temperature. After two 
times of PBS wash, the cells were blocked by adding the blocking solution for 30 min at room 
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temperature. By this time, the primary antibodies were prepared according to the dilution factor 
in blocking solution. Later, the cells were incubated with primary antibodies for overnight at 
4C. On the next day, secondary antibodies were added to cells after washing with PBS twice. 
After this, the cells were incubated at room temperature for 1 hour protected from light. The 
nucleus staining was carried out with Hoechst (1:10000) (Sigma Aldrich) for two min 
incubation in the dark. Later several PBS and distilled water wash, the cells were mounted with 
Fluoromount G (Biotium UK) until the imaging was done. Imaging was performed by 
fluorescent microscopy at 20X magnification. 
2.4.4.   Viability assay 
The viability of CPs on CLGS was analysed by performing the live-dead assay. The scaffolds 
were first sterilised before seeding the cells as described above. After sterilisation, the scaffolds 
were seeded with 20,000 cells and incubated at 37C. After two days, the confluency was 
checked, and staining was performed as per the manufacturer’s protocol. For this, 2 ml of the 
media was added with 1μl of Calcein AM and 1 μl of Hoechst along with 4 μl of Ethidium 
homodimer III (EthDIII). This was followed by vortex, and 500 μl of the media was added to 
each well. Then it was incubated at 37°C for 30 min and viewed under Fluorescence 
microscope (Zeiss, model- AxioVert 200M). The viability assay kit was supplied by (Biotium, 
UK). For performing the assay, ECGM-2 basal media was used. 
2.4.5.   Immunocytochemistry (ICC) assay of CPs on scaffolds 
Immunocytochemistry assay was performed to investigate whether CPs are maintaining their 
phenotypic characteristics and stemness when seeded on CLGS. The phenotypic markers 
Vimentin, NG2 and the stemness marker OCT4, were used for the ICC assay. The details of 
dilution factor, primary and secondary antibodies etc. are listed in table.2.4. 
 59 
The scaffolds were cut into 8mm diameter using accupunch and were sterilised as described 
above. For each scaffold, duplicates were taken, and the same staining protocol for CPs 
characterisation was used. CPs seeded on 8 chamber slides were taken as a control for each 
cell line. The cell seeding density was 20,000 cells/well. 
2.4.6. Cell adhesion studies 
The cell attachment studies were carried out to compare the CPs shapes and morphology when 
they were seeded on CLGS with different matrix stiffness. For this, SEM was used to observe 
the morphologies of CPs on scaffolds after 7 days of incubation. The CPs seeded on plastic 
were used as the control.  
The scaffolds were cut into small pieces of 8 mm in diameter and were sterilised.  CPs were 
then seeded onto the scaffolds at a cell density of 20,000 cell/well. Media change was given in 
two days of the time interval to keep the cells alive. After 7 days of incubation, the CPs were 
fixed with 4 % PFA and dehydrated through a series of graded-ethanol solutions and air-dried. 
After that, they were fixed on aluminium stubs with sticky carbon tapes on it. They were silver 
coated in the vacuum with a thickness of 15nm and were examined under SEM. Backscattered 
electron detector was used for SEM analysis for better imaging. 
2.4.7.   Proliferation studies 
The ability of the cells to proliferate on the CLGS were evaluated by using Click-iT EdU (5-
ethynyl-2´-deoxyuridine) Imaging Kits. The assay kit was supplied by Invitrogen. The 
scaffolds were cut into 8mm diameter, and sterilisation was done. The scaffolds were later 
seeded with 20,000 cells and incubated at 37C. After two days, the cells were treated with 
EdU (Component A) along with the media. EdU stock solution was prepared by adding 2 ml 
of Dimethyl sulfoxide (DMSO, Component C). From this stock 1 l was taken and mixed with 
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1ml of the ECGM2 media to prepare the working solution. The cells treated with Edu on plastic 
was considered as the positive control and the cells not treated with EdU on scaffolds were 
recognised as the negative control. 
 
After four days of incubation, the media was removed, and the cells were fixed with 4% PFA 
and incubated at room temperature for 15 min. The cells were washed twice with 3% BSA 
(Bovine Serum Albumin) in PBS, and the permeabilisation step was carried out. For this, 0.5% 
Triton in PBS was added to each well and incubated at room temperature for 20 min. The 
permeabilisation buffer was removed, and the cells were again washed with 3% BSA in PBS. 
The EdU detection was performed by incubating the scaffolds with a reaction cocktail for 30 
min at room temperature, protected from light. The reaction cocktail was prepared according 
to the manufacturer’s instructions. The details of the ingredients added to make the reaction 
cocktail are listed in Table 2.5. The components were added in the same order as listed in the 
table, and the volume of each reagent was changed according to the number of wells.  
 
Table 2.5. Preparation of Click-iT reaction cocktail for EdU detection. 
 
Reaction Components Number of coverslips (10) 
1X Click-iT  reaction buffer (Component D) 4.3 ml 
CuSO4 (Component E) 200 l 
Alexa Fluor azide (Component B) 12.5 l 
1X Reaction buffer additive (Component F) 500 l 
Total volume 5 ml 
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 The working solution of Component D was prepared by transferring all the solution (4 ml) in 
the Component D bottle to 36 ml of deionised water. The Component F reaction additive buffer 
(1X) was attained by diluting the 10X additive reaction buffer in the ratio of 1: 10 in deionised 
water. This solution was made fresh and used on the same day. The 10X additive reaction 
buffer was obtained by adding 2 ml of deionised water to the vial and mixed well until it gets 
fully dissolved. The stock solution was stored at -20C. 
 
After 30 min of incubation, the reaction cocktail was removed, and the cells were washed twice 
with 3% BSA in PBS.  For nuclear staining, Hoechst (Component G) (1:10000) in PBS was 
added to the scaffolds and incubated for two min followed by PBS wash and distilled water 
wash. Later, they were stored by adding glycerol until the imaging was done. Imaging was 
done in the Fluorescent microscopy at 20X magnification. The number of proliferating cells 
were found out using Image J software.  
 
2.4.8. Enzyme-linked immunosorbent assay (ELISA) test 
 
Protein secretion of CPs was analysed using ELISA by collecting the media after 48 hours of 
incubating the CPs on 2X, 5X and 8X CLGS. The quantities of Angiopoietin-1 (ANG-1), 
Angiopoietin-2 (ANG-2) and human vascular endothelial growth factor-A (VEGF-A) (R&D 
Systems, UK) were determined when CPs on scaffolds were exposed to the ECGM2 media. 
The scaffolds were cut into 8mm diameter using accupunch, and sterilisation was done. The 
scaffolds were later seeded with 20,000 cells and incubated at 37C. After 48 hours, the cell 
culture media was collected and frozen for performing ELISA. The same protocol was used 
for performing ELISA for all proteins. The concentration of capture antibody, detection 
antibody and standard were changed accordingly for each protein based on the manufacturer’s 
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protocol. Different concentrations of each protein were used as the standard according to the 
manufacturer’s protocol. R&D Systems supplied the DuoSet Ancillary Reagent Kit for ELISA. 
Each kit contained 96 well microplates, plate sealers, substrate solution, stop solution and 
Reagent Diluent Concentrate 2. 
 
For ANG-1, the standard graph was plotted with different concentrations of ANG-1. The 
concentrations used for this were 10,000, 5000, 2500, 1250, 625, 313,156 and 0 pg/ml. The 
higher concentration was prepared from the standard stock solution, and the other 
concentrations were made by serial dilution.  Each concentration of protein was prepared in 
reagent diluent (1X). After obtaining the standard graph, the plate preparation was carried out. 
The concentration of each antibody used for the preparation of the stock solution and working 
solution of ANG-1are mentioned in table.2.6. 
 
Table. 2.6. Details of the antibodies used for the detection of ANG-1. 
 
Description Stock Concentration Working Concentration 
ANG-1 Capture Antibody 720 g/ml 4 g/ml 
ANG-1 Detection Antibody 36 g/ml 200 ng/ml 
ANG-1 Standard 330 g/ml 10,000 pg/ml 
   
Firstly, the ELISA plate was prepared by adding 100 l/well of the diluted capture antibody in 
PBS. The pate was sealed and incubated overnight at room temperature. Next day, the washing 
step was performed by adding 300 l of wash buffer. The wash buffer was prepared by adding 
0.05% Tween 20 in PBS (pH 7.2-7.4). Three washes were done for each well, and the 
washing was done by using an auto washer (Thermo scientific). After the last wash, the 
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remaining wash buffer was removed by inverting the plate and blotting it against clean paper 
towels. It is because complete removal of the liquid at each step is essential for the proper 
performance of the assay. The plate was then blocked by adding 300 l of Reagent Diluent to 
each well and incubated at room temperature for an hour. After the washing step, the sample 
addition was done. For this, 100 l of each sample (culture media from 2X, 5X, 8X CLGS and 
plastic) and standards in Reagent Diluent was added to each well. The plate was then covered 
with an adhesive strip and incubated at room temperature for 2 hours, followed by the washing 
step. After this, 100 l of detection antibody diluted in Reagent Diluent was added to the wells 
and kept at room temperature for 2 hours. The washing step was repeated after the incubation. 
The working solution of 100 l Streptavidin-HRP (1:200) was added to each well and 
incubated at room temperature for 20 min in the dark, followed by the washing step. 
 
Later, 100 l of substrate solution was added to each well and incubated for 20 min at room 
temperature without placing the plate in direct sunlight. The substrate solution was prepared 
by adding 1:1 mixture of Colour Reagent A (H2O2) and Colour Reagent B (Tetramethyl 
Benzidine). This reaction was then stopped by adding 50 l of stop solution to each well by 
gently tapping the plate to ensure thorough mixing. The optical density of each well was 
determined immediately by using a microplate reader (Opsys MR, DYNEX Technologies) set 
to 450nm and 570 nm. The readings obtained at 570 nm is subtracted from the readings 
obtained at 450nm to do the wavelength correction. This subtraction is done to correct the 
optical imperfections in the plate. The data were normalised for the number of cells at the end 
of the collection time. 
 
The same procedure was used for performing the ELISA for ANG-2 and VEGF but with 
different concentrations of reagents. The standard graph for ANG-2 was plotted with the 
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different concentrations (6000 pg/ml, 3000 pg/ml, 1500 pg/ml, 750 pg/ml, 375 pg/ml, 188 
pg/ml and 93.8 pg/ml) of ANG-2. The standard graph for VEGF was plotted with different 
concentrations (10000 pg/ml, 5000 pg/ml, 2500 pg/ml, 1250 pg/ml, 625 pg/ml, 313 pg/ml and 
156pg/ml) of VEGF.  The concentrations of capture antibody, detection antibody and standards 
used for ANG-2 and VEGF are given in table.2.7. and table.2.8. respectively. 
 
Table. 2.7. Details of the antibodies used for the detection of ANG-2. 
 
Description Stock Concentration Working Concentration 
ANG-2 Capture Antibody 180 g/ml 1 g/ml 
ANG-2 Detection Antibody 90 g/ml 500 ng/ml 
ANG-2 Standard 170 ng/ml 6000 pg/ml 
 
 
Table. 2.8. Details of the antibodies used for the detection of VEGF-A. 
 
Description Stock Concentration Working Concentration 
VEGF Capture Antibody 120 g/ml 1 g/ml 
VEGF Detection Antibody 6 g/ml 100 ng/ml 
VEGF Standard 120 ng/ml 2000 pg/ml 
 
2.4.9.  Differentiation Assay 
 
In differentiation assay, CPs were exposed to inductive media to promote differentiation into 
vascular smooth muscle cells (VSMCs). The CPs on CLGS cultured in ECGM2 media was 
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used as the negative control. The CLGS were cut into 8mm diameter using accupunch, and 
sterilisation was done. The CPs (20,000/well) were seeded on the scaffolds and cultured in the 
ECGM2 media. After 48 hours, ECGM2 medium was substituted with ECGM2 medium added 
with 2ng/mL human Transforming growth factor beta 1 (TGF-β1, Pepro-Tech).   The 
differentiation assay was performed at two different time points (7th day and 14th day) after 
adding the differentiation media. This media was replaced with fresh media every two days of 
the time interval.  
 
At each time points, the scaffolds were taken, and the cells were fixed by treating the scaffolds 
with 4% paraformaldehyde (PFA) for 15 min at room temperature after a PBS wash.  Later, 
PFA was removed, and the scaffolds were washed with PBS twice. The cells were 
permeabilised with 0.1% Triton (Sigma Aldrich) in PBS for 10 min at room temperature. After 
two times of PBS wash, the cells were blocked by adding the blocking solution for 30 min at 
room temperature.  The staining was performed as same as for ICC and the primary antibodies 
Smooth Muscle (SM)-Calponin and Smooth Muscle alpha Actin (α-SMA) were used. The 
details of the antibodies used for the staining are listed in table.2.9. 
Table. 2.9. The details of antibodies used for the differentiation assay. 
Primary Antibody TritonX Supplier Dilution Secondary Antibody 
Calponin Yes Abcam 1:100 Alexa Fluor 647 Goat anti-Rb 
α-SMA Yes DAKO 1:100 Alexa Fluor 647 Goat anti-ms 
 
After staining the scaffolds were stored in glycerol until the imaging was performed using 
Fluorescence microscopy at 20X magnification. To quantitatively assess the stress fibers 
formed by CPs on the scaffolds, the mean intensity of the stained images was measured using 
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Image J. For this, all stained images were converted into grey scale images and were white 
balanced for standardisation.  The mean stress fiber intensity per cell was calculated by 
selecting different regions in the image and dividing the obtained intensity by the number of 
nuclei counted. 
 
2.5.   Statistical analysis  
 
Each characterisation experiment was completed in triplicate. For cell studies, each scaffolds 
were duplicated and evaluated with CPs isolated from three different donors except for viability 
assay. For viability assay, the cells from four different donors were used.  GraphPad Prism was 
used to perform the statistical analysis. The statistical significance was determined by the one-
way ANOVA test, and a p-value of < 0.05 was considered as statistically significant. Data are 













3. RESULTS AND DISCUSSIONS I: FABRICATION AND CHARACTERISATION 
OF IN SITU CROSS-LINKED GELATIN NANOFIBROUS SCAFFOLDS (CLGS) 
 
Nanofibrous scaffolds have been widely used for a variety of biomedical applications such as 
wound dressings, tissue engineering and drug delivery applications, because of their high 
surface-to-volume ratio, tunable physical and mechanical properties and their structural 
similarity to the ECM. Electrospinning is the most common method used for the fabrication of 
nanofibers. It has been used for decades for the synthesis of nanofibers using both natural and 
synthetic polymers (119). In this work, gelatin was used for electrospinning to obtain non-
woven nanofibers. 
 
As discussed in section 2.7, naturally derived gelatin has indicated to have potential 
applications in the field of tissue engineering and regenerative medicine. Its biological origin, 
biocompatibility and commercial availability make gelatin an ideal polymer for the tissue 
engineering applications (158). However, the electrospinnability of gelatin is poor due to the 
polyelectrolytic nature of gelatin. In addition, gelatin forms strong hydrogen bonds at room 
temperature, which in turn reduces the mobility of polymer chains (14). Hence for the 
successful electrospinning of gelatin, it is essential to have a suitable solvent to aid the process 
of electrospinning as electrospinnability is strongly dependent on polymer chain confirmations 
and entanglements (159). 
  
 In most of the studies, researchers have used high-polarity solvents such as 2,2,2, -
trifluoroethanol (TFE), acetic acid and hexafluoroisopropanol (HFIP) for the electrospinning 
of  gelatin polymer nanofibers (160-162). For example, in 2004, Huang et al. reported the use 
of TFE for the successful electrospinning of gelatin for the first time. They used gelatin solution 
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concentrations of 5 to 12.5% and successfully electrospun gelatin nanofibers of diameter 
ranging from 100 to 340 nm (162). Since the first report, there have been several other studies, 
where they used alternative organic solvents for electrospinning gelatin.  These high-polarity 
solvents are required to break the cross-links between the polymer chains (139). But they are 
often expensive or toxic which adversely affect the biocompatibility of electrospun gelatin 
nanofibers. For this reason, the incorporation of organic solvents for the nanofiber synthesis is 
completely evaded as one of the objectives of this study was to fabricate biomimetic and 
biocompatible gelatin nanofibers.  Therefore, an alternative cheap and biocompatible water 
solvent system is used for the electrospinning of gelatin nanofibers. 
 
3.1.   ELECTROSPINNING OF GELATIN NANOFIBERS IN AQUEOUS SOLUTION 
 
A solvent has to perform two crucial roles in the process of electrospinning. Firstly, to dissolve 
the polymer molecules and secondly to carry those dissolved polymer molecules to the 
collector. From the literature, it has been found that it is impossible to spin gelatin in pure water 
solvent at room temperature, despite the fact that gelatin is water soluble. This is because of its 
polyelectrolytic characteristics and gelatin results in ionizable groups when it is dissolved in 
water [3-6]. Gelatin also exhibits a semi-solid gel at a temperature 40C due to the formation 
of strong hydrogen bonds. This means the aqueous gelatin solution forms a gel at room 
temperature, which makes gelatin difficult to electrospin. Moreover, the slow evaporation rate 
of water adversely affects the electrospinning process by hindering the conversion of solution 
into dry nanofibers during the travel between the needle and collector (139). It is hypothesised 
that heating will inhibit the formation of gel and allows the gelatin solution to be electrospun 
at elevated temperature (119). In this work, the challenge of electrospinning gelatin in aqueous 
solution was accomplished by raising the temperature and humidity, and by keeping the whole 
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electrospinning setup in an enclosed incubator. The temperature was set above 40C using a 
hot plate and humidity was maintained above 50% using an ultrasound nebuliser. This made 
the favourable conditions for electrospinning gelatin nanofibers in water solvent. 
 
Temperature and humidity are the two environmental factors that significantly influence the 
electrospinnability of gelatin, particularly in aqueous solution. High temperature and humidity 
are crucial to prevent the gelation and successful formation of the spinning jet. There are also 
works stating the dependence of humidity in fiber morphology. In 2014, Li et al. studied the 
influence of relative humidity on the morphology of gelatin nanofibers when electrospun in 
aqueous solution. They obtained curled nanofibers at a lower humidity below 50% and 
converted into helical structures as the humidity is further increased (163). In another study, a 
relatively lower humidity (<50%) resulted in fiber breakage due to decreased electrostatic 
discharge from the jet, whereas high humidity resulted in the loss of fiber morphology as a 
result of increased water absorption (164).     
 
Hence, to achieve electrospinning, in addition to the optimization of various standard 
parameters such as the concentration of the polymer, the flow rate at which the polymer 
solution is ejected from the needle, applied voltage and the distance between the needle and 
the collector, the non-conventional parameters such as temperature and humidity are necessary. 
The influences of these parameters on the electrospinnability of gelatin in aqueous solutions 
were investigated and are discussed below. 
 
In the process of electrospinning, an optimum concentration of polymer solution is needed for 
the formation of nanofibers without beads. Other solution parameters that play an essential role 
in electrospinning are molecular weight and viscosity. All these factors can change the 
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rheological properties of the polymer solution, which in turn affects the forces acting on the 
spinning jet. 
 
From the literature, it has been found that at lower concentrations of solutions, the electrospun 
scaffolds produced a mixture of fibers and beads, whereas when the concentration is increased, 
the shape of the beads changed from spherical to spindle-like and finally resulted in the 
formation of uniform fibers without any beads (165).  High polymer concentrations are often 
not spinnable because of their high viscosity. Since viscosity is directly proportional to the 
concentration of polymer solution, an increase in polymer concentration results in a higher 
number of polymer chain entanglements and can hinder the formation of a spinning jet. At 
lower concentrations, the viscosity of the solution will be lower, and below a particular 
concentration, the deposition of droplets occurs rather than fibers. Hence, the study started with 
a lower concentration of 10% (wt/vol) and increased to 15% (wt/vol) of gelatin solution to 
perform electrospinning.  
 
Initially, when a lower concentration of gelatin (10% wt/vol) with different flow rates (3 l/min 
and 5 l/min) were used, the obtained fibers were with beads. Table 3.1 shows the parameters 
used for the electrospinning of 10% (wt/vol) gelatin solution and the SEM images of obtained 








Table.3.1.  Parameters used for spinning 10% (wt/vol) gelatin solution 
 
Parameters Values used 
Concentration of gelatin 10% 
Flow rate 3 l/min and 5 l/min 
Distance between the needle and collector 10 cm 
Applied voltage 20 kV 
Temperature Above 40C 





Figure 3.1. SEM images of 10% (wt/vol) gelatin fibers electrospun at different flow rates. The 
first row represents the images of electrospun gelatin fibers at a flow rate of 3 l/min (a, b and 
c) and second row represent the images of electrospun gelatin fibers at a flow rate of 5l/min 
(d, e and f). The applied voltage was set to 20 kV. Images (b),(c), (e) and (f ) are the higher 
magnification images to show the beads. 
 
 72 
From the SEM images, it was apparent that both the flow rates created fibers with beads and 
were not suitable for further studies. There was not much difference in the size of the beads 
when the flow rate was increased. This indicates that the solution properties are not appropriate 
for the formation of gelatin nanofibers. 
 
 Next, a higher concentration of gelatin (15% wt/vol) was attempted to get a better morphology 
of fibers. When the gelatin solution of 15% (wt/vol)  was electrospun, the obtained fibers were 
still with beads but with reduced size. Table 3.2. shows the parameters used for electrospinning 
15% (wt/vol) gelatin solution and the SEM images of obtained fibers are shown in figure.3.2. 
 
Table.3.2.  Parameters used for spinning 15% (wt/vol) gelatin solution 
 
Parameters Values 
Concentration of gelatin 15% 
Flow rate 3 l/min 













Figure 3.2. SEM images of 15% electrospun gelatin fibers at a flow rate of 3 µl/min and 10 kV 
applied voltage.  Images (b) and (c) represents the higher magnification images of image (a). 
 
As the concentration increased to 15% (wt/vol),, the fibers formed were of better morphology 
compared to 10% (wt/vol),  electrospun gelatin fibers. From the images, it was evident that the 
size of the beads was reduced, and the shape of the beads changed from spherical to spindle-
like. Hence it was found that 15% (wt/vol), will be the optimum gelatin concentration for 
electrospinning gelatin in aqueous solution. Also, it was found that changing the other 
parameters such as applied voltage or flow rate slightly by maintaining the gelatin 
concentration to 15% (wt/vol),, will result in the creation of nonwoven ultra-thin nanofibers 
without beads.  
 
When the polymer concentration was increased to 15% (wt/vol),, the applied voltage was 10 
kV, as it was the first instance where the fibers were deposited on the collector. According to 
the literature, the fibers are produced when the electrostatic force of repulsion overcomes the 
surface tension of the solution. When the concentration is higher, the viscosity increases and 
the solution carries more charges because of the higher solution conductivity (165). The 
polymer solution carries the same charges, and under the influence of an electric field, they 
experience an electrostatic force of repulsion. To overcome this electrostatic force of repulsion, 
and for the successful formation of the Taylor cone, there should be sufficient applied voltage. 
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Therefore, from the results, it was assumed that even though fibers were formed at an applied 
voltage of 10 kV, it was not adequate to produce nanofibers with proper morphology.  
 
The next trial was performed by increasing the applied voltage to 20 kV, while other parameters 
such as the concentration of gelatin polymer, distance and flow rate were kept constant. The 
higher concentration of gelatin helped the solution to get viscous enough to form a Taylor cone 
and the increase in voltage aided the solution to overcome the surface tension and to eject from 




Figure 3.3. SEM images of optimised gelatin nanofibers at a flow rate of 3 µl/min and 20 kV 
applied voltage. Images (b) and (c) represents the higher magnification images of (a). In image 
(c), the diameters of nanofibers measured by Image J software are shown.The histogram 
represents the average fiber diameter was 19030 nm. 
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From the SEM images, the attained nanofibers were beads-free and randomly oriented ultra-
thin nonwoven nanofibers. The fibers were continuous with a three-dimensional network 
structure having interconnected pores which resemble the ECM (Figure.3.3. a&b). The 
nanofibers were found to have an average diameter of 19030 nm (Figure.3.3. c). Hence these 
parameters were found to be desired parameters for electrospinning gelatin in aqueous solution. 
The optimised conditions for spinning gelatin nanofibers in pure water solvent are listed in 
table 3.3. and the photographs of gelatin nanofibrous scaffolds are shown in figure 3.4. 
Table 3.3. Optimised conditions for electrospinning gelatin nanofibers in aqueous solution 
 
Parameters Optimised values 
Concentration of gelatin 15% 
Flow rate 3 l/min 
Distance between the needle and collector 10 cm 
Applied voltage 20 kV 
Temperature Above 40C 




Figure 3.4. Photographs of gelatin nanofibrous scaffolds peeled off from the aluminium foil. 
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From the SEM images, it was evident that the electrospinning is dependent highly on the 
concentration of the gelatin. When the concentration of gelatin increased from 10% to 15%, 
the number of beads formed was reduced, and the fiber morphology of beads on a string was 
obtained (Figure. 3.2). The effect of polymer concentration on electrospinning nanofibers has 
been reported in several studies (165-170). In 2013, Oraby et al. reported that an increase in 
the concentration of gelatin solution from 30% to 50% w/v produced beads or smooth fibers 
depending on the concentration range. Acetic acid was used as the solvent for preparing the 
gelatin solution, and the electrospinning was carried out at 20 kV applied voltage and a distance 
of 18 cm. At 30% gelatin concentration, no fibers were observed, but when the concentration 
was increased to 40%, the fibers were found bonded at their contact sites. It is assumed that 
this can be due to the incomplete evaporation of the solvent. A further increase in the 
concentration of gelatin polymer to 50% resulted in fibers with proper morphology. In this 
article, they have also reported the dependence of fiber diameter on gelatin polymer 
concentration. When the gelatin concentration was increased from 40% to 50%, the fiber 
diameter also increased (165). This result was in agreement with the result obtained by Huang 
et al. in 2004 (161). 
 
Another parameter investigated during the process of electrospinning gelatin was the applied 
voltage. It was found that when the voltage is increased from 15 kV to 20 kV, by keeping all 
other processing parameters and solution concentration constant, the morphology of the fibers 
also changed from beads on a string to ultra-fine fibers without any beads. It has been already 
reported that attainment of a threshold voltage is essential for the initiating drop to stretch 
enough to form a Taylor cone along with an electric field to start the electrospinning process 
(165).  The applied voltage can induce necessary charges on the polymer solution and helps to 
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overcome the surface tension under the influence of the electric field. It has also been reported 
that the increase in applied voltage, increases the electrostatic force of repulsion on the polymer 
solution and hence results in the easy breakage of the initiating drop to enhance the process of 
electrospinning and thereby to narrow the fiber diameter (166). But higher voltage is not always 
recommended as there is an increased probability of occurring beads (166, 167). Hence the 
optimum applied voltage should be chosen carefully while considering other factors such as 
the concentration and conductivity of the polymer. 
 
Therefore, the parameters for electrospinning gelatin nanofibers were optimised by 
maintaining the temperature and humidity above 40C and 50% respectively. Since one of the 
aims of this study was to investigate stem cell responses to ECM-like scaffolds with different 
matrix stiffness, an in situ cross-linking electrospinning technique was opted to obtain gelatin 
nanofibrous scaffolds with tunable mechanical properties.       
 
3.2.   ELECTROSPINNING OF CLGS 
 
The gelatin nanofibers should be well cross-linked to be used as a promising material for tissue 
engineering and regenerative medicine applications. This is because it is of utmost importance 
that these nanofibers should maintain their structural integrity in aqueous environments. 
Moreover, since our study was based on how the material’s matrix stiffness is affecting the 
stem cell fate, it was crucial that the nanofibers should retain its structure at least for three 
weeks to facilitate the stem cell adhesion, proliferation and differentiation. 
 
As discussed in section 2.7.1, there are different cross-linking methods available to make 
gelatin suitable for tissue engineering applications. The most commonly used cross-linking 
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method is the external cross-linking in which the cross-linking is done externally after 
performing the electrospinning. This is usually carried out by soaking the electrospun 
nanofibrous scaffolds in the cross-linking reagent for a desired period of time. Among the 
cross-linking reagents, EDC/NHS is the widely used carbodiimide for cross-linking gelatin. 
The schematic representation of chemical cross-linking with EDC/NHS is explained in the 
Materials and Methods chapter. There are many studies where EDC/NHS were used for the 
successful cross-linking of gelatin nanofibers (144, 145, 156, 171). For example, Mota et al. 
reported the use of EDC/NHS as an efficient cross-linking method for cross-linking a peptide 
modified PCL/gelatin nanofibrous scaffolds. These scaffolds were used for investigating the 
behaviours of human bone marrow-derived Mesenchymal Stem Cells (MSCs) when cultured 
on EDC/NHS cross-linked PCL/gelatin nanofibrous scaffolds (156). There are some other 
studies in which the researchers compared the crosslinking abilities of EDC/NHS and genipin 
and have found that EDC/NHS is superior to genipin in terms of its cross-linking strength and 
biocompatibility [15-17]. In a study conducted by R. Yao et al., they analysed the cross-linking 
efficacy of EDC/NHS and genipin by treating PCL/gelatin nanofibrous scaffolds with 1% 
genipin, 2% genipin and EDC/NHS respectively. After cross-linking, the genipin cross-linked 
PCL/gelatin nanofibers were found to be merged and fused together at the junctions.  However, 
the EDC/NHS cross-linked PCL/gelatin nanofibers were less merged and showed no 
significant difference in the fiber morphology and dimensions. Additionally, they showed 
enhanced MSCs attachment on the scaffolds, demonstrating their biocompatibility (144). For 
this reason, EDC/NHS was selected as the cross-linking agent for effectively cross-linking 
gelatin nanofibers in our study. 
 
Since the objective of this study was to fabricate gelatin nanofibrous scaffolds with different 
mechanical stiffness, which is dependent on cross-linking densities, an alternative method 
 79 
named ‘in situ cross-linking electrospinning’ was preferred. One of the main advantages of 
using this method is that the amount of cross-linking agent incorporated into the polymer 
solution can be controlled internally.  The homogeneity of the cross-linking should be 
improved compared to externally cross-linked nanofibers. In the case of conventional external 
cross-linking methods, the cross-linking agent is introduced into electrospun nanofibers 
through diffusion. Also, the cross-linking is not as efficient because increased cross-linking on 
the surface leads to the reduced diffusion hence decreased chemical bonding inside the 
nanofibers. There are chances for these weakly cross-linked bonds to disrupt in an aqueous 
environment, which results in the loss of fiber morphology and structural integrity. Moreover, 
the external cross-linking requires additional post-processing steps to remove the unreacted 
residues in order to reduce cytotoxicity. Hence, an in situ cross-linking electrospinning method 
was opted to produce gelatin nanofibers with EDC/NHS as the internal cross-linking agent.  
 
In situ cross-linking is usually achieved by mixing the polymer solution with the cross-linking 
agent vigorously for an extended period of time to attain homogeneous mixing. For example, 
in 2016, Takeda et al. fabricated nanofibrous collagen scaffolds by an in situ cross-linking 
method. In that work, they used HFIP as the solvent for collagen solution preparation, and this 
solution was homogeneously mixed with 25% of glutaraldehyde solution to achieve in situ 
cross-linking (172). Although in situ cross-linking was effectively accomplished, the method 
described by Takeda et al. does have some drawbacks. Firstly, the cross-linking agent 
glutaraldehyde is toxic to the cells, and when it is internally cross-linked, there are chances for 
the unreacted glutaraldehyde residues to remain in the scaffold itself. This will be directly taken 
up by the cells during the degradation of scaffolds and results in apoptosis of cells in in vitro 
(173-175). Glutaraldehyde cross-linking can also cause calcification in vivo (176). Another 
limitation of this method is that 100% of cross-linking degree cannot be achieved through 
 80 
mixing and the amount of cross-linking agent that to be incorporated cannot be fine-tuned. 
Hence, another work done by Kishan et.al, was followed, where they used a double-barrel 
syringe setup to carry out the in situ cross-linking of gelatin nanofibers.  They used TFE as the 
solvent for mixing gelatin molecules, and a catalyst 1,4-diazabicyclo [2,2,2] octane (DABCO) 
was also added to the 5% gelatin solution before electrospinning. A solution of hexamethylene 
diisocyanate (HDI) was used as the cross-linker, and the barrel ratio used for in situ cross-
linking was 1:1 with attachable mixing heads (97). 
 
 This study also adopted the same method of synthesis as of Kishan et al., but with a small 
difference in the barrel ratio. The aim was to totally minimise the use of any organic solvents 
during the fabrication process; hence a double barrel syringe of barrel ratio 10:1 was used, and 
the EDC/NHS was introduced into the smaller barrel. This facilitated in the blending of 
EDC/NHS with gelatin polymer solution in the required amount for the cross-linking to occur. 
It is possible to spin conventionally mixed gelatin-EDC/NHS solution with a normal syringe 
(21G), but the electrospinning was not continuous and resulted in 80% of solution wastage as 
the viscosity increases with increasing cross-linking density. Therefore double-barrel syringe 
was utilized to aid electrospinning by mixing the gelatin and EDC/NHS just before it is ejected 
from the needle and this reduced the chances of clogging. This resulted in the formation of 
uniform scaffolds and increased the reproducibility. 
 
Thus, gelatin nanofibrous scaffolds with different cross-linking densities (denoted as 2X, 5X 
and 8X) were developed, and the 10X solution was not spinnable because of the high viscosity 
of the solution. This made the gelatin solution to get stuck inside the needle and inhibited the 
formation of a spinning jet. Hence it was worth examining the rheology of gelatin solution with 
different cross-linking density to find out at what viscosity the solution is not spinnable and to 
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understand the flow behaviour. The rheological behaviour of gelatin solution with different 
cross-linking concentrations is discussed below. 
 
3.2.1.  Solution characterisation 
 
The solution rheology was analysed to find out the viscosity at which the solution is not 
spannable and to assess the flow behaviour. The most noticeable effect of increasing the cross-
linking concentrations of EDC/NHS on the gelatin solution was a rise in shear viscosity, shown 
in figure 3.5. This can be explained as the effect of increased cross-linking between the gelatin 
solution and EDC/NHS. As the concentration of EDC/NHS increased, more overlapping of 
polymer chains and cross-linker in the solution occurred, and this created a greater opportunity 
for the chains to interact. Therefore, as the cross-linking concentration is increased, new bonds 
are formed by resisting the flow of gelatin solution, which in turn resulted in higher viscosity. 
According to the literature, as the concentration is increased, more dynamic polymer chains 
entangling and disentangling occurs. This requires tremendous energy, and hence, more of the 
kinetic energy introduced by the shearing force is dissipated during the process of chain 
entanglements (177). This results in the resistance of the solution to flow and thereby an 










                                       
 
Figure.3.5.  Graph showing the viscosity vs shear rate characteristics of gelatin solution (a), 
flow behaviour of 2X gelatin solution (b), flow behaviour of 5X gelatin solution (c) and flow 
behaviour of 8X gelatin solution (d). The log viscosity vs shear rate graph of 2X, 5X and 8X 
solutions shows the increase in viscosity as the cross-linking concentration of EDC/NHS is 




From figure.3.5, it was evident that as the cross-linking density increased not only the viscosity, 
but the shape of the viscosity vs shear rate curves also differs. The pure gelatin solution 
followed almost a Newtonian curve at shear rates up to 9 reciprocal seconds (Figure.3.5. a), 
means the viscosity of gelatin solution is independent of the shear rate. Most of the polymer 
solution shows a linear, Newtonian region in the viscosity vs shear rate curve. For Newtonian 
fluids, the viscosity remains constant even though different forces are applied to make the 
solution flow. For gelatin solutions incorporated with varying concentrations of EDC/NHS, the 
viscosity vs shear rate curves exhibited a Non-Newtonian shear-thinning behaviour (Figure 
3.5. b), c) and d). The viscosity of 47.55 Pa.s was obtained for a 2X solution and was increased 
to 64.35 Pa.s and 129.6 Pa.s for 5X and 8X solutions respectively at a shear rate of 0.11s-1. 
Therefore, as the cross-linking density is increased, the viscosity also increased (Figure 3.5. 
e). For 2X, 5X and 8X solutions, the viscosity decreased with an increase in the shear rate. A 
rapid decrease in the viscosity was found for 2X, 5X, and 8X solutions at low shear rates 
compared to high shear rates. For example, a 2X solution exhibited a rapid decrease in the 
viscosity from 350 Pa.s to 50 Pa.s. at a lower shear rate (less than 1 s-1) (Figure 3.5. b). This 
is because of the shear thinning behaviour of the solutions.  This shear thinning response is an 
indication that the polymer solution has more complex molecular chains. The decrease in 
viscosity with respect to an increase in shear rate could be explained because of the alignment 
attained by the polymer molecules upon applied shear force. This molecular alignment made 
the solution to flow more quickly, which reduced the viscosity at increased shear rates. The 
shear thinning behaviour of the polymer solutions was also investigated by Diego et. al. They 
also found that polymer solutions tested were non-Newtonian pseudo plastic fluids, and the 
apparent viscosity decreased with increasing shear rate (178).  
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According to the literature, the viscosity of the polymer solution much depends on various 
factors such as molecular weight, the shape of the molecules, the interaction between the 
polymer molecules and the solvent, the concentration of the polymer solution and the 
hydrophilic nature of the polymer (179). So, the change in viscosity of the polymer solution is 
due to the synergistic effect of all these factors.  In this study, the increase in concentration of 
the cross-linking agent resulted in more bond formation and made the solution more viscous. 
It was also found that the gelatin solution is not spinnable above an average viscosity of 900 
Pa.s.  In 1994, Yasuo et al. investigated the rheological behaviour of the ultra-high molecular 
weight polyethene (UHMWPE) to access its application in the gel spinning technology. In that 
work, they found that polyethene solutions exhibit a shear thinning behaviour at a shear rate 
ranging from 10−4 to 103 s−1. Furthermore, as the concentration of PE solutions was increased, 
the non-Newtonian behaviour was more evident (180). Our findings were also similar to this 
study, which supports the theory. 
 
Hence from the rheology testing, it was found that as the concentration of EDC/NHS increased, 
the viscosity of the solution also increased, and the solution is not spinnable above an average 
viscosity of 900 Pa.s. Therefore, the solution characterisation was carried out, and the 
optimisation of other electrospinning parameters for the fabrication of CLGS are explained in 
the next section. 
 
3.2.2.  Optimisation of CLGS 
 
The CLGS were fabricated by optimising the injection flow rate of the polymer solution from 
the needle to the collector and applied voltage while keeping constant the distance between the 
needle and the collector (10 cm) and the gelatin concentration (15%). The optimised 
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electrospinning conditions for different concentrations of cross-linking agents EDC/NHS 
(range from 2 times of 14 mM EDC and 5.5 mM NHS to 8 times of 14 mM EDC and 5.5 mM 
NHS, denoted as 2X, 5X and 8X) is shown in table.3.4.  
 
Table.3.4. Optimised electrospinning conditions for CLGS. The temperature was set to above 
40C and humidity above 50% for all the electrospinning process. 
 
Cross-linking density 
(X=14 mM EDC and 
5.5 mM NHS )  
Concentration of gelatin 
(wt\vol) 






2X 15% 25 10 18 
5X 15% 10 10 22 
8X 15% 7 10 22 
 
The concentration of gelatin was kept constant because, at 15% (wt/vol) gelatin concentration, 
the fibers formed were beads-free and were with good morphology. So, by following the gelatin 
concentration to 15% (wt/vol) and distance at 10 cm, the flow rate and applied voltage were 
adjusted to obtain gelatin nanofibers with different cross-linking densities and therefore 
different stiffness.  
 
3.3.  CHARACTERISATION OF CLGS 
 
To analyse the effect of matrix stiffness on CPs fate, the fabricated gelatin nanofibrous 
scaffolds should be well cross-linked and structurally stable to be used in the cell culture media 
for the CPs to adhere, proliferate and differentiate into cardiac specific lineages. Furthermore, 
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it should be mechanically tested to inspect the effect of increasing cross-linking density in the 
matrix stiffness. 
 
So, the as-fabricated CLGS were physiochemically characterized by SEM, AFM and FT-IR. 
The SEM and AFM studies were carried out to investigate the morphological and topographical 
behaviour of the synthesised gelatin nanofibers. FTIR characterisation was performed to 
confirm the cross-linking by analysing the characteristics peaks while the ninhydrin assay was 
conducted to evaluate the efficiency of cross-linking. The stability of the fabricated scaffolds 
was examined by performing the dissolvability test. The mechanical characterization of the 
scaffolds was carried out to measure Young’s modulus of the scaffolds in both wet and dry 
conditions. 
 
3.3.1.  Morphological characterisation of CLGS 
 
The morphological analysis of the developed CLGS was carried out by using SEM. The SEM 









Figure. 3.6. SEM images of CLGS. SEM images of 2X CLGS (a & b), 5X CLGS (c & d), and 
8X CLGS (e & f). The figures (b), (d) and (f) are the magnified SEM images of (a), (c) and (e), 
respectively. Bar graph represents the average fiber diameter of each scaffold (uncross-linked 
gelatin nanofibers were used as the control, and the average fiber diameter is also shown for 
comparison). The histogram representing the average fiber diameter of 2X (h), 5X (i) and 8X 
(j) scaffolds are also shown. Values are mean and SE, N=3 repeats. ANOVA, P<0.01; Tukey’s 
multiple comparisons test adjusted P values: **P<0.01 vs. control, ++P<0.01 vs. 2X, ##P<0.01 
vs 5X.  
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The SEM images showed that the obtained in situ cross-linked nanofibrous structures were 
beads-free, porous and randomly arranged nonwoven fibers (Figure.3.6. a)-f). The 2X and 5X 
CLGS were appeared to be of webbed morphology rather that intact ultrathin nanofibers and 
have an average diameter of 3986 nm and 2535 nm, respectively (Figure 3.6. a)- d). Among 
the three concentrations of EDC/NHS, the gelatin nanofibers cross-linked with the 8X 
concentration of EDC/NHS were found to be of uniform structure and good fiber morphology, 
having an average diameter of 12710 nm (Figure 3.6. e) and f). Hence it was found that as 
the cross-linking density is increased the fiber diameter reduced significantly (bar graph). This 
is due to the synergistic influence of electrospinning parameters such as voltage and flow rate. 
An increase in applied voltage and a decrease in flow rate resulted in nanofibers with reduced 
fiber diameter. The cross-linking density has also influenced the fiber diameter. An increase in 
cross-linking density resulted in the new bond formation and shrinkage in fiber dimensions by 
reducing the fiber diameter significantly. The diameter measurements of individual nanofibers 
were done by using Image J software.  
 
As discussed in section 4.1.1, many factors such as the concentration of the polymer solution, 
applied voltage and flow rate can affect the fiber diameter. Here the decrease in fiber diameter 
can be recognised mainly due to the increase in cross-linking density. When the cross-linking 
density is increased, new bonds were formed, and the shrinkage of fiber dimensions occurred. 
There were not many works explaining the effect of cross-linking density on fiber diameter 
since most of the studies were dealt with external cross-linking in which it was difficult to 
control the cross-linking density. In work by Kishan et al., gelatin scaffolds with different 
cross-linking densities were fabricated by in situ cross-linking with HDI. In this work, they 
found that the average fiber diameter of the developed 1X mesh was 0.74 ± 0.32 μm, 5X and 
10X was 0.77 ± 0.17 μm and 0.72 ± 0.29 μm respectively (where X represents different 
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concentrations HDI) (97). There was a slight decrease in the fiber diameter when the cross-
linking degree was increased, but it was not significant. Hence it is hypothesized that the 
decrease in gelatin fiber diameter was due to the synergistic effect of increased applied voltage, 
decreased flow rate and increase in cross-linking density. All these processing parameters 
collectively contributed to the reduction in gelatin fiber diameter as the cross-linking 
concentration of EDC/NHS is increased. 
 
Therefore, all the obtained CLGS were morphologically analysed and found that as the cross-
linking density is increased, the fiber diameter decreased and the 8X scaffolds have good 
morphology with randomly oriented ultra-thin fibers compared to other counterparts. 
 
3.3.2.   Topographical characterisation of CLGS 
 
The topography of CLGS was tested by using AFM. The 3D surface plot of individual 
nanofibers is shown in figure.3.7. This shows the topographical behaviour of cross-linked 
gelatin nanofibers with different concentrations of EDC/NHS. The height information of the 









Figure.3.7. AFM images of individual nanofibers.  The image (a) represents uncross-linked 
gelatin, (b)-2X cross-linked gelatin, (c)-5X cross-linked gelatin and (d)-8X cross-linked gelatin 
nanofiber. 
 
All individual fibers were found to have an average height of 10610 nm. The height 
information directly reflects the surface roughness of the nanofibers, which is closely related 
to the aspect ratio (181). In all images, the relative height information is displayed in a colour 
bar, and the brightest point represents the maximum height of each fiber. In the 3D images, the 
brightest point shows the nanofiber and dark portion is the substrate, which is aluminium foil. 
The fiber diameter was also evident from the images. Since they were individual fiber 





From the images, all the individual nanofibers exhibited a smooth surface. The surface 
topography of uncross-linked gelatin nanofiber and cross-linked gelatin nanofibers were 
similar. This showed that there was no change in the topography even after the cross-linking 
of gelatin nanofibers. In work done by Jaiswal et al., they found that when Poly-L-lactic acid 
PLLA is incorporated with collagen and gelatin is combined with PLLA; the obtained 
nanofibers showed a higher degree of surface roughness when compared to the pure PLLA and 
pure gelatin (30). Hence the addition of another polymer resulted in a higher degree of 
roughness. In this work, the retention of surface topography after cross-linking can be 
explained as because of the cross-linking occurred between the polymer chains or due to the 
intermolecular reaction. 
 
It is worth mentioning that the roughness of the material can enhance the cell adhesion and 
proliferation on nanofibrous scaffolds. In the cell culture study conducted by Jaiswal et al., the 
scaffolds with a higher degree of roughness (mean root square roughness (Sq) of 1409 nm,) 
showed improved cell adhesion and spreading compared to other scaffolds (182). They 
discovered that the blending of PLLA with gelatin increased the surface roughness and reduced 
the hydrophobicity of PLLA. Since this study was based on the effect of matrix stiffness on the 
stem cell fate, it was paramount that the surface topography should be smooth to nullify the 
effect of roughness. Hence from the AFM analysis, it was confirmed that all the obtained 
nanofibers were smooth which reduced the possibility of occurring alterations in the cellular 
behaviour that could have happened by surface roughness and all the tested nanofibers were 




3.3.3.   Structural stability of CLGS 
 
The dissolvability test was performed to check whether the nanofibrous scaffolds are retaining 
their structural properties when it is immersed in PBS. It was essential for the fibers to maintain 
their structural integrity at least for three weeks for the cells to adhere, proliferate and 
differentiate. Cross-linking agents like EDC/NHS, are reportedly less efficient in maintaining 
structural stability over 3 weeks. This could preclude the use of scaffolds for tissue/cell 
engineering applications in the wet condition (150). Therefore, the dissolvability property of 
the EDC/NHS scaffolds were tested and verified if this can be improved by the addition of 
meagre percentage of Glutaraldehyde (Glu) vapour (5%) which can create stronger aldimine 
linkages. Reports suggest that glutaraldehyde concentration of  up to 8% is non-toxic to cells 
(183, 184). The SEM images of as-spun scaffolds, EDC/NHS, cross-linked scaffolds after two 
weeks, and Glu treated EDC/NHS scaffolds after three weeks immersed in PBS are shown in 
figure. 3.8. The average fiber diameter of hydrated Glu/EDC/NHS cross-linked scaffolds after 









Figure.3.8. Degradation test of gelatin nanofibrous scaffolds. The first row represents SEM 
images of 2X, 5X and 8X EDC/NHS CLGS (a, b and c). The second row represents the SEM 
images of 2X, 5X and 8X EDC/NHS CLGS after two weeks immersed in PBS (d, e) and f). 
The third row represents Glu vapour treated EDC/NHS cross-linked 2X, 5X and 8X gelatin 
nanofibers after 3 weeks immersed in PBS (g, h and i). Image (j) represents the bar diagram 
showing the average fiber diameter of Glu/EDC/NHS CLGS after 3 weeks in aqueous solution. 
Values are mean and SE, N=3 repeats. ANOVA, P<0.01; Tukey’s multiple comparisons test 
adjusted P values: *P<0.05 vs. 2X, +P<0.05 vs. 5X, **P<0.01 vs 8X. 
 
SEM imaging of as-spun CLGS confirmed the porous and nonwoven fibrous structures of the 
fabricated scaffolds with different matrix stiffness (Figure.3.8. (a-c).  The as-spun EDC/NHS 
cross-linked 2X gelatin nanofibers were fully dissolved, and the material disappeared after two 
weeks of immersion in PBS (Figure.3.8. d). This showed the instability of the gelatin 
nanofibers when cross-linked with a 2X concentration of EDC/NHS. While 5X and 8X 
EDC/NHS cross-linked gelatin nanofibers changed its morphology to a film rather than intact 
nanofibers (Figure.3.8. e and f). As mentioned earlier, since the study was based on the effect 
of matrix stiffness on stem cell fate, it was important to retain the nanofibrous structure for the 
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cells to adhere, proliferate and differentiate on the material. So, when an external cross-linking 
was done with Glu vapour, all scaffolds retained their structure, and a fibrous morphology was 
obtained even after three weeks immersed in PBS (Figure.3.8. g, h and i). This showed the 
efficiency of the chemical cross-linking method and the stability of the material to be used as 
a scaffold for tissue engineering and regenerative medicine applications. The diameter of the 
2X, 5X and 8X Glu/EDC/NHS cross-linked gelatin nanofibers after 3 weeks immersion in 
aqueous solution were found to be 3385 nm, 2403nm and 11045nm respectively 
(Figure.3.8. j).  
  
From the quantification analysis of fiber diameter, all scaffolds slightly reduced their fiber 
dimensions after 3 weeks, and the 8X scaffold displayed ultrathin fibers. Our results were 
contradictory to the results obtained by Kishen et.al. In his work, the gelatin nanofibers were 
cross-linked with glutaraldehyde, and when immersed in water for a week, the fibers were 
flattened and formed a webbed morphology (97). Here they have stopped the dissolvability test 
after a week of immersion in water. If they had continued the experiment until the third week, 
they would have observed the same morphology of fibers as this work. The reduction in fiber 
dimensions in this work can be recognized as the effect of partial dissolution of gelatin 
nanofibers by hydrolysis. 
 
From the dissolvability test, the retention of structural integrity was observed after three weeks, 
when they are cross-linked both internally (with EDC/NHS) and externally (with Glu). Thus, 
we obtained well cross-linked and stable CLGS. Therefore, this fabrication process was further 
assessed for physicochemical characterisation of the scaffolds and studies of tissue engineering 
with human cells. 
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3.3.4. FTIR analysis of CLGS 
 
The presence of EDC/NHS and Glu in the CLGS was explored by using FTIR.  The FTIR 
spectra of pure gelatin nanofibers, Glu cross-linked gelatin nanofibers and Glu treated various 
concentrations of EDC/NHS cross-linked gelatin nanofibers are shown in figure.3.9.  
 
                    
 
Figure. 3.9. FTIR spectra of pure gelatin and cross-linked gelatin nanofibers (A). The spectrum 
(a) denotes uncross-linked gelatin nanofibers, (b) represents Glu alone cross-linked gelatin 
nanofibers, (c) is the spectrum of Glu treated 2X EDC/NHS cross-linked gelatin nanofibers, 
(d) is the spectrum of Glu treated 5X EDC/NHS cross-linked gelatin nanofibers and (e) is the 
spectrum of Glu treated 8X EDC/NHS cross-linked gelatin nanofibers. 
 
The black trace in the figure shows that the characteristic peaks of gelatin were obtained at at 
1650 cm-1, which denotes the amide I peak (C=O stretching vibrations), at 1540 cm-1, which 
corresponds to the amide II peak (N-H bending and C-H stretching vibrations), and at 1240 
cm-1, which signifies amide III peak (C-N stretching + N-H in phase bending) (Figure.3.9. a). 
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Similarly, the characteristic absorption peak for aldimine linkage was observed at 1690 cm-1 in 
the Glu crosslinked gelatin nanofibers (Figure. 3.9. b). The peak intensities were much lower 
for the nanofibers cross-linked with both Glu and EDC/NHS as compared with the Glu alone 
(Figure.3.9. c), with the decrease in peak intensity, is further enhanced by increasing the 
concentration of EDC/NHS (Figure.3.9. d and e). This phenomenon can be attributed to the 
EDC/NHS and Glu capability to reduce the amino groups of gelatin. The structure of gelatin 
was further disturbed when higher concentrations of EDC/NHS (5X and 8X) were used by 
eliminating Amide III peaks (1240 cm-1) (Figure.3.9. d and e).  
      
It has been reported that the amide A peaks due to N-H stretching vibrations usually arise at 
3400 cm-1   to 3340 cm-1 (185, 186). In the obtained FTIR spectra, the incidence of amide A 
peak was at 3300 cm-1. This shift in the amide A band to a lower frequency may be because 
the N-H groups are involved in the hydrogen bond formation (185, 187). The amide I peak at 
1650 cm-1 in the spectra of uncross-linked gelatin (Figure.3.9. a) and cross-linked gelatin 
nanofibers (Figure.3.9. b-e) have different intensities. In the Glu/EDC/NHS cross-linked 
gelatin nanofibers, the intensity of amide I peak at 1650 cm-1 (Figure.3.9. c-e) was much lower 
when compared to that of uncross-linked gelatin (Figure.3.9. a) and Glu alone cross-linked 
gelatin nanofibers (Figure.3.9. b). This difference in peak intensities upon cross-linking can 
be justified as because of the weakening of C=O bond in gelatin. As the cross-linking 
happened, the C=O bond in the gelatin is weakened because of the formation of new bonds 
between carboxyl groups and amine groups (185, 188). The peak at 1240 cm-1, which denotes 
the amide III bonds was much weaker for the Glu/2X EDC/NHS cross-linked gelatin 
nanofibers [Figure.4.9. (c)] compared to the uncross-linked gelatin nanofibers (Figure.3.9. a). 
This showed that the structure of pure gelatin was not disturbed by the cross-linking of Glu and 
EDC/NHS; however, the peak intensities were reduced. But, when higher concentrations of 
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EDC/NHS (5X and 8X) were used, the structure of gelatin was further disturbed by eliminating 
Amide A (3300 cm-1) and Amide III peaks (1240 cm-1), respectively (Figure.3.9. d and e).  
 
These findings were comparable with the results of Zhan et. al. (2016). They fabricated 
glutaraldehyde-gelatin nanofibrous scaffolds by mixing glutaraldehyde along with the gelatin 
solution to attain in situ cross-linking. In the FTIR spectra, amide A band was observed at 3409 
cm–1, amide I band was detected at 1644 cm–1, amide II band was observed at 1541 cm–1 and 
amide III bands at 1234 cm–1. All these frequencies were similar to that of the spectra obtained 
in our study. Another critical observation by Zhan et al. was the shift in frequencies of Amide 
I peaks after cross-linking with different concentrations of glutaraldehyde. As the concentration 
of glutaraldehyde increased, the amide I peaks shifted to lower frequencies. This is explained 
as because of the disruption of the helical structure of gelatin by excess glutaraldehyde (147). 
In the spectra obtained in this work did not show any peak shifts, which shows the incorporation 
of an exact amount of glutaraldehyde for the gelatin nanofibers to cross-link. 
 
Hence the scaffolds were well cross-linked with EDC/NHS, and Glu and their presence were 
confirmed by the reduction in the amino group of gelatin. Later, the extent of this cross-linking 
was investigated by performing the ninhydrin assay. 
 
3.3.5.  Cross-linking degree of CLGS 
 
Ninhydrin assay was carried out to estimate the cross-linking degree of gelatin nanofibers after 
cross-linked with Glu and EDC/NHS.  The colour change obtained when the scaffolds are 




       
 
Figure.3.10. Ninhydrin assay ofCLGS. (a) Represents the colour change of ninhydrin solution 
with respect to the cross-linking density. For Glu/EDC/NHS cross-linked gelatin nanofibers, 
the solution colour remained the same while the nanofibers with lowest cross-linking density 
changed the ninhydrin solution colour to light blue. (b) Shows the cross-linking degree of 
gelatin nanofibers. Values are mean and SE, N=3 repeats. ANOVA, P<0.01; Tukey’s multiple 
comparisons test adjusted P values: *P<0.05 and **P<0.01 vs. 2X EDC/NHS, ++P<0.01 vs. 
5X EDC/NHS, ##P<0.01 vs 8X EDC/NHS. 
 
The ninhydrin can react with the free amino groups in lysine residues of gelatin nanofibers 
upon heating. This caused the 2X nanofibrous scaffolds to change their colour to blue, and as 
a result, the ninhydrin solution also turned blue (Figure.3.10. a).  As the cross-linking density 
is increased, the blue colour of the solution faded and for the Glu/EDC/NHS cross-linked 
gelatin nanofibers, the ninhydrin solution remained as yellow (Figure.3.10. a). This exhibited 
the cross-linking ability of Glu and EDC/NHS when cross-linked externally and internally.  
 
The cross-linking degree was also quantified and found that the cross-linking degree of 
Glu/EDC/NHS cross-linked gelatin nanofibers was significantly higher than the 2X, 5X and 
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8X EDC/NHS alone cross-linked scaffolds (Figure.3.10. b). Almost 100% of cross-linking 
was achieved by Glu/EDC/NHS cross-linking whereas EDC/NHS cross-linked 2X, 5X and 8X 
scaffolds attained 309%, 505% and 652% respectively. Moreover, there was a significant 
difference in the cross-linking degree obtained among the 2X, 5X and 8XCLGS. The lowest 
concentration of Glu/EDC/NHS (2X) cross-linked scaffolds were tested in order to understand 
the effect of cross-linking and to get a significant result. Hence the Glu/EDC/NHS crosslinked 
scaffolds were found to be more efficient than EDC/NHS alone cross-linked scaffolds. 
 
In internal cross-linking with EDC/NHS, the carboxyl group of EDC/NHS reacts with the 
amino groups of gelatin to form amide bonds. In external cross-linking with Glu, the aldehyde 
group in the Glu can react with the amino group in the lysine residues of gelatin to create 
aldimine linkages. These were the two chemical reactions that occurred when the gelatin 
nanofibers were cross-linked both internally and externally with EDC/NHS and Glu. As a result 
of these two reactions, almost 100% cross-linking efficacy was obtained. The lower cross-
linking efficiency of 2X, 5X and 8X EDC/NHS alone cross-linked scaffolds demonstrated the 
existence of free amino groups. This proved the inefficiency of EDC/NHS cross-linking alone 
compared to EDC/NHS and Glu cross-linking. As the cross-linking concentration of 
EDC/NHS was increased to 8X, the maximum cross-linking degree achieved was around 70%. 
When these scaffolds were cross-linked with glutaraldehyde, approximately 100 % of the 
cross-linking degree was attained. 
 
In work done by Mota et al.(2014), they used a ninhydrin test as an indicator to investigate the 
presence of free amino groups. They fabricated PCL/gelatin nanofibrous scaffolds cross-linked 
with EDC/NHS and found that the uncross-linked PCL/gelatin scaffolds were blue in colour 
upon heat treatment, while the cross-linked PCL/gelatin scaffolds remained the same. Here 
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they have not performed the quantification analysis to assess the degree of cross-linking 
attained. Hence it was difficult to compare the results with our study and entirely rely on the 
qualitative result. In another study done by Hui-Kang Ma et al.(2010), the amniotic membranes 
(AM) were cross-linked with different concentrations of EDC/NHS (0.01, 0.05 and 0.25mM 
EDC/mg AM). In the ninhydrin assay, it was found that the membranes cross-linked with 
higher concentrations (0.05 and 0.25 mM EDC/mg AM) of EDC/NHS had a significantly 
higher cross-linking degree when compared to membranes with lower concentrations (0.01 
mM EDC/mg AM) (189). Hence the results obtained in this study were in accordance with 
Hui-Kang Ma et al.(2010), that the extent of cross-linking increased with an increase in the 
concentration of EDC/NHS. Additionally, in their work, the maximum cross-linking index 
obtained was around 50% for a lower concentration of 0.25 mM EDC/NHS, which was much 
lower than the concentration used in this study. The highest cross-linking degree of 70% with 
EDC/NHS in this study can be denoted as the increase in the concentration of EDC/NHS 
compared to the work of Hui-Kang Ma et.al(2010).  
 
The superiority of glutaraldehyde in the cross-linking efficiency compared to other cross-
linking agents such as EDC/NHS and genipin has been mentioned in several articles (183, 190, 
191). For example, in a review article regarding the cross-linking of biopolymers for 
biomedical applications by Reddy et al., concluded that glutaraldehyde is the most efficient 
and practical cross-linking agent despite their limitations and cytotoxicity (183). In 2010, Lai 
et al., evaluated the potential of EDC cross-linked and glutaraldehyde cross-linked gelatin 
membranes to be used as delivery carriers for retinal sheets. They reported that the cross-
linking index of EDC cross-linked gelatin membranes was 55.4 ± 3.2% and that of 
glutaraldehyde cross-linked gelatin membrane was 72.6 ± 2.7%. This difference between the 
two groups was statistically significant, as well. But the EDC cross-linked gelatin membranes 
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exhibited higher cytocompatibility which showed the toxic nature of glutaraldehyde. However, 
the cytotoxicity of glutaraldehyde depends on the concentration used and exposure time, and 
it has been reported that up to 8% of glutaraldehyde is non-toxic to cells (183, 184). Therefore, 
the combined cross-linking effect of EDC/NHS and Glu made the gelatin nanofibers more 
suitable to be used as a right candidate for further in vitro studies. 
 
Thus, it was found out that as the cross-linking density is increased, the cross-linking efficiency 
of the scaffolds also increased resulting in the new bond formation and Glu/EDC/NHS 
scaffolds showed highest cross-linking degree. Hence all the scaffolds used for the further in 
vitro studies were both internally and externally cross-linked scaffolds with different matrix 
stiffness.  
 
3.3.6. Mechanical properties of CLGS 
 
The mechanical properties of the scaffolds were measured by calculating the Young’s Modulus 
(YM) from the stress-strain graphs. The Young’s modulus is directly related to the stiffness of 
the material. The main aim of this work was to assess the effect of matrix stiffness on the stem 
cell fate; hence, it was very critical to measure the stiffness at both dry and wet conditions. The 
stiffness of the material will be different in both states, and therefore, the behaviour of the cell 
will also be altered. Thus, it was imperative to find out the matrix stiffness at the wet condition 
to evaluate the cell behaviour. The Young’s Modulus of uncross-linked gelatin and 







Figure. 3.11. Mechanical testing of scaffolds. (a) YM of scaffolds in the dry condition, (b) YM 
of scaffolds in wet condition. Values are mean and SE, N=3 repeats. ANOVA, P<0.01; Tukey’s 
multiple comparisons test adjusted P values: **P<0.01 vs. un-cross gelatin, ++P<0.01 vs. 2X 
EDC/NHS, ##P<0.01 vs 5X EDC/NHS. 
 
As expected, the scaffolds showed higher YM in the dry state (Figure.3.11. a) because of the 
rigid protein network when compared to the scaffolds in the wet state (Figure.3.11. b).  This 
can also be explained as because of the rigid and brittle properties attained by the scaffolds in 
the absence of water (88). Hence, in the dry state, the scaffolds showed increased YM as the 
cross-linking density is increased (Figure.3.11. a). When the cross-linking density is higher, 
the new bonds are formed between the functional groups of the gelatin, which in turn results 
in the formation of denser and compact structures. This attributed to the increased YM with an 
increase in cross-linking density. In work done by Vanderhoof et al., they prepared hyaluronan 
cross-linked gelatin hydrogels and investigated their rheological properties. They found that 
the gel stiffness was entirely dependent on the concentration and cross-linking density of the 
cross-linker. When they increased the ratio of thiol-modified gelatin, the effective 
concentration of the hyaluronan decreased, which in turn reduced the gel stiffness (192). This 
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result was in accordance with the results in this study, stating that as the cross-linking density 
is increased, the stiffness of the material also increases.  
 
 In both wet and dry conditions, the 8X CLGSshowed a significant difference in the YM when 
compared to that of pure gelatin, 2X and 5X CLGS. In the dry state, the 8X scaffolds showed 
an average YM of around 15 MPa, while 2X and 5X CLGS exhibited an average YM of around 
4 MPa and 10 MPa (Figure.3.11. a). There was also a significant difference in the YM among 
2X and 5X CLGS. The uncross-linked gelatin nanofibers indicated an average YM of around 
2 MPa which was very low compared to that of 5X and 8X cross-linked gelatin nanofibers. 
There was no significant difference in the YM among 2X and uncross-linked gelatin scaffolds. 
Dias et al. recently conducted a study to find out the best composite structures that match 
closely with the mechanical properties of skin for wound healing applications. They fabricated 
hybrid electrospun meshes with PCL and gelatin and evaluated its physical, chemical and 
mechanical properties. In the mechanical testing of scaffolds, they have reported that the 
gelatin nanofibers exhibited the lowest YM compared to the hybrid and PCL scaffolds. The 
obtained YM for gelatin scaffolds was less than 1 MPa (193). This result was supplementary 
to results obtained in this study, as the relative YM of uncross-linked gelatin nanofibers was 
around 2 MPa. Even though there are numerous works comparing the YM of nanofibrous 
scaffolds with different polymers, there are only a few works based on the effect of cross-
linking density on the YM of nanofibrous scaffolds. In work done by Jiang et al., they 
synthesised Pullulan/dextran (P/D) nanofibers by in situ cross-linking with different 
concentrations of sodium trimetaphosphate (SMTP) to obtain P/D scaffolds with different 
matrix stiffness. The YM analysis results were consistent with this study in which they found 
that as the cross-linking density is increased the YM of the P/D nanofibrous scaffolds also 
 104 
increased. The YM of  P/D scaffolds, when cross-linked with 10% of SMTP, was 7.71 ± 4.58, 
and the YM value increased 11.08 ± 6.36 kPa for 16% cross-linked P/D scaffolds (194). 
 
In wet condition, the presence of water contributed to a massive difference in the YM of 
scaffolds (Figure.3.11. b). Usually, the YM of nanofibrous scaffolds is in the range of KPa in 
the wet conditions. For example, in the previously mentioned work by Jiang et al., when the 
mechanical testing was done with hydrated samples to obtain the YM, the values were in KPa. 
The YM for 10 % SMTP cross-linked P/D samples were around 2KPa, whereas that for the 16 
% SMTP cross-linked P/D scaffolds were around 3 KPa (194). In this work, the YM of gelatin 
nanofibers were in the range of MPa. This can be justified as because of the cross-linking effect 
of EDC/NHS and Glu on the gelatin nanofibrous scaffolds. It is hypothesised that as the cross-
linking density is increased, the water absorption capacity of the scaffolds will decrease. Hence 
the fibers absorb less water as new bonds are formed, and the polymer chains come closer upon 
cross-linking, which in turn makes the scaffolds to have higher retraction forces (195, 196). 
The YM of 8X CLGS were found to be around 1 MPa and was significantly higher than all 
other scaffolds (Figure 3.11.b). The difference in the YM of uncross-linked gelatin scaffolds, 
2X and 5X CLGS did not show any statistical significance. The lower YM of gelatin, which 
was less than 0.1 MPa, clearly demonstrates the hydrogel formation in the presence of water 
(88). In the presence of water, hydrogen bonds are formed with new polymer networks, made 
the structure more viscoelastic and resulted in reduced YM compared to dry state. 
 
Hence from the mechanical studies, it was detected that the CLGS were stiffer in dry conditions 
than in the wet state. Additionally, as the cross-linking density is increased, the YM of the 
scaffolds also increased in the dry state while in the wet state, the YM of uncross-linked gelatin, 
 105 
2X and 5X CLGS were more or less the same and 8X CLGS showed a significant difference 
























4. RESULTS AND DISCUSSIONS II: IN VITRO CELL STUDIES TO ASSESS THE 
EFFECT OF MATRIX STIFFNESS ON CARDIAC PERICYTES BEHAVIOUR 
 
The stem cell fate is determined by a lot of microenvironmental factors such as biophysical 
cues, chemical cues and mechanical cues. All these factors play an essential role in deciding 
stem cell fate. It has been reported that the endothelium and smooth muscle layers can sense 
the mechanical stimulations such as shear stress and stretching imparted by the pulsated blood 
flow and thus regulates the normal physiological functions of the cardiovascular system (74, 
197-199).  Even though there are many works explaining the effect of biophysical cues and 
chemical cues in affecting the stem cell fate, the impact of mechanical properties, mainly how 
the matrix stiffness of the material affects the stem cell fate is limited. 
 
This work aims to investigate the effect of matrix stiffness in determining the cardiac pericyte 
fate. Changes in stiffness occur in the hearts and arterial vessels of patients with congenital 
heart disease, currently acknowledged as the most common congenital anomaly responsible 
for 7.5% of all infant deaths and for an increasing heart failure morbidity and mortality (32) 
As mentioned in the section 2.3.1, CPs are gaining wide-spread attention to be used as one of 
the potential candidates for tissue repair and regeneration. There are reports showing that 
pericytes can be effectively used for the repair of infarcted heart, myocardial ischemia, 
cardiovascular replacement, skeletal muscle tissue engineering etc. (22, 24-28).  In work done 
by Avolio et al., also states the potential use CPs to create stem cell engineered cardiac implants 
to treat CHDs  (21). Exploration is taking place towards this aspect and researchers are finding 
ways to differentiate CPs into cardiac specific lineages such as vascular smooth muscle cells 
(VSMCs), endothelial cells and cardiomyocytes. 
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In order to be used as an implant for treating CHDs, it is really significant to investigate how 
the matrix stiffness of the substrate material is affecting the CPs fate in terms of its adhesion, 
proliferation and differentiation into cardiac specific lineages. This information will help the 
researchers in the design and modelling of prospective cardiac implants to treat CHDs. 
Therefore, in this work, CPs were isolated from the neonatal cardiac tissues and were 
incorporated to the fabricated gelatin nanofibrous scaffolds with varying matrix stiffness. 
These stem cell engineered nanofibrous scaffolds were then examined in vitro to analyse the 
biocompatibility, CPs attachment, proliferation and differentiation as a function of varying 
matrix stiffness. 
 
In this chapter, the experiments were performed with cells from three different donors except 
for viability assay (the details of cells used are mentioned in the Materials and Methods 
section). Firstly, the results of the experiments carried out in each type of cell cultures are 
reported separately, and later, the cumulative quantification results from all cell cultures are 
summarized for viability, ICC and differentiation assay.  
 
4.1. Cardiac Pericytes (CPs) Characterisation 
 
To perform cell studies, the CPs were isolated from the surgical leftovers of children who 
underwent corrective surgery for CHDs. The microscopic image of isolated CPs is shown in 
figure.4.1. The CPs were found to be healthy, and all were showing the characteristic spindle-
shaped morphology of CPs. The results were consistent with the results reported by Avolio et 
al. in their work on the isolation, expansion and characterisation of CPs from neonatal cardiac 
tissues (31).  
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Figure.4.1. Phase contrast microscopic image of CPs at Passage 6 of culture (P6). 
Magnification is 10X.  
  
The isolated CPs were then characterized by ICC assay. The cell expression to each of the 
pericyte markers and stemness markers are shown in figure.4.2. The blue colour represents the 
DAPI stained nuclei, and the green represents the positive stains of markers for 








             
 
Figure.4.2. Immunofluorescence staining for CPs isolated from different donors. . The first 
column represents the cells stained with Vimentin, the second column shows the cells stained 
with NG2/CSPG4 (Chondroitin sulphate proteoglycan 4), and the third column displays the 
cells stained with OCT4 (Octamer-binding protein 4).  The fourth column is the rabbit antibody 
stained nuclei which are the negative control without primary antibodies.  CPs were at passage 
6 (P6) n=3. Scale bar: 50m. 
 
The Vimentin can bind to the cytoskeleton, and all the cells stained with an antibody anti-
Vimentin expressed strong fluorescence, which confirmed the phenotypic characteristics of 
isolated CPs at P6 (Figure.4.2. 1st column). The cells labelled with an antibody anti-NG2 
showed positive expression of the cells, but they were not strong in fluorescence when 
compared to Vimentin stained CPs. Even though all the cells were positive to the pericyte 
marker NG2 (Figure.4.2. 2nd column). When the cells were stained with an antibody anti-
OCT4, it bound to the nuclei of the cells and showed a positive expression of the marker which 
means the isolated CPs are maintaining their stemness characteristics (Figure.4.2. 3rd column). 
A small percentage of cells was negative for OCT4, but most of the cells showed a positive 
expression. 
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The primary antibodies bind to the specific cell surface receptors (antigens) that are present on 
the cells. The secondary antibodies labelled with fluorochromes can bind specifically to the 
epitopes of those primary antibodies, and upon light incidence, they emit fluorescence. The 
pericyte marker Vimentin bound to the cytoskeleton, NG2 is combined with the plasma 
membrane and stemness marker OCT4 is incorporated to the nucleus of the CPs and exhibited 
positive expression to the corresponding markers. The fluorescence intensity is also a factor to 
determine the extent of CPs expression to each marker. CPs stained with Vimentin, displayed 
enhanced fluorescence intensity while the CPs stained with NG2 were observed with less 
fluorescence intensity. Moreover, only a few numbers of cells were expressive for the OCT4 
stain, and this can be due to the loss of stemness characteristics of CPs at P6. The quantification 
of cell density of each cell line is done separately and is given in figure.4.3. 
 
                          
 
Figure 4.3. Quantification of ICC on a glass slide. Bar graph represents the percentage of 
positive cells when CPs are stained with Vimentin, NG2 and OCT4 in CP10, CP11 and CP12 




In the quantification analysis, all cell cultures demonstrated 100% positive expression for 
Vimentin. In CP11 and CP12, 100% of CPs were positive when stained with NG2, however in 
CP10 cell lines, only 803% of the cells were positive, and this difference was significant. The 
OCT4 represented the lowest percentage of positive cells in all three cell cultures, and this 
difference was statistically significant when compared to the other counterparts in all three cell 
cultures (Figure.4.3). Previous studies had reported that when the cells were expanded to 
several passages, the CPs reduced their positive expression. This means as the cells reach 
higher passages, they will lose their specific characteristic features (31). For example, in the 
work of Avolio et al., they observed a substantial reduction in the CP’s expression of stemness 
markers OCT4 and NANOG when they were cultured up to 9 passages (31). Here also we 
observed the same trend of reduction in the stemness marker expression of OCT4 when CPs 
were stained at passage 6. 
 
Hence the isolated CPs were characterized and found that they were positive for all the tested 
markers while a reduced expression for stemness marker at P6. The next step was to study the 
cytocompatibility of gelatin nanofibrous scaffolds with different matrix stiffness and to find 
out which scaffold/matrix stiffness is more favourable for the cells to attach. 
 
4.2.  Effect of matrix stiffness on CPs viability  
 
The live/dead assay was performed to determine whether stiffness can affect the CPs’ viability. 
After 7 days of incubation in the ECGM2 media, the CPs-seeded scaffolds were stained with 
Calcein AM and EthD III to image the viable and dead cells. This assay was also performed to 
understand whether the EDC/NHS and Glu cross-linked gelatin nanofibrous scaffolds are 
biocompatible to CPs and they are supporting the attachment of CPs. An ideal scaffold should 
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be well-suited for CPs to support the cell attachment and thereby proliferation and 
differentiation. The experiments were done in four cell cultures isolated from four different 
donors to relate the behaviour of CPs isolated from different patients and to obtain a meaningful 
result. The result of the viability assay carried out in CP10 cell line is given in figure.4.4.  
 
 
       
 
Figure.4.4. Viability assay of CP10 (P5) cells on gelatin scaffolds with different cross-linking 
densities. In the image (a), the first row represents the CPs on 2X CLGS; the second row shows 
the CPs on 5X CLGS and third row displays the CPs on 8XCLGS. The green colour represents 
the live cells, and the nuclei are shown in blue colour. The bar diagram (b) denotes the 
quantification of viable cell density on each scaffold (*p˂0.05), cells were at passage 5 (P5). 
Values are expressed as means±SEM. Scale bar: 50m. 
 
From the images, it was found that none of the cells on the scaffolds were positive to Ethidium 
III. Consequently, all the cells expressed green fluorescence, which indicated live cells 
(Figure.4.4. a). Calcein AM is a membrane permeable non-fluorescent esterase substrate, 
which enters the cytoplasm of live cells and the esterase in live cells cleaves calcein AM into 
 113 
calcein and yields green fluorescence. EthD III penetrates the dead cells and stains the nucleus 
with bright red fluorescence. Therefore, almost 100% viability was obtained for all scaffolds 
irrespective of their matrix stiffness, which means they are non-toxic and support CPs 
attachment even after 7 days of incubation. It was evident that there was more CPs attachment 
on the 5X and 8X CLGS when compared to 2X CLGS. The cell density was also quantified to 
distinguish the number of cells alive and attaching on each scaffold. It was found that the cell 
density on 5X and 8X CLGS were similar, whereas the cell density on 2X CLGS exhibited a 
significant difference when compared to 5X CLGS (Figure.4.4. b). The cell density of 2X 
scaffolds were found to be 1205 cells/mm2 . The 5X scaffolds showed an average cell density 
of 16010 cells/mm2, while 8X scaffolds revealed a similar trend of 12030 cells/mm2 . 
 
Next, the viability assay was performed in the CP11 cell culture, and the results are displayed 









Figure.4.5. Viability assay of CP11 (P5) cells on scaffolds with different cross-linking 
densities. In mage (a), the first row represents the CPs on 2X CLGS; second row shows the 
CPs on 5X CLGS and third row displays the CPs on 8X CLGS. The green colour represents 
the live cells, and the nuclei are shown in blue colour. The bar diagram (b) denotes the 
quantification of cell density on each scaffold (*p˂0.05), cells were at passage 5 (P5). Values 
are expressed as means±SEM. Scale bar: 50m. 
 
Similar to the result obtained from the CP10 cell line, here also CPs were 100% viable on all 
scaffolds irrespective of their matrix stiffness (Figure.4.5. a). The only difference was in the 
cell density among the three scaffolds. In CP11cell line, the 2X and 5X CLGS presented the 
highest cell density compared to 8XCLGS. The difference in the cell density of 8X CLGS was 
statistically significant with respect to the other two counterparts (Figure.4.5. b). An average 




 However, the 8X scaffolds showed the lowest cell density of 15050 
cells/mm2 (Figure. 4.5. b). 
 
Following the viability checks in CP10 and CP11 cell lines, the live-dead assay was performed 
in CP12 cells cultured on each scaffold. The results of the viability assay examined in the CP12 




Figure.4.6. Viability assay of CP12 (P5) cells on scaffolds with different cross-linking 
densities. In the image (a), the first row represents the CPs on 2X CLGS; second row shows 
the CPs on 5X CLGS and third row displays the CPs on 8X CLGS. The green colour represents 
the live cells, and the nuclei are shown in blue colour. The bar diagram (b) denotes the 
quantification of cell density on each scaffold (*p˂0.05), cells were at passage 5 (P5). Values 




From the images, it was clear that the same trend of 100% viability was acquired by all the 
scaffolds (Figure.4.6. a). As observed in CP11, the 8X CLGS displayed reduced cell density, 
and this reduction was significant when compared to the 2X CLGS (Figure.4.6. b). The 2X 
scaffolds denoted highest cell density of 25020 cells/mm2 and this showed a considerable 
increase compared to 5X and 8XCLGS. The 5X and 8X CLGS presented an average cell 
density of 20010 cells/mm2 (Figure.4.6. b). 
 
The viability assay was performed in one more cell culture as the results obtained was not 
sufficient in attaining a substantial outcome. The next cell culture used for the viability assay 









            
Figure.4.7. Viability assay of CP32 (P5) cells on scaffolds with different cross-linking 
densities. In the image (a), the first row represents the CPs on 2X CLGS; second row shows 
the CPs on 5X CLGS and third row displays the CPs on 8X CLGS. The green colour represents 
the live cells, and the nuclei are shown in blue colour. The bar diagram (b) denotes the 
quantification of cell density on each scaffold (*p˂0.05), cells were at passage 5 (P5). Values 
are expressed as means±SEM. Scale bar: 50m. 
 
In the CP32 cell line, even though all cells were viable, there observed a massive difference in 
the cell density of CPs on the 8X CLGS with respect to other scaffolds (Figure.4.7. a). The 
cell density of both 2X and 5X CLGS were found to be 15030 cells/mm2 and 10040 
cells/mm2, respectively. The cell density of 8X CLGS were considerably lower and was 3020 
cells/mm2 (Figure.4.7. b). 
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All four cell cultures exhibited different cell density on the scaffolds. The CP11 and CP12 cell 
lines showed similar results in the maximum cells adhered on the scaffolds, while the CP10 
and CP32 cell cultures displayed a lower number of cell attachment on scaffolds. This can be 
explained as because of the effect of matrix stiffness and different confluency rates among the 
cell cultures. From the images, it was observed that both CP10 and CP32 cells were less 
confluent on the scaffolds when compared to CP11 and CP12. It is hypothesised that not all 
cells should acquire the same confluency even if they are in the same passage. The confluency 
depends on various factors such as the nutrients in the growth medium, temperature, humidity 
and carbon dioxide supply. Here in this work, all cell cultures were maintained in the same 
conditions and supplemented with the same ECGM2 media, but CPs exhibited different 
confluency on the scaffolds. So, the possible reason for this reduced confluency in different 
cell lines may be due to the effect of matrix stiffness and variance in the characteristic features 
of the tissue donors. Even though the cells were obtained from the neonatal heart tissues; they 
were from different donors with different pathology. Another observation in the viability assay 
was the anisotropic behaviour of CPs on scaffolds with lower stiffness, i.e. 2X CLGS 
(Figure.4.5 a). Nevertheless, this was evident only for CP12 cells. The higher confluency of 
CP12 would have contributed for this anisotropic behaviour of CPs on 2X CLGS. Further 
experiments with an increased number of cell cultures and duration are essential to justify this 
observation. 
 
In order to find out the optimal scaffold for CPs adhesion and to analyse the effect of matrix 
stiffness on CPs adhesion, a cumulative cell density of all four cell types was calculated, and 
results are shown in figure.4.8.  
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Figure. 4.8. Bar graph representing cumulative cell density on different types of scaffolds. 
Values are mean and SE, n=4 cell cultures at passage 5 of culture. ANOVA, P<0.05; Tukey’s 
multiple comparisons test adjusted P values: *P<0.05 vs 2X. 
 
There observed a substantial difference in the cell density of 8X scaffolds compared to the 2X 
CLGS, but there was no statistical difference in the cell density between the 5X and 8X CLGS. 
This suggests that CPs are more likely to attach and flourish on softer substrates that have an 
average fibre diameter of 400nm. The 2X CLGS exhibited a cumulative cell density of 22060 
cells/mm2 while 5X and 8X CLGS displayed a cell density of 19060 cells/mm2 and 12010 
cells/mm2 respectively (Figure.4.8). 
 
There are many studies associated with the influence of matrix stiffness on cell adhesion and 
spreading (35, 199-202). As mentioned in section 2.2, the cell-material interactions are aided 
by a complex network of proteins called integrins, which are the transmembrane proteins bound 
to the ECM. These adhesion proteins bind the ECM and cytoskeleton of the cells. As a result, 
the cell experiences forces that are exerted by the ECM and the cells adapt to these 
microenvironmental forces by adjusting their cytoskeletal contractility. In response to this 
cytoskeletal contractility, substrates with different matrix stiffness generate different types of 
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adhesion (203-205). Hence the matrix stiffness plays a vital role in creating the focal adhesions, 
which are essential for tissue formation (205). From the results, it was evident that CPs are 
happier to adhere either on softer substrates or substrates with a higher magnitude of fiber 
diameter (2X scaffolds). The softer substrates with larger fiber diameter would have created 
more focal adhesions for the CPs to attach. Hence the coupled effect of scaffold elasticity and 
morphology generated more adhesion sites by altering the cytoskeletal contractility. 
 
Pelham and Wang in 1997, reported that cell attachment and spreading is the first cell function 
that is influenced by the matrix stiffness/elasticity (206). Subsequent studies have explained 
the cell-material interactions as a function of matrix elasticity by culturing different cell types 
on gels or scaffolds with varying matrix stiffness (207-212). For example, when smooth muscle 
cells (SMCs) were cultured on substrates with different matrix elasticity, it was found that the 
SMC’s spreading increased with matrix elasticity (80, 207). Similarly, the endothelial cells 
grown on softer substrates of maleic acid copolymer (MACP)-coated polyacrylamide (PAAm) 
gel showed enhanced cell attachment and spreading (213). In contrast, the cell spreading of the 
pre-osteoblast cell line (MC3T3-E1) on type I collagen-modified hydrogels were found to be 
independent of the matrix stiffness. This shows the difference in the cell-material interaction 
based on different cell types. These variations in the cell-matrix interactions also suggest the 
importance of exploring different cell’s interactions with the matrix, specifically as different 
cell types experience different cytoskeletal contractility based on the matrix stiffness. 
 
Furthermore, the CPs adhesion on all scaffolds without any dead cells implicates the 
cytocompatibility of the scaffolds. An ideal scaffold should be non-toxic, porous, 
biodegradable and mechanically strong to be used for tissue engineering applications (35, 201, 
202). The biomimetic nanofibrous structure, which resembles the native ECM and gelatin’s 
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innate ability to foster cell adhesion and promote proteolytic degradation also would have 
helped CPs to remain viable on all scaffolds (214, 215). 
 
Hence the live/dead assay demonstrated the CLGS capability to support CPs adhesion and 
thereby the biocompatibility of scaffolds irrespective of their matrix stiffness. Additionally, the 
softer substrates with a fiber diameter of ~400nm exhibited increased CPs adhesion compared 
to other scaffolds. After this, the CPs ability to maintain its characteristic features on scaffolds 
with different matrix stiffness were analysed by performing immunocytochemistry (ICC) 
assay. 
 
4.3. Effect of matrix stiffness on CPs expression of typical phenotypic and stemness 
markers 
 
Using immunocytochemistry (ICC), this study next assessed if variation in stiffness could 
affect the expression of typical antigenic markers. The CPs seeded on scaffolds were incubated 
for two days in the ECGM2 media and then permeabilised/fixed for staining with primary 
antibodies followed by secondary antibody staining. The purpose of this assay was to 
investigate whether the CPs are maintaining their characteristics features when seeded on 
CLGS with varying matrix stiffness. This experiment was also performed in three cell cultures 
in order to establish a substantial result. The result of the ICC assay on CP10 cell culture is 






Figure. 4.9. ICC of CP10 (P6) cells on scaffolds with different matrix stiffness . A) Fluorescent 
microscopic images of CPs expression on 2X, 5X and 8X CLGS. a-c): CPs expression for the 
markers Vimentin, NG2 and OCT4 on glass slide (positive control), e-g): CPs expression for 
the markers Vimentin, NG2 and OCT4 on 2X CLGS, i-k): CPs expression for the markers 
Vimentin, NG2 and OCT4 on 5X CLGS. m-o): CPs expression for the markers Vimentin, NG2 
and OCT4 on 8X CLGS.  d), h), i) and p) displays the images of negative control without 
primary antibody. An enlarged view of the marked section of the image g) is also shown, which 
represents the positive expression of OCT4 on 2X CLGS. The bar diagram B) displays the 
quantification of CPs expression on 2X, 5X and 8X CLGS, respectively (*p˂0.05). Scale bar: 
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50m. Values are expressed as means±SEM. Green fluorescence represents the 
cytoskeleton/plasma membrane and blue represents DAPI stained nuclei. 
 
From the images, it was evident that the number of cells on all scaffolds were lower compared 
to the control. This result was supporting the report from the viability assay that the CP10 cells 
were less confluent on scaffolds. The CPs seeded on glass slides were used as the control, and 
they exhibited positive expression when stained with Vimentin, NG2 and OCT4 (Figure.4.9. 
a-c). The CPs morphology on 2X CLGS when stained with antibody anti-Vimentin were found 
to be round, and there were not many cells expressing the Vimentin marker (Figure.4.9. e). 
This indicates that either CPs were deprived of nutrients essential for their growth or the effect 
of the matrix would have hindered the formation of their characteristic spindle shape. Whereas 
both 5X and 8X CLGS exhibited a strong green fluorescence when stained with Vimentin as 
obtained in control (Figure 4.9. i&m). For NG2, only a few numbers of cells exhibited a 
positive expression on all scaffolds and the fluorescence was not strong compared to the control 
(Figure.4.9. f, j&n). Nevertheless, more than half of the CPs showed the phenotypic features 
on each scaffold by expressing NG2 even at the 5th passage of the culture. All the scaffolds 
expressed a positive signal for OCT4 stained CPs by binding to the nucleus, but they showed 
a smaller number of positive expressed cells (Figure.4.9. g, k&o). As mentioned earlier, it is 
not necessary that all cells were positive for the same markers. The OCT4 expression of CPs 
was clearly visible in the enlarged section of the image (g). The appearance of small granules 
revealed the positive expression of CPs on different scaffolds when stained with OCT4. Hence, 
we found that CPs demonstrated their characteristic stemness even at the 5th passage of the 
culture but with a reduced number of positive cell expression. 
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From the quantification analysis, it was found that 100% of CPs were positive when stained 
with Vimentin; however, 2X CLGS expressed a noteworthy reduction of 80% when stained 
with Vimentin. There was no statistical difference in the appearance of CPs on scaffolds with 
different matrix stiffness when stained with NG2. The OCT4 stained CPs disclosed the lowest 
percentage of cell expression when compared to the markers Vimentin and NG2. Here as the 
matrix stiffness of the scaffolds increased, the OCT 4 expression of CPs reduced. Otherwise, 
as the matrix stiffness of gelatin nanofibrous scaffolds increased the stemness behaviour of 
CPs decreased. This reduction was substantial among the three scaffolds (Figure.4.9. B). This 
potential difference can be attributed because of the difference in the matrix stiffness of the 
scaffolds. 
 
Later, the ICC staining was performed in CP11 cells to analyse the effect of matrix stiffness in 
maintaining CPs phenotypic characteristics and stemness on scaffolds with different matrix 







        
 
                       
 Figure. 4.10. ICC of CP11 (P6) cells on scaffolds with different matrix stiffness. A) 
Fluorescent microscopic images of CPs expression on 2X, 5X and 8X CLGS. a-c): CPs 
expression for the markers Vimentin, NG2 and OCT4 on glass slide (positive control), e-g): 
CPs expression for the markers Vimentin, NG2 and OCT4 on 2X CLGS, i-k): CPs expression 
for the markers Vimentin, NG2 and OCT4 on 5X CLGS. m-o): CPs expression for the markers 
Vimentin, NG2 and OCT4 on 8X CLGS.  d), h), l) and p) displays the images of negative 
control without primary antibody. An enlarged view of the marked section of image k) is also 
shown, which represents the positive expression of OCT4 on 5X CLGS. The bar diagram B) 
displays the quantification of CPs expression on 2X, 5X and 8X CLGS, respectively (*p˂0.05), 
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Scale bar: 50 µm. Values are expressed as means ± SEM. Green fluorescence represents the 
cytoskeleton/plasma membrane and blue represents DAPI stained nuclei.  
 
 
The CPs seeded on glass slides were used as the control, and they exhibited positive expression 
when stained with Vimentin, NG2 and OCT4 (Figure.4.10. a-c). From the images, it was 
obvious that the CPs stained with Vimentin showed strong fluorescence on both 2X and 5X 
CLGS while 8X CLGS exposed light fluorescence with a smaller number of positive cells 
(Figure.4.10. e, i&m).   The CPs morphology on 8X CLGS when stained with Vimentin were 
found to be elongated, and they were stretched so that they lost their spindle-shaped 
morphology (Figure.4.10. m). For NG2, a similar result was obtained as that of CP10 cells. 
All scaffolds displayed the positive expression of NG2, but the number of positive CPs were 
less compared to control (Figure.4.10. f, j&n). In the case of OCT4 stained cells, a low 
percentage of CPs exhibited the positive signals (Figure.4.10. g, k&o), and the enlarged image 
of the enclosed section of the image (k) clearly confirmed the positive appearance of OCT4 on 
5X CLGS.  
 
From the quantification analysis, it was found that almost 100% of CPs were positive when 
stained with Vimentin on all scaffolds. However, the number of cells on the 8X CLGS were 
less compared to the control and other counterparts (Figure.4.10. B). When CPs were stained 
with NG2, a gradual decrease in the percentage of positive cells was found with increased 
matrix stiffness. For example, around 60% of CPs were positive for NG2 stained 2X CLGS, 
whereas 5X and 8X CLGS were measured with an average positive cell of about 40% and 30% 
respectively (Figure.4.10. B). They exhibited a considerable difference in the percentage of 
positive CPs when stained with NG2. Furthermore, the OCT4 stained CPs disclosed the lowest 
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percentage of cell expression when compared to the markers Vimentin and NG2. When the 
CPs were stained with OCT4, both 2X and 5X CLGS displayed an average of 50 % positive 
expression, while the 8X CLGS revealed less than 20% of positive cells. This reduction was 
substantial when compared with 2X and 5X CLGS (Figure.4.10. B). 
 
The next step was to analyse the CP12 cell cultures. The results of the ICC assay on CP12 cells 











    
 
 
Figure. 4.11. ICC of CP12 (P6) cells on scaffolds with different matrix stiffness. A) Fluorescent 
microscopic images of CPs expression on 2X, 5X and 8X CLGS. a)-c): CPs expression for the 
markers Vimentin, NG2 and OCT4 on glass slide (positive control), e)-g): CPs expression for 
the markers Vimentin, NG2 and OCT4 on 2X CLGS, i)-k): CPs expression for the markers 
Vimentin, NG2 and OCT4 on 5X CLGS. m)-o): CPs expression for the markers Vimentin, 
NG2 and OCT4 on 8X CLGS.  d), h), l) and p) displays the images of negative control without 
primary antibody. An enlarged view of the marked section of the image g) is also shown, which 
represents the positive expression of OCT4 on 2X CLGS. The bar diagram B) displays the 
quantification of CPs expression on 2X, 5X and 8X CLGS respectively. Scale bar: 50 µm. 
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Values are expressed as means ± SEM. Green fluorescence represents the cytoskeleton/plasma 
membrane and blue represents DAPI stained nuclei. 
 
The CPs seeded on glass slides were used as the control, and they exhibited positive expression 
when stained with Vimentin, NG2 and OCT4 (Figure.4.11. a-c). From the images, it was 
noticeable that the CPs stained with Vimentin presented strong fluorescence on all the scaffolds 
irrespective of their matrix stiffness (Figure.4.11. e, i&m).   All CLGS demonstrated positive 
expression of NG2, but the fluorescence intensity was less compared to control (Figure.4.11. 
f, j& n). In OCT4 stained cells, more CPs were found to be positive when compared to the 
other two cell cultures (Figure.4.11. g, k & o). Also, the enlarged image of the enclosed section 
of the image (g) clearly confirmed the positive appearance of OCT4 on 2X CLGS. 
 
From the quantification analysis, almost all the scaffolds exhibited100% positive signals when 
stained with Vimentin (Figure.4.11. B). As different from other cell cultures, when CPs were 
stained with NG2, a gradual increase in the percentage of positive cells were found with 
increased matrix stiffness, but this difference was not statistically significant. Additionally, the 
percentage of positive CPs when stained with OCT4 were higher when compared to the other 
two cell cultures. Also, there was no substantial difference in the percentage of positive cells 
among each scaffold (Figure.4.10. B).  
 
Hence from the fluorescent images of all three cell cultures, concluded that all CPs were 
maintaining their phenotype and stemness on all scaffolds irrespective of their stiffness. But in 
order to get a meaningful quantification result, the cumulative percentage of positive cell 
expression for each marker in all three cell cultures were calculated and the graph showing 





Figure. 4.12. Cumulative quantification of CPs expression on scaffolds with different matrix 
stiffness. Bar graphs show the quantification analysis of the positive expression of markers 
Vimentin (a), NG2 (b) and OCT4 (c) on each scaffold compared to control (glass slide). Values 
are expressed as means±SEM (n=3 CPs, *p˂0.05) 
 
CPs exhibited almost 100% positive signals when stained with Vimentin, which was the same 
when compared to the control (Figure.4.12. a). NG2 stained CPs also showed a similar amount 
of positive expression compared to the control (Figure.4.12. b). Hence from the results of three 
cell cultures, it was concluded that CPs are maintaining their specific antigenic phenotype in 
all scaffolds irrespective of their matrix stiffness. Whereas in OCT4, CPs displayed a reduced 
expression on the 8X CLGS, which was around 4515%; however, there was no significant 
difference when compared to the control. All other counterparts revealed a similar percentage 
of expression when compared to the control (Figure.5.12. c). Therefore, it was found that the 
CPs maintained their unique antigenic properties independent of their matrix stiffness. 
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In work done by Avolio et al., they seeded CPs in a xenograft scaffold called CorMatrix and 
analysed the possibility of creating CPs-engineered graft for treating CHDs.  They also 
investigated the CPs ability to maintain their phenotypic characteristics by performing the 
fluorescence staining with Vimentin, NG2 and PDGFR-. They found that the CPs were able 
to retain their antigenic properties by showing positive expression for Vimentin, NG2 and 
PDGFR- antibodies (31). Our study also supports this finding as all CPs cultured on  CLGS 
exhibited positive signals for Vimentin and NG2 antibodies. 
 
Hence from the results, it was found that CPs seeded on CLGS with different matrix stiffness 
maintained their antigenic profile. Later, the morphology of CPs when cultured on CLGS were 
analysed. 
 
4.4. Effect of matrix stiffness on CPs morphology 
 
To further investigate the morphological changes induced by variation in matrix stiffness, CPs 
were incubated on scaffolds for seven days and then fixed, dried and sputter coated for SEM 
analysis. The SEM images of cell attachment on plastic, 2X, 5X and 8X CLGS after 7 days of 
incubation are shown in figure.4.12. Plastic was used as the control to understand the changes 
in cell shape and morphology compared to CPs attached on scaffolds. The cells used in this 





Figure.4.13. Figure.4.13. SEM images of CPs adhesion on scaffolds with different matrix 
stiffness. (a-d) displays the CPs attachment on plastic, 2X, 5X and 8X CLGS, respectively. (e-
h) Denotes the higher magnification images of CPs attachment on plastic, 2X, 5X and 8X 
CLGS respectively. 
 
From the SEM images, CPs exhibited a combination of round and spindle-shaped morphology 
(Figure.4.13. a). When seeded on scaffolds, CPs were widespread to generate a 3D cellular 
network (Figure.4.13. b-d). The typical spindle-shape of CPs were well observed in both 2X 
and 5X scaffolds (Figure. 4.13. f & g) while in the 8X CLGS, the cells were elongated, and 
the spindle shape was not evident (Figure. 4.13.h).  The cell margins were clearly understood 
in the SEM images of 2X, and 5X CLGS and the CPs were widespread to generate a cellular 
network. In contrast, CPs seeded on the 8X CLGS were merged to the nanofibers. Wide 
spreading of CPs while maintaining their characteristic spindle-shape was witnessed in both 
2X and 5X CLGS compared to the control. 
  
The CPs morphological change on the 8X CLGS could be due to several factors. The cell 
elongation often represents that the cells are deprived of nutrients and are stretching their 
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structure to find more favourable conditions for their growth. Previous studies have shown that 
porosity of the scaffolds plays a vital role in cell adhesion and growth by providing essential 
nutrients and gaseous exchange (216-218). The increased cross-linking density of 8X scaffold 
might have caused the reduction in pore size and thereby, inadequate nutrient supply to CPs. 
There are studies suggesting porosity of the graft is crucial for cell migration and deep cell 
infiltration (219, 220). For example, Druecke et al., evaluated the effect of different pore size 
of poly (ether ester) block‐copolymer scaffolds on vascularization when implanted into the 
dorsal skinfold chamber of mice. They found that the highest neovascularization was attained 
by the scaffolds with a pore size of 250-300m (220). Hence optimum porosity is essential for 
sufficient nutrient supply for the cells to grow and assist vascularization. So, the morphological 
behaviour of CPs on 2X and 5X CLGS indicated that they have enough pore size for CPs to 
maintain their spindle-shape by providing sufficient nutrient supply. 
 
The widespread cellular network formation in both 2X and 5X CLGS can be explained as 
because of the biocompatible and non-toxic behaviour of the prepared CLGS. There are reports 
highlighting the excellent properties of gelatin to foster cell adhesion and promote proteolytic 
degradation, which is fundamental for the cell spreading in a 3D environment (214). The 
increased cross-linking density of the 8X CLGS can reduce the matrix elasticity and thereby 
mitigate the focal adhesion points. This would have resulted in the reduced degradation of the 
scaffolds by cell-secreted matrix metalloproteinase (MMP), which adversely affected the 
healthy cell spreading. Additionally, the results also proved that the proteolytic degradation 
products of the gelatin nanofibrous scaffolds are non-toxic for CPs to adhere to the scaffolds.  
 
In a study conducted by Adelow et al. (2008), they fabricated peptide functionalised poly 
(ethylene glycol) hydrogel with different matrix stiffness by altering the ratios of cross-linker 
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and the polymer-peptide ratios. They then encapsulated Mesenchymal stem cells (MSCs)and 
SMCs to examine the viability and spreading of cells in different matrix stiffness. They found 
that the cells were susceptible to gel mechanics, and the softer hydrogels allowed broad cell 
spreading and viability while the stiffer hydrogels only remained as viable without any cell 
spreading. This result agrees to our findings, although the scaffolds differed in the range of 
matrix stiffness (221).  
 
SEM analysis has been widely used to assess the biocompatibility and cell attachment of the 
fabricated scaffolds (216-218). For example, Sudheesh et al. developed chitosan nanofibrin 
composite hydrogels for skin tissue regeneration and evaluated the adhesion of Human 
Umbilical Cord Vein Endothelial cells (HUVECs) and Human Dermal Fibroblasts (HDF) on 
scaffolds with different concentration of nanofibrin. They found that cells changed their 
morphology and were nicely spread when cells seeded on scaffolds with 2% nanofibrin than 
the control (217). Hence the SEM analysis also supports the fact that the prepared CLGS are 
non-toxic and provide physical support as native ECM does in vivo. Moreover, flexible and 
softer substrates were found to be more favourable for the CPs to adhere and grow than the 
plastic proved the closer resemblance of 2X and 5X CLGS with native proteoglycans (214). 
 
 
Thus, from the results, it was found that cells are happier to adhere, grow and flourish on softer 
substrates rather than stiffer substrates. As the cross-linking density increased, the cells 
changed its shape from spindle to elongated structure and found to be merged entirely to the 




4.5. Effect of matrix stiffness on CPs proliferation 
 
Next, the proliferation of CPs on 2X, 5X and 8X CLGS using the EdU incorporation assay, 
which is an indicator of active DNA synthesis was examined (87). The proliferation of CPs on 
2X, 5X and 8X CLGS are shown in figure.4.14. The red colour represents the nuclei of the 











Figure.4.14. Proliferation assay by DNA staining on scaffolds with different matrix stiffness. 
Fluorescent microscopic images of proliferating CPs on plastic (positive control) a), e) & i), 
2X CLGS b), f) & j), 5X CLGS c), g) & k) and 8X CLGS d), h) & l). Data expressed as 
means±SEM. Scale bar: 50m. (*p˂0.05, n=3). Values are mean and SE, N=3 CPs at passage 
5 of culture. ANOVA, P<0.05; Tukey’s multiple comparisons test adjusted P values. *P˂0.05 
vs. control. 
 
From the fluorescence microscopy images, it was very evident that the 2X CLGS has a higher 
number of proliferating cells than 5X and 8X CLGS (Figure.4.14. A). The quantification 
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analysis also supported this observation as there was a significant reduction in the number of 
proliferating cells on the 5X and 8X CLGS when compared to the control (Figure.4.14. B). 
But the percentage of proliferating cells on 2X CLGS were similar to that of control. Merely 
125 % of CPs were proliferating on 8X CLGS whereas both 5X and 8X CLGS supported the 
proliferation of around 305 % and 3815% of CPs respectively when seeded on each scaffold.  
Consequently, it was found that as the matrix stiffness increased, the number of proliferating 
cells decreased considerably. This shows that CPs prefer to grow and proliferate on a softer 
substrate than stiffer substrates. 
 
No studies till date have reported the proliferation of CPs on scaffolds. However, there has 
been reported a study conducted by Qiu et al., where the ovine and murine cardiac side 
population cells (CSP) were isolated and seeded on polydimethylsiloxane substrates with 
different elastic modulus to investigate the effect of matrix stiffness on CSP proliferation and 
differentiation. They found that the stiffening of the microenvironment could lead to the 
enhanced proliferation of cardiac stem cells than differentiation (222). But the YM range 
investigated in their study was ranging from 18 to 145 kPa, while the range studied in this study 
was 263 to 1000 kPA in the wet state. The observation in this work was that proliferation 
decreases with the increase in stiffness. Hence by combining both the results, it suggests that 
proliferation of cardiac stromal cells reaches its peak between 140 and 260 KPa (stiffness of 
fibrotic myocardium) and the fibrotic remodelling of the heart might favour the expansion of 
the stromal cell compartment. However, more studies are required to confirm this possibility. 
 
There are also studies on the effect of substrate rigidity in the regulation of VSMCs contractility 
and proliferation (214, 223, 224). Peyton et al. found that even though the contractility of the 
cells was directly dependent on the substrate stiffness, the proliferation of smooth muscle cells 
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was self-regulating. They combined SMCs into gels made of polyethene glycol (PEG) and 
fibrinogen with different matrix stiffness ranging from 4448 Pa to 5408 Pa. Their results 
showed that the SMCs contractile phenotype was regulated by matrix stiffness showing 
enhanced expression of -SMA and calponin. Although other groups have demonstrated the 
dependence of matrix stiffness on SMCs proliferation rate (223). In 2010, Liu et al. developed 
a biomimetic hydrogel made of methacrylated and lysine functionalized dextran-gelatin with 
different matrix stiffness by changing the degree of methacrylation of polymers and the 
concentration of the precursor solution. They cultured SMCs on these scaffolds and the cell 
spreading, proliferation rate and differentiation of SMCs were studied. The proliferation assay 
was performed by using Bromodeoxyuridine (BrdU), which can bind to the DNA of 
proliferating cells. In the results, they found an extensive cell spreading, proliferation and 
widespread cellular network formation in the hydrogels with low mechanical stiffness. This 
result was in compliance with our results (214). In another study where SMCs were 
incorporated on polyacrylamide gels, and stiffer surfaces showed increased cell area and 
proliferation rate (71). From all these reported studies, it is well-defined that even a subtle 
change in the mechanical properties of the matrix substrate will affect the cell adhesion, 
spreading and proliferation.  
 
Thus, from the results, it was found that the CPs exhibited enhanced proliferation in softer 
substrates with large fiber diameter (~400nm) and having a matrix stiffness ranging from 0.2 
to 0.3 MPa, whereas the stiffer substrates showed only 125 % of proliferating cells. Next, the 





4.6. Effect of matrix stiffness on CPs secretome 
 
The effect of matrix stiffness of the CP angiocrine secretome was assessed by performing 
ELISA assays on conditioned media collected after 48 hrs from cell seeding. After two days of 
incubation on scaffolds the CPs ability to secrete the growth factors such as Angiopoietin-1 
(ANG-1), Angiopoietin-2 (ANG-2) and vascular endothelial growth factors A (VEGF-A) were 
assessed. The absolute concentration in media was normalized for the number of cells to avoid 




               
Figure.4.15. ELISA test to show the angiogenic growth factor synthesis of CPs on scaffolds 
with different matrix stiffness. Bar graphs show the concentration of ANG-1 a), ANG-2 b) and 
VEGF-A c) secreted by CPs on scaffolds with different matrix stiffness. Values are mean and 
SE, N=3 cell at passage 5 of culture. ANOVA, P<0.05; Tukey’s multiple comparisons test 
adjusted P values. *P˂0.05 vs control. 
 
From the bar diagram, it was found that VEGF is the most abundant secreted growth factor, 
followed by ANG-1 and ANG-2. For ANG-1, all scaffolds secreted similar concentrations as 
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of control (Figure.4.15. a) whereas the 2X CLGS secreted more ANG-2 and VEGF compared 
to control (Figure.4.15. b & c). In contrast, both 5X and 8X CLGS did not show any statistical 
significance in the released concentration of ANG-2 and VEGF-A. (Figure.4.15. b & c).  
 
In work done by Avolio et al., the CPs secretome were investigated and found that the most 
abundant secreted growth factor was a hepatocyte growth factor. The other secreted proteins 
were in the order ANG-1, VEGF-A, ANG-2, stromal cell-derived factor-1, and fibroblast 
growth factor-B. They also found that CPs released procollagen type-1, which is an essential 
constituent of cardiac ECM. Also, they exhibited enhanced secretion of all the above-
mentioned proteins than the saphenous vein-derived pericytes (21). 
 
It has been proved that VEGFs, angiopoietins and fibroblast growth factors (FGFs) secreted by 
stromal cells such as fibroblasts and pericytes or by endothelial cells themselves are essential 
for sprouting angiogenesis (225, 226). Angiogenesis is the process of formation of new blood 
vessels from the pre-existing vascular tubes (227). In fact, these growth factors act as 
angiogenic stimuli to activate endothelial cells by binding to the tyrosine kinase receptor 2(Tie-
2). The activated endothelial cells undergo different mechanisms such as vessel destabilization 
by altering basement membrane proteolytic degradation and this results in the dissociation of 
pericytes from the capillary. Finally, the endothelial cell migration, proliferation and sprouting 
occur in the normal physiological angiogenesis (228). 
 
Previous studies have demonstrated the role of angiopoietins and VEGF in blood vessel 
formation and maturation (229-231). For example, Thurston et al. compared the 
overexpression of these growth factors in the skin of transgenic mice and discovered that the 
overexpression of Ang-1 in mice resulted in capillaries with increased vessel diameter. 
 141 
Additionally, these vessels contained an enhanced number of endothelial cells and pericytes, 
which confirmed the potential of Ang-1 in the endothelial cell maintenance, proliferation and 
thereby vessel maturation. Although, in transgenic mice overexpressing only VEGF-A, were 
found to be with leaky blood vessels. But the mice expressing both Ang-1 and VEGF-A 
resulted in enlarged and highly differentiated blood vessels with an overlay of pericytes and 
were non-leaky. Hence the vessel sprouting, and growth is initiated by the expression of VEGF 
while Ang-1 mediates blood vessel remodelling and maturation. Thus, from these findings, 
they concluded that the co-expression of Ang-1 and VEGF-A is paramount to regulate the 
process of angiogenesis by performing their unique functions (229). In another work by 
Augustin et al., observed that in mice deficient with Ang-1 and Tie-2 lead to lethality at 
embryonic day 10.5, because of improper vessel maturation and organization. Also, in mice 
with overexpression of Ang-2 had no distinct angiogenesis-related phenotype and death 
occurred in the late gestation period. They also detected an increased level of Ang-2 in diseased 
conditions associated with vascular dysfunction (230). Hence the same phenotype is observed 
in the mice deficient of Ang-1 and Tie-2 as well as in mice overexpressed with Ang-2. This 
made to a conclusion that Ang-2 acts as an antagonist in Tie-2 signalling (232, 233). Therefore, 
from all these data it was noticeable that Ang/Tie system is essential for maintaining vessel 
homeostasis in adults and also plays a critical role in mural cell recruitment, vessel remodelling 
and maturation during embryonic development (231). 
 
It is well-documented that in perivascular cells such as pericytes, VSMCs and fibroblasts, the 
expression of Ang-1 is predominant (234-236). Ang-1 binds to the Tie-2 receptors on the 
endothelial cells and activates the phosphoinositide 3- kinase (PI3K) signalling pathways and 
helps in the endothelial cell survival and quiescent vascularity (237). From our results, it was 
found that CPs on all scaffolds produced Ang-1same as that of control and is a good sign that 
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the produced Ang-1 can act as an agonist of Tie-2 signalling which helps in the endothelial cell 
survival, remodelling and sprouting. 
 
The Ang-2 expression is upregulated during the angiogenic activation of endothelial cells; 
however, the agonist activity of Ang-2 is much lower than that of Ang-1(238). It has been 
reported that when endothelial cells treated in specific conditions such as high concentrations 
of Ang-2, and prolonged stimulations only induced Tie-2 activation (239, 240). In another 
study, the activation of Tie-2 happened only when endothelial cells were subjected to increased 
stress (241). Besides, it has been reported that Ang-2 lead to the deterioration of blood vessels 
in the absence of VEGF and showed enhanced angiogenesis in the presence of VEGF (242). 
Thus, the data suggests that a fair proportion of both Ang-1 and Ang-2 is essential for regulating 
Tie-2 assisted signalling pathways and to maintain vascular homeostasis. Moreover, Ang-2 
was also found to have an essential role in binding to the integrins and stimulate focal adhesion  
Kinase (PAK) phosphorylation (243). 
 
VEGF-A can bind to the cell surface receptors such as VEGFR-1 and VEGFR-2 and regulates 
vascular permeability and angiogenesis (244). Some other functions of VEGF-A include 
regulating vascular permeability, pro-angiogenic activity and stimulate cell migration (245, 
246). The predominant secretion of VEGF-A by CPs on scaffolds than plastic shows the 
adaptability and favourable conditions of CPs on scaffolds than plastic which is essential for 
promoting vascular permeability, gene expression, cell migration and angiogenesis (247).  
 
Hence from the results, it was found that CPs are capable of producing ANG-1 and enhanced 
amount of ANG-2 and VEGF-A when seeded on scaffolds with lower matrix stiffness and fiber 
diameter of ~400nm, which is essential for activating Tie-2 associated signalling pathways and 
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thereby endothelial cell migration, proliferation and angiogenesis. Followed by this, the 
differentiation potential of CPs into VSMCs were investigated when seeded on scaffolds with 
different matrix stiffness. 
 
4.7. Differentiation Potential of CPs into VSMs on scaffolds with different matrix stiffness 
 
Finally, the CPs were seeded on plastic (control) or scaffolds with increasing concentrations of 
Glu/EDC/NHS and cultured either in the maintenance ECGM2 media or in differentiation 
media enriched with TGF-β1 for 7 or 14 days. When CPs on scaffolds were treated with 
ECGM2 media, none of the cells showed a positive expression towards smooth muscle-
calponin and alpha-smooth muscle actin at both time points. But when the CPs were exposed 
to the differentiation media enriched with TGF-β1, they exhibited positive expression for the 
markers SM-Calponin and α-SMA irrespective of their matrix stiffness. This shows the 
mechanical cues alone are inadequate for differentiation and the essentiality of chemical signals 
for inducing differentiation of CPs. Previous studies from our group have also reported the 
failure of CPs to differentiate in the absence of inductive media (200). In order to achieve CPs 
differentiation into VSMCs, differentiation medium added with 20 ng/ml of human PDGF-BB 
was used previously from our group. In this study, TGF-1was used as an alternative to PDGF-
BB as TGF-1 has known effects in inducing VSMCs differentiation. For example, in a study 
Zang et al., investigated the differentiation capability of stem cells from human exfoliated 
deciduous teeth (SHED) into functional VSMCs by utilizing two cytokines of TGF-β family 
such as transforming growth factor beta 1 (TGF-β1) and bone morphogenetic protein 4 
(BMP4). The concluded that TGF-β1regulated SHED differentiation into VSMCs by activating 
ALK5 signalling pathway. As same as other experiments, the differentiation assay was also 
performed in 3 cell cultures and at two different time points (7th day and 14th day). The results 
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Figure.4.16. Differentiation of CP10 (P6) cells on 2X, 5X and 8X CLGS into VSMCs: A) 
Shows the positive expression of CPs when stained with α-SMA, B) indicates the positive 
expression of CPs when stained with Calponin.  Negative control represents the CPs on 
scaffolds cultured in ECGM2 media. Positive control is the CPs cultured on glass slides in 
inductive media. Green colour represents F-actin stained cytoskeleton, and blue colour is DAPI 
stained nuclei.  
 
 145 
From the pictures, it was observed that no differentiation for CPs cultured in the ECGM2 media 
(Figure.4.16. a&b) whereas the CPs treated with inductive media expressed positive signals 
to both α-SMA (Figure.4.16. A(c-j) and calponin (Figure.4.16. B (c-j) by staining the actin 
filaments of CPs. This shows the contractile phenotype of VSMCs and the actin filaments were 
widespread on the scaffolds. Therefore, the CPs were found to be differentiating into VSMCs 
independent of their matrix stiffness in CP10 cells. Followed by CP10, CP11 cell lines were 











Figure.4.17. Differentiation of CP11 (P6) cells on 2X, 5X and 8X CLGS into VSMCs: A) 
shows the positive expression of CPs when stained with α-SMA, B) indicates the positive 
expression of CPs when stained with Calponin.  Negative control represents the CPs on 
scaffolds cultured in ECGM2 media. Positive control is the CPs cultured on glass slides 
in inductive media. Green colour represents F-actin stained cytoskeleton, and blue colour 
is DAPI stained nuclei.  
As of CP10 cells, CP11 cells also showed no differentiation for CPs cultured in the ECGM2 
media (Figure.4.17. a&b) while the CPs treated with inductive media expressed positive 
signals to both α-SMA (Figure.4.17. A(c-j) and calponin (Figure.4.17. B (c-j). Both calponin 
and α-SMA stained the actin filaments of CPs and exhibited strong fluorescence (Figure.4.17. 
A&B (c-j). Calponin stained CPs were found to be more expressive compared to the α-SMA 
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stained CPs. The contractile phenotype of VSMCs was well observed on calponin stained CPs, 
and the actin filaments were widespread on the scaffolds as that of control (Figure. 4.17. B (c-
j). Therefore, the CPs were found to be differentiating into VSMCs independent of their matrix 
stiffness in CP11 cell line. Followed by CP10 and CP11 cell cultures, the differentiation 




Figure.4.18. Differentiation of CP12 (P6) cells on 2X, 5X and 8X CLGS into VSMCs: A) 
shows the positive expression of CPs when stained with α-SMA, B) indicates the positive 
expression of CPs when stained with Calponin.  Negative control represents the CPs on 
scaffolds cultured in ECGM2 media. Positive control is the CPs cultured on glass slides in 
inductive media. Green colour represents F-actin stained cytoskeleton, and blue colour is DAPI 
stained nuclei.  
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From the figure, no differentiation was observed for CPs cultured in the ECGM2 media 
(Figure.4.18. a&b). The contractile phenotype of VSMCs was well observed on both calponin, 
and α-SMA stained CPs and the actin filaments were widespread on the scaffolds as that of 
control (Figure. 4.18. A&B (c-j). Therefore, the CPs were found to be differentiating into 
VSMCs independent of their matrix stiffness also in CP12 cell line. In order to attain a 
meaningful result in the expression of CPs towards the VSMCs differentiation, the actin stress 
fibers were quantified by measuring the intensity of stress fibers per cell. It was impossible to 
quantify the number of differentiating cells as the actin filaments were well assembled and 
widespread on the entire scaffold with the possibility of overlapping of cells. Therefore, the 




Figure.4.19. Stress fiber quantification. (a) Represents the cumulative stress fiber intensity on 
the 7th day after the addition of inductive media. (b) Shows the cumulative stress fiber intensity 
on the 14th day after the addition of inductive media. (A.U.-arbitrary unit). Values are mean 
and SE, N=3 cell cultures at passage 5 of culture. ANOVA, P<0.05; Tukey’s multiple 
comparisons test adjusted P values. *P˂0.05 vs control.  
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The stress fiber intensity analysis was performed and found that on the 7th day, the CPs cultured 
on 2X CLGS exhibited higher intensity compared to control and other counterparts (Figure. 
4.19. (a). However, there was no significant difference in the stress fiber intensity among the 
scaffolds with respect to the control (Figure.4.19. (b) on the 14th day. Furthermore, a 
substantial accumulation and alignment of F-actin on softer substrates forming extensive stress 
fibers agrees with the theory that the cells adapt themselves to the 3 D microenvironment and 
alter their cytoskeletal organisations (248). As explained in section 2.4, the cell experiences 
various forces from the external microenvironment and the cell surface receptors (integrins) 
sense these signals and transmit these signals to the nucleus by initiating specific cell signalling 
pathways (5). Stress fibers are long and aligned contractile actin bundles, which detect and 
transmit forces to the ECM through focal adhesions (249). These actin bundles can adjust 
themselves to the external forces from the microenvironments and thus the shape of the cells. 
Hence the cytoskeletal contractility is much dependent on the elastic modulus (stiffness) of the 
ECM (67). The higher elasticity fiber diameter of the scaffolds would have provided additional 
focal adhesion points, which helps in the creation and alignment of F-actin stress fibers and 
results in the actin polymerisation. Therefore, the cells adapt to these mechanical stimuli by 
modulating their cytoskeletal contractility and exerts cellular traction forces back to the ECM. 
Thus, there occurs a tensional homeostasis or force balance between the external forces (from 
the microenvironment to the cells) and the force exerted by the cells (traction force) due to 
their endogenous cytoskeletal contractility. This plays an essential role in the basic cellular 
functions such as adhesion, proliferation, differentiation, survival and apoptosis (5, 66, 67). 
Hence the increased stress fiber formation on softer substrates shows that matrix has optimum 
stiffness for CPs to alter their cytoskeletal contractility and thereby differentiation into VSMCs.  
 
 150 
The mechanotransduction and the signalling pathways that determine the assembly of stress 
fibers is yet to be well understood. In 1997, Kaibuchi et al. proposed the dependence of Rho-
kinase in the formation of actin stress fibers and focal adhesions. The extracellular signals such 
as lysophosphatidic acid (LPA) stimulates the cells by converting guanosine diphosphate 
(GDP)-Rho to guanosine triphosphatase (GTP)-Rho and participates in the Rho-mediated 
signalling pathways which are essential for stress fiber formation and focal adhesions. They 
proved the influence of Rho-kinase by testing the formation of focal adhesion and stress fibers 
by injecting the catalytic domain of Rho-kinase to serum-starved Swiss 3T3 cells. They 
observed the development of focal adhesions and stress fibers in the cells injected with the 
catalytic domain of Rho-kinase, whereas the cells injected with the inactive domain of Rho-
kinase were deprived of stress fibers and focal adhesions (250). In another study, Tojkander et 
al., recently showed that the Ca2+ influxes activate Ca2+ calmodulin-dependent kinase 2 
(CaMKK2) at focal adhesions and act as an upstream factor for the phosphorylation of 50AMP-
activated protein kinase (AMPK) which in turn promotes the maturation of actomyosin bundles 
(251). Hence, several types of research are still carrying out works towards exploring how cells 
sense these signals and perform cytoskeletal organisations.  
 
Further investigation is required to identify the exact mechanism involved in the CPs adhesion 
and interaction with the gelatin nanofibrous scaffolds to proliferate and differentiate into 
VSMCs. This includes various cell and molecular-based assays to identify the signalling 
cascades involved in transmitting the forces through focal adhesions and the gene expressions 
during the differentiation process. 
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Hence from the differentiation assay, it was found that CPs differentiated into VSMCs when 
seeded on all scaffolds irrespective of their matrix stiffness, but there was an enhanced stress 
























5       THESIS SUMMARY AND CONCLUSIONS 
 
 
The objectives of the work described in this thesis were first to fabricate biomimetic gelatin 
nanofibrous scaffolds with varying matrix stiffness in aqueous solution by in situ cross-linking 
electrospinning technique, and secondly, to investigate the effect of matrix stiffness in 
regulating Cardiac Pericytes (CPs) behaviour by analysing CPs antigenic profile, morphology, 
viability, proliferation, angiocrine activity and capacity to differentiate into vascular smooth 
muscle cells (VSMCs) on gelatin nanofibrous scaffolds with different matrix stiffness.  
 
This chapter will summarise the main studies that were conducted, along with the most relevant 
findings. Finally, the conclusions of the work will be presented, and suggestions for future 
work are also mentioned. 
 
5.1     SUMMARY OF FINDINGS 
 
5.1.1 Fabrication and characterization of mechanically tunable gelatin nanofibrous 
scaffolds 
 
One of the main milestones in our study was the fabrication of a scaffold made of 
electrospinning gelatin nanofibers in aqueous solution. This study opted an alternative method 
of electrospinning gelatin in a pure water solvent, approaching this challenge by raising the 
environmental temperature (40C) and humidity (above 50%) using a hot plate and ultrasound 
nebuliser and by keeping the whole setup in an enclosed incubator.  
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Another accomplishment of this study was the preparation of electrospun gelatin nanofibrous 
scaffolds with different matrix stiffness by utilizing in situ cross-linking technique. This was 
achieved by employing a double-barrel syringe (10:1-barrel ratio) to introduce cross-linking 
agents during electrospinning to make uniformly cross-linked gelatin nanofibers with defined 
morphology and mechanical properties since the cross-linking reaction between gelatin and 
EDC/NHS occurred as soon as they were mixed (252), the processing window needed to be 
carefully controlled in order not to compromise the electrospinnability, as the viscosity of the 
solution increased with the increasing crosslink degree. The 10:1 double-barrel syringe was 
chosen to serve this purpose. Moreover, to aid electrospinning, the voltage was augmented with 
a reduced flow rate accordingly.  
 
The morphological and topographical characterisation of gelatin nanofibrous scaffolds 
revealed a considerable reduction in the fiber dimensions according to the progressive increase 
in cross-linking density while maintaining the same height. This is due to the synergistic 
influence of electrospinning parameters, in particular, the increase in applied voltage and the 
decrease in flow rate being determinants in creating nanofibers with reduced fiber diameter. 
Moreover, high cross-linking densities can contribute to shrinking the gelatin nanofibers as 
new bonds are formed between the polymer chains, which in turn can diminish the 
intermolecular space. 
 
The initial hypothesis was to create the gelatin nanofibrous scaffolds cross-linked internally 
with different concentrations of EDC/NHS. However, data from the literature indicate that 
cross-linking agents, like EDC/NHS, which creates amide bonds are less efficient in 
maintaining the structural stability over 3 weeks in aqueous solution (150); this could preclude 
the use of scaffold in the wet condition for tissue/cell engineering applications. Therefore, the 
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dissolvability property of the EDC/NHS cross-linked scaffolds were tested and verified their 
stability over three weeks. The scaffolds cross-linked with lower concentrations of EDC/NHS 
were disappeared entirely within two weeks of immersion in the aqueous solution. Hence, it 
was further assessed if this can be improved by the addition of Glutaraldehyde (Glu) vapour 
cross-linking, which can create stronger aldimine linkages. As expected, this significantly 
facilitated to maintain the scaffolds structural stability even after three weeks. Retention of 
structural stability by cross-linking was an essential requisite for subsequent functional studies 
on living cells.   
 
The prepared gelatin nanofibrous scaffolds were well-crosslinked as shown in the results, using 
the Ninhydrin assay and assessing peak intensities, which indicated a reduction in the lysine 
amine groups through the interaction with the aldehyde group of Glu. In Ninhydrin assay, the 
intensity of the blue colour faded with increasing concentrations of the EDC/NHS and became 
yellow in samples cross-linked with Glu\EDC\NHS. Quantification of the data indicated that 
Glu/EDC/NHS had superior cross-linking activity as compared with the other conditions. In 
the FTIR analysis, the peak intensities were much lower for the nanofibers cross-linked with 
both Glu and EDC/NHS as compared with the Glu alone, and the reduction in peak intensity 
was further enhanced by increasing the concentration of EDC/NHS. Moreover, the structure of 
the gelatin was also disturbed when higher concentrations of EDC/NHS were used. 
 
The scaffolds showed higher YM values in the dry state as the cross-linking concentration of 
EDC/NHS increased. This is likely the consequence of the new bonds between the functional 
groups of the polymer, causing the formation of denser and more compact structures. Ina wet 
state, the presence of water contributed to the acquisition of viscoelastic properties and 
reduction in the YM, which also became remarkably different among scaffolds.  The Glu and 
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8X EDC/NHS cross-linked scaffolds exhibited an average YM of 0.90.3 MPa, which was 
higher than the other crosslinked scaffolds, showing values <0.3 MPa, or uncross-linked 
gelatin, whose YM was <0.1 MPa. 
 
5.1.2   Effect of matrix stiffness on CPs fate in terms of its adhesion, proliferation and 
differentiation into VSMCs 
 
The in vitro cell studies showed that subtle changes in the mechanical properties of the matrix 
substrate could remarkably influence the behaviour of human cardiac cells. This study focused 
on CPs because of the increasing evidence these cells modulate cardiovascular repair and 
remodelling through the interaction with adjacent cells and the surrounding ECM. Birbair et 
al. reported the presence of two pericyte subtypes in mice, type-1 (Nestin-GFP-/NG2-DsRed+) 
and type-2 (Nestin-GFP+/NG2-DsRed+), surrounding blood vessels in heart, lungs, kidneys,  
spinal cord, and brain (253). Type-1, but not type-2, pericytes increase and accumulate near 
the fibrotic tissue in all organs analysed (253). However, it remains unclear whether cardiac 
microvascular pericytes could lead to cardiac fibrosis following an ischaemic injury (254). Our 
group have previously identified a clonogenic population of CPs in the heart of patients with 
CHD and demonstrated that, after exposure to differentiation media, they acquired markers of 
VSMCs, but failed to differentiate into endothelial cells or cardiomyocytes (255). In a Matrigel 
assay, CPs form networks and enhance the network capacity of endothelial cells (255). 
Moreover, they produce collagen-1 and release chemo-attractants that stimulate the migration 
of c-Kit+ cardiac stromal cells (255). When seeded onto clinically approved xenograft scaffolds 
and cultured in a bioreactor, CPs showed the ability to penetrate into and colonize the graft 
(255).  Extending these findings, this study shows that CPs are capable of colonizing and 
remaining viable within gelatin nanofiber scaffolds. They also exhibited enhanced cell density, 
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proliferation and extensive spreading in the softer substrates with large fiber diameter, while 
maintaining their antigenic phenotype and stemness features.  
 
The elasticity of the scaffolds would have resulted in more focal adhesion points and hence 
favoured cell retention. The biomimetic nanofibrous structure, which resembles the native 
ECM, together with the porous structure favouring essential nutrients and gaseous exchange 
(218) and the gelatin’s ability to support cell adhesion and promote proteolytic degradation, 
(214) might also have helped CPs to remain viable and proliferate extensively on softer 
scaffolds. Cell proliferation capacity has been previously found to increase in response to 
microenvironment stiffening for other non-cardiac progenitor cell populations (256, 257). A 
study on ovine cardiac stromal cells showed elevated substrate stiffness increased cell 
proliferation (33). However, the elastic moduli examined in that study ranged from 18 to 145 
kPa, while the range studied here was 263 to 1000 kPa in the wet state. It was observed that 
proliferation decreased with the increase in stiffness. Altogether, this suggests that proliferation 
of cardiac stromal cells reaches its peak between 140 and 260 KPa. The reported elastic moduli 
of myocardium range from (7, 27). It is tempting to speculate that fibrotic remodelling of the 
heart might favour additional expansion of the stromal cell compartment.  
 
It has been reported that the proangiogenic capacity of human CP is associated with  the release 
of a number of angiocrine factors (255). In this study, it was found that seeding CPs on gelatin 
scaffolds increased their capacity to release VEGF-A into the medium. However, no effect of 
stiffness on the angiocrine secretome was found, except for an increased Ang-2 release when 
CPs were seeded in softer scaffolds. The Ang/Tie-2 pathway plays a crucial role in the 
paracrine cross-talk between the pericytes and endothelial cells. The tie-2 receptor is expressed 
by endothelial cells and activated by pericytes-secreted Ang-1, resulting in the induction of 
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survival, proliferation, migration, and anti-inflammatory signals. Ang-2 acts as a partial agonist 
of Tie-2, inhibiting Tie-2 signalling in the presence of Ang-1, but activating Tie-2 in the 
absence of Ang-1. Additional experiments allowing larger changes in stiffness are warranted 
to determine whether the angiogenic activity of CP can be modulated by manipulating the 
elastic moduli of the matrix. 
  
Changes in stiffness did not alter the differentiation capacity of CPs. However, a substantial 
accumulation and alignment of F-actin fibers in CPs on softer substrates with increased fiber 
diameter. This is in keeping with the theory that cells adapt their cytoskeletal organisation to 
the elastic modulus of the surrounding microenvironment (258, 259). Cytoskeletal contraction 
transfers traction forces back to the ECM. In this study, the higher elasticity and diameter of 
softer scaffolds might have provided focal adhesion points aiding the creation and alignment 
of F-actin stress fibers resulting in the actin polymerisation.  
 
5.2.   CONCLUSIONS 
 
This study resulted in the successful production of biomimetic gelatin nanofibrous scaffolds in 
a water solvent system with different matrix stiffness using an in situ cross-linking 
electrospinning method.  
 
The CLGS with a randomly oriented topography and that combine a matrix stiffness of 0.3 
MPa and ~400nm diameter, induced better CP adhesion, extensive cell spreading, proliferation 
and stress fiber formation. These data support the feasibility of modulating the behaviour of 
human cardiac stromal cells through the manipulation of mechanical characteristics of the 
substrate. The study has, however, some limitations. This study explored a narrow range of 
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matrix stiffness and also limited the observation to a relatively short-duration culture. Further 
studies are warranted to enhance the therapeutic potential of CPs through modulation of the 
accompanying matrix substrate for the corrective treatments of cardiac defects.  
 
5.3   FUTURE WORK 
 
With regards to continuing the work that has been presented in this thesis, further investigations 
can be made into the fabrication of scaffolds with other natural polymers (collagen, alginate, 
chitosan etc.) or synthetic polymers (PCL, PLLA, PEG etc.), or a combination of both, to obtain 
scaffolds with a wide range of matrix stiffness. In this work, the range studied was 263 to 1000 
kPa in the wet state. The reported elastic moduli of myocardium range from 18 to 60 kPa in 
normal myocardium and 55 to 295 kPa in fibrotic myocardium. Hence, it is worth investigating 
the effect of comparatively lower matrix stiffness in regulating CPs behaviour as changes in 
stiffness occur in the hearts, and arterial vessels of patients with congenital heart disease are 
regarded as one of the most common congenital anomalies in infants.  
 
Another point of research interest would be the characterization of nanofibers using AFM. In 
this study, an attempt to measure the Young’s Modulus of individual nanofiber specimens were 
made by utilizing the Peak Force Tapping Technology using a Multi-mode VIII AFM with 
Nanoscope V controller. It was found that the single fibers are accessible by AFM to measure 
the YM, but the values obtained were in a higher order of magnitude (GPa). The values 
obtained in the tensile testing of the fibrous scaffolds in this study were in the range of MPs, 
and hence the values attained for individual fibers using AFM was not reliable in terms of its 
higher order of magnitude and uniformity. This implies that the experimental design needs to 
be improved. Hence more AFM measurements with a greater number of samples are required 
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to justify this observation. Also, the AFM measurements using other probes such as colloidal 
probes serve as another potential approach to examine the YM of nanofibers.   
 
The anisotropic behaviour of CPs on softer substrates that was observed in one of the most 
confluent cell cultures is quite interesting to take forward that concept to further investigate the 
effect of nanofiber orientation on CPs fate. For example, when CP12 cell lines were seeded on 
scaffolds with low stiffness (2X), the CPs were found to be of highly aligned even if they were 
cultured on a randomly oriented nanofibrous structure. Hence it is crucial to analyse the effect 
of nanofiber orientation in stem cell behaviour by producing nanofibrous structures with 
different orientations.  
 
Further investigations with long-duration cell culture and with a more significant number of 
cell cultures are requisite for the better understanding of CPs behaviour in order to obtain the 
accurate knowledge of the therapeutic potential of CPs through modulation of the 
accompanying matrix substrate for the corrective treatments of cardiac defects. To address this, 
it may also be possible to target the cellular signalling pathways responsible for the 
mechanotransduction by utilizing molecular biology techniques and gene expression analysis 
using Polymer Chain Reactions (PCR). Further investigations can be carried out on how these 
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